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ABSTRACT 
Control of molecular motion is an important step towards the envisaged development 
of molecular scale devices and machines. A large amount of research has been 
documented regarding the control of molecular rotation and shuttling processes, but 
relatively few examples of control over nitrogen pyramidal inversion exist and so far 
no examples that require solely physical inputs such as light and heat have been 
reported. The first part of this thesis describes attempts to control nitrogen pyramidal 
inversion in aziridines and azetidines, using only light and heat to switch between 
two states with differing rates of inversion. Three avenues of research utilising 
anthracene photochemistry are discussed. The strategies employed include 
modifying ring strain by fused macrocycle formation; introduction of ring strain via 
small ring formation; and disruption of transition state stabilising hydrogen bonds 
through macrocycle formation. Finally, and more successfully, azobenzene 
photochemistry was used to modify a π-system adjacent to an aziridine nitrogen 
centre resulting in different inversion rates in the cis and trans azobenzene isomers. 
The experimentally derived inversion rates were supported by ab initio calculations. 
 
The second part of this thesis outlines attempts to develop photoactivated β-lactam 
antimicrobial agents. Two families of compounds were synthesised, based on amine 
linked bis-anthracene, and 2-pyridone isomerisations. Their antimicrobial activity 
was evaluated against B. Subtilis and E. Coli using the Kirby-Bauer disk diffusion 
method. One β-lactam produced by anthracene photodimerisation displayed modest 
activity against B. Subtilis. However, control experiments suggested the acyclic 
precursor possessed higher levels of antimicrobial activity.  
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1.1 Introduction 
1.1.1 Importance of Molecular Devices and Machines 
The greatest improvements in the productivity and standard of living for the human 
race have derived directly from the invention and subsequent development of novel 
devices and machines. For most of history this has focused around mechanical 
machines, however in more recent times the greatest advancements have come from 
the development of electronic devices and computer controlled machines. A device 
is defined as something which is created for a specific purpose, whilst a machine is 
any combination of mechanisms designed to utilize, modify, apply or transmit 
energy.
1
 This concept can also be applied on a molecular level as it is possible to 
arrange a number of molecular components in such a way that it gives the overall 
assembly a specific purpose such as reactivity, or can do useful work such as 
directional rotation or ratchet like movements.
1
 
 
The development of any molecular devices or machines faces adversity in the form 
of powerful random thermal Brownian motion and dominant viscous forces. The 
challenges to creating useful molecular devices often seem insurmountable, however 
evidence that it can be achieved is all around us in every biological system 
imaginable.
2
 Central to the development of these new devices is the control of many 
different modes of molecular motion which can be modified by external inputs and 
applied in a way to fulfil a useful function. 
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1.1.2 Application of Molecular Devices and Machines 
If developments in electronic devices are to continue, the power of computer 
processors and memory density must correspondingly increase.
3
 Currently, all of 
these devices are silicon based and comprise of millions of individual transistors that 
are created on single crystals of silicon using nano lithography techniques. These 
production methods continue to evolve and the size of the transistors that can be 
produced has fallen as low as 22 nm, allowing 1.4 billion transistors to be fitted on 
an area of only 160 mm
2
.
4
 However, current methodology can only go so far before 
the classical mechanics of bulk materials become overshadowed by quantum 
mechanical properties of small dimensions and the systems fail to function.
5
 
 
Small molecules are measured in the order of Ångströms, which are many orders of 
magnitude smaller than current transistors. If molecules could be created which 
allowed for a reversible transformation between two stable states that could be easily 
differentiated, then a molecular transistor or switch could be created.
6
 
 
Hope also lies in the ability to synthesise molecules capable of doing mechanical 
work in the same way as macroscopic machines.
7
 The control of molecular motion, 
such that there is control of direction, amplitude and rate of movement rather than 
random Brownian motion, is crucial in this application.
8
 Particular attention has been 
paid to molecules which can contract and expand in the hope that synthetic muscles 
can be synthesised. Directional control of rotation, to form motor like molecules, and 
meshed rotors, which provide gearbox like functionality, are important steps towards 
molecular machines. However, fundamentally, all of these systems require some 
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form of switching mechanism that allows control between the different states of 
motion.
7
 
 
1.1.3 Literature Examples 
1.1.3.1 Small Molecules 
There are numerous examples of configurational changes in small molecules, some 
of which are shown in Figure 1.1. These can take the form of a wide variety of 
transformations, from ring formations to isomerisations but, importantly, they must 
be stable in two or more different configurations and the interconversion must be 
reversible. A great benefit of these simple small systems, is that it is commonly 
possible to achieve this without the use of chemical reagents, as many systems can 
be controlled using physical inputs such as light and heat. Amongst the most 
common examples, is double bond cis-trans isomerisation. Whilst the amplitude of 
the motion is often not significant enough for use as a molecular machine on their 
own, they offer excellent photoactive handles for use as molecular switches, or as a 
control receptor in larger molecular machines.
9
 These are some of the most studied 
systems, with stilbenes having been investigated for over 55 years,
10
 and commonly 
display distinct physical changes between states such as colour changes. 
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Figure 1.1. Common photochromes used extensively as molecular switches and other devices, figure 
reproduced from Angewandte Chemie Int. Ed.
7
 
 
These compounds have been used in many applications which rely on changes to the 
3-dimensional structure and, when used to control the shape of larger molecules, the 
rather insignificant motion of the subunit is amplified over the much larger molecule. 
Often these molecules are used as part of larger switching systems based on binding 
or interlocked systems. The small molecule fragment is used as the photochrome 
switch which changes the tertiary shape of a larger molecule, turning a binding or 
shuttling process on or off.
11
 Gust et al
12
 has taken the simple molecular switching 
properties of these small molecules and, by covalently linking them to other 
chromophores in a fashion which allows either electron or energy transfer, has 
turned them into much more complicated molecular logic operators with many more 
potential states.  
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Azobenzenes in particular have been put to great use in a wide variety of 
applications. Koshima et al
13
 have shown that whilst the amplitude of the 
isomerisation motion may be small, it has a significant effect on crystal packing. 
They irradiated the (001) face of large, thin platelet crystals of trans-4-
(dimethylamino)azobenzene which had one end fixed to a glass substrate. 
Observations using a CCD microscope showed the crystals bending away from the 
light source and then returning to their original position a few seconds after 
irradiation ceased. Importantly, this could be repeated hundreds of times with no 
detrimental effect on the crystal (Figure 1.2). 
 
 
Figure 1.2. Bending a crystal using the isomerisation of azobenzenes, the process can be cycled many 
times as demonstrated by Koshima et al, figure reproduced from the Journal of the American 
Chemical Society.
13
 
 
These small molecule fragments have also been used to create biological switches, 
where the activity of important biological molecules can be turned on or off.
14
 As 
biological systems are widely regarded as being the most advanced form of 
molecular machines and devices, the ability to gain control over these highly evolved 
molecular systems is a significant step forward. Many examples incorporate 
azobenzenes or spiropyrans into existing biological molecules, and the new 
molecules are initially tested to ensure the modification has not disrupted the 
bioactivity. The switching of the photochrome is then expected to significantly alter 
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the tertiary structure of the molecule so that it is no longer able to partake in the 
necessary binding interactions to fulfil its biological role.
11,15
 
 
Control of bond rotation has been an area of great interest due to the obvious 
similarities with mechanical motors. There are many examples of bond rotations, in 
fact almost all single bonds are freely rotating. The great difficulty comes from 
controlling this so that there is specific directional control above the random thermal 
motion. This motion is common in biological systems
16
 but surprisingly hard to 
reproduce synthetically. The first example of this by Feringa et al
17,18
 requires four 
isomerisations using ultraviolet light and heat in order to complete 360
o
 of rotation 
(Scheme 1.1). The axial chirality and two chiral centres were found to be 
instrumental in the directional control of the rotation. Isomerisation of the alkene 
allows for rotation through 180
o
, and a thermally controlled helical inversion allows 
continued rotation, preventing rotation in the wrong direction. 
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Scheme 1.1. Feringa’s uni-directional switch requires four steps to complete one 360o rotation, 
scheme reproduced from Nature.
18
  
 
There are some examples of small molecule switches being applied to surfaces in 
order to reversibly alter the surface properties on demand. A notable example is the 
alteration of the wetting properties of glass surfaces using spyropyrans. The contact 
angle of water droplets was measured on glass surfaces before and after irradiation 
with UV light. After irradiation with UV light, the contact angle was found to 
decrease by 14
o
 as the surface wetted easier, whilst irradiation with visible light 
returned the glass to its original properties.
19
 Self-assembled monolayers of rigid 
azobenzenes on gold surfaces have been used in a number of devices. Ferri et al
20
 
have used conducting azobenzenes between two electrodes as a photocontrolled 
current switch, since the distance between the terminus of the molecule and the 
electrode can be changed by the cis to trans isomerisation (Figure 1.3).  
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Figure 1.3. Ferri demonstrates the use of azobenzene isomerisation as an electronic transistor, figure 
reproduced from Angewandte Chemie Int. Ed.
20
 
 
1.1.3.2 Interlocked Systems 
The control and application of motion to interlocked supramolecular systems has 
seen massive progression in recent years.
21
 Developments in synthetic techniques, 
the stability, and the flexibility of these systems has made them very popular targets 
for a variety of applications.
22
 Rotaxanes are molecules where a threaded cyclic 
“ring” molecule is trapped on a linear “axle” by bulky terminal stopper groups, but is 
not connected to the axel by covalent bonds. Catenanes are compounds comprised of 
two mechanically interlocked ring systems. Both of these have been put to great use 
as examples of controlled molecular motion and as molecules capable of doing 
useful work. Shuttling processes in both of these systems are the crucial motif, and 
dominate their use in these systems.
23
  
 
Shuttling is brought about by engineering two or more segments of the linear axle 
molecule, where there is a stabilising interaction with complementary functional 
groups on the captive ring molecule. In many cases the interaction of the sites with 
the ring is similar, but there is a small barrier between the lower energy positions 
which leads to degenerate rotaxanes where both states are equally populated. If it is 
possible to alter the strength or favourability of the ring’s interaction with one or 
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 21 - 
 
other of the binding sites using any external stimuli, be that chemical or physical, 
then the molecule becomes a molecular switch (Figure 1.4). However, due to the 
larger size of these molecules and their very mechanical nature, the application of 
these molecules has developed far beyond simple switching systems. The 
applications of this control of molecular motion are very broad and seemingly only 
limited by the imagination of their inventors. 
 
 
Figure 1.4. If the interaction between the macrocycle and axle site can be modified or blocked, it 
becomes possible to modify the potential energy surface forcing the bulk of the molecules to switch 
site positions. Figure reproduced from the Journal of Materials Chemistry.
24
 
 
Examples of molecules that exhibit muscle and lift like motion have been 
demonstrated in solution, which requires the use of chemical inputs.
25-27
 These are 
most commonly operated by changes in solution pH and have proven to be very 
effective. Similar systems exist that do not require chemical inputs but are instead 
controlled by physical inputs such as light
28
 and electrochemistry.
29
 However, due to 
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 22 - 
 
increased complexity in design, their function is commonly not as advanced as in 
chemical-based systems.  
 
The most significant advancement with interlocked systems has come from the 
ability to arrange them on surfaces, which has been used in many applications to 
functionalise surfaces, achieve useful work and alter bulk properties. Berná et al
30
 
have shown great ingenuity by using a simple photo-promoted shuttling rotaxane to 
modify the hydrophilicity of the surface. A self-assembled monolayer of 11-
mercaptoundecanoic acid on a Au(111) surface was coated with the rotaxane, which 
was held in place by a hydrogen bonding interaction with the carboxylic acid of the 
monolayer. One station is fluorine rich with a weak interaction with the ring. 
However, there is a stronger interaction with the fumaramide subunit, causing the 
fluorine rich zone to be exposed. Irradiation with UV light causes a 50% 
isomerisation of the fumaramide to maleamide, which has a very poor binding 
affinity for the ring. This causes 50% of the molecules to shuttle to the fluorine zone, 
causing an increase in hydrophilicity of the irradiated area. By irradiating the area 
along the leading edge of a liquid droplet, it was possible to encourage the droplet to 
move in that direction. Using this technique it was possible to move a 1.25 µL liquid 
droplet of diiodomethane along a surface and even up gradients of 12
o
. 
 
Mimicking the action of biological muscles with molecular machines has always 
been of great appeal as it relates so closely with the action of the human body. 
Whilst creating interlocked systems which are able to resemble some macroscopic 
movements has been successful, the action of a muscle requires directional 
orientation and complex attachment to a surface. This has been demonstrated by Liu 
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and co-workers in the form of a linear controlled muscle, based on a rotaxane 
(Figure 1.5).
31
 
 
 
Figure 1.5. A symmetric rotaxane where the two rings are bonded to a gold surface by the thiol 
linkers. Redox chemistry can be used to shuttle the rings which causes a contraction to occur. Figure 
reproduced from the Journal of the American Chemical Society.
31
 
 
Figure 1.5 illustrates how the muscle works. Redox chemistry controls which site is 
preferred, the rings are tethered to a gold surface in the extended position and when 
the rings move to the alternate position, this forces a contraction of the muscle. This 
has been successfully demonstrated on a very thin gold cantilever where one side 
was coated with a layer of this compound. Activation resulted in a measurable 
deflection of the cantilever. 
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1.1.4 Challenges 
There are a number of challenges faced by molecular scale systems and one of these 
relates to the stability and reactivity of individual molecules. Commonly, the bulk is 
what is measured, with the results and compound stability coming from a statistical 
analysis of a very large number of molecules. Researchers have worked around this 
by using relatively small matrices of molecules and taking results from the average 
output of the matrix.
32
 
 
A large amount of progress has occurred over the last 20 years. Many of these 
literature examples have demonstrated how chemists are now able to design and 
synthesise highly innovative molecular systems. The design of compounds which 
allow for the control of molecular motion has become more advanced, however the 
next step needs to be taken to integrate the molecules into more complex 
environments. Attachment of molecular devices to bulk materials to do useful work 
can be difficult. Control over their orientations so that they are ordered allows the 
molecular motions to be combined, causing a macroscopic effect.  
 
Finally, many systems reported so far are dependent on the addition of chemical 
reagents, or “fuel”, to switch between states. This causes a large amount of waste, 
but also limits the number of possible cycles before samples either become too 
diluted or degradation occurs. Ideally, the use of physical inputs is attractive, 
potentially allowing endless cycling and also allowing the systems to be taken out of 
solvent so that they become easier to implement into solid-state devices.  
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1.1.5 Pyramidal Inversion 
Much of the recent published research has been directed at controlled rotation around 
atomic bonds and supramolecular interactions, such as rotating rings and shuttling 
processes. Very little effort has thus far been put towards control of the lever like 
motion of nitrogen pyramidal inversion. If a tricoordinate molecule exists in a non 
planar ground state, it becomes theoretically possible that it can exist in two distinct 
geometric configurations (Scheme 1.2). These configurations are then 
interchangeable by transposition of the substituents to the opposite side of the central 
atom, thereby forming a mirror image of the original molecule. This process is given 
the name pyramidal inversion, from the pyramidal shape of the molecules involved 
and the fact that the net result is inversion of the stereochemistry at that centre. 
Whilst there are many possible mechanisms by which this process may occur,
33
 
those of interest here do not involve the making and breaking of atomic bonds, nor 
excitation from the electronic ground state. 
 
 
Scheme 1.2. Nitrogen Pyramidal Inversion. 
 
There are two competitive modes by which pyramidal inversion can proceed. A 
classical vibrational pathway proceeds through a planar transition state, the rate of 
which is dependent on the relative populations of vibrational energy levels above and 
below the potential energy barrier to inversion. By non classical methods, inversion 
is believed to occur via quantum mechanical tunnelling from one side of the 
activation barrier to the other. In practice, for pyramidal inversion this pathway only 
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becomes significant when one of the substituents of the central nitrogen atom is 
hydrogen or deuterium, and at temperatures where vibrational energy levels within 6 
kcal mol
-1
 are heavily populated.
33
 In the context of the research described in this 
thesis, it is assumed that the classical vibrational pathway is dominant and that where 
inversion rates between systems are compared, the quantum mechanical rate 
contribution remains consistently small due to the substituents remaining constant 
and of significant mass. 
 
The research in this thesis is focused on systems where nitrogen is the inversion 
centre. Nitrogen pyramidal inversion, also called “umbrella motion”, has been the 
subject of much experimental and theoretical investigation since it was first observed 
in 1929.
34
 The process derives from the rapid oscillation of the lone electron pair in 
trisubstituted amines through the X, Y, Z, plane resulting in the formation of the 
opposite enantiomer (Scheme 1.2). Due to the low barrier to pyramidal inversion, the 
process takes place rapidly at room temperature for ammonia and other simple 
amines. The nature of the X, Y and Z substituents can greatly affect the rate of this 
process through a number of different mechanisms. 
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1.1.6 Rate Controlling Factors in Pyramidal Inversion
33,35,36
 
1.1.6.1 Isotope Effects 
Substitution of the inversion centre with many different isotopes has been shown to 
have no significant effect on inversion rates. Similarly, isotope substitution on large 
groups such as CH3 to CD3 also made no measurable difference to inversion barriers. 
However, when an NH aziridine was compared with an ND aziridine, the activation 
energy was found to increase by 3 kcal mol
-1
.
33
 This difference is due to the 
significant proportion of inversion due to tunnelling in NH aziridines, because the 
probability for a particle to tunnel into the classically forbidden region declines 
exponentially with the mass of the particle. The doubling in mass between hydrogen 
and deuterium is the most significant change in mass between isotopes of the same 
element and is one of the few examples where the mass of the substituent is low 
enough to make quantum mechanical tunnelling significant. 
 
1.1.6.2 Strain Effects 
There are two significant strain effects to consider. When two of the substituents are 
connected to form a ring, there becomes a discrepancy between the actual and ideal 
bond angles. Little strain is observed in six membered rings, however, as the rings 
get larger or smaller, the strain increases as deviation from the ideal bond angle 
increases.  
 
If the inverting atom forms part of a small ring, the resulting ring strain is greater in 
the transition state than in the ground state. This is due to a greater deviance from the 
desired bond angle (Figure 1.6). In aziridines the bond angle is constrained to 60
o
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and, as the nitrogen hybridization changes from sp
3
 (107
o
) to sp
2
 (120
o
) in the ground 
state and transition state, the deviation from the ideal angle increases. This 
destabilizes the transition state relative to the ground state, making the activation 
energy larger and therefore the inversion rate slower. 
 
 
Figure 1.6. Bond angles. 
 
Steric strain is also an important factor. Non-bonding repulsions can cause either 
acceleration, or slowing of inversion, depending on whether the interaction is 
strongest in the ground state or transition state. Most commonly, steric interactions 
in the ground state are observed when the Van der Waals volume of the inverting 
substituent becomes larger. These interactions are relieved somewhat in the sp
2
 
transition state due to the increased angular separation (Scheme 1.3). The non-
bonding interactions in the ground state increase its energy relative to the transition 
state, thereby lowering the activation barrier. Occasionally, more distant sectors of a 
molecule may sit in the same plane as the inversion transition state, causing the same 
but opposite effect as a result of steric strain in the ground state (Scheme 1.3). 
 
 
Scheme 1.3. Left, steric crowding in the ground state. Right, steric destabilisation of the transition 
state.
33
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1.1.6.3 Conjugative Interactions 
A molecular π-orbital on a substituent attached to the inverting centre allows for 
conjugation of the nitrogen’s lone pair. In the ground state, the lone pair occupies an 
sp
3
 orbital whereas in the transition state the lone pair sits in a pure p-orbital. The 
overlap of the π-orbital and the p-orbital is much better than with the hybridized 
orbital, allowing for greater conjugation and therefore increased stabilization of the 
transition state compared with the ground state (Figure 1.7). This effect is strongest 
when the substituent is –COR, –NO or –NO2 because the orbital energy overlap is 
greatest.
33
 
 
 
Figure 1.7. Stabilization of the transition state by increased resonance. 
1.1.6.4 Inductive Effects 
Replacement of a nitrogen substituent for a more electronegative one results in an 
increase in the free energy of activation. This is demonstrated in the series shown in 
Figure 1.8. An increase in s character of the hybridized non-bonding orbital in the 
ground state causes stabilization. As the transition state lone pair rests in a purely p 
orbital, no stabilization can be obtained.
33
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Figure 1.8. The effect of induction on pyramidal inversion.
33
 
 
1.1.6.5 Bonding and Complexation 
Association of the ground state lone pair in coordination or bonding interactions 
retards inversion. Commonly, this causes inversion to halt when a strong bond is 
formed, such as protonation of the nitrogen atom. Because the stabilizing interaction 
must be broken before inversion can occur, the barrier rises by a similar amount to 
the strength of the bonding interaction (Figure 1.9). Similarly, any bonds formed in 
the ground state that will impart additional strain reaching the transition state or 
opposite invertomer, will raise the barrier to inversion. 
 
 
Figure 1.9. Ground state stabilization through lone pair interactions. 
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1.1.7 Inversion Rate Determination
33,37-39
 
The ring strain inherent in small rings causes an increase in the activation energy of 
inversion, due to additional ring strain energy when progressing from the sp
3
 ground 
state to sp
2
 transition state. This is very important as it slows the rate of the inversion 
process to such an extent that it becomes similar to the NMR time scale, allowing the 
rate to be probed using variable temperature NMR techniques. Three different 
methods have been developed to extract rate data from VT-NMR spectra, and all of 
them have been shown
40-42
 to provide reliable data as long as some requirements are 
met for each method. Where possible, a combination of these methods is used to 
further validate the results and assist with error analysis. 
 
1.1.7.1 Coalescence Temperature Calculations 
The quickest and simplest method requires knowing only the fully resolved signal 
separation and temperature at which the signals coalesce. Using Equations 1.1 and 
1.2, the rate and activation barrier of the process can be calculated at the coalescence 
temperature. Under ideal conditions, this method has been shown to yield very 
accurate data, however, there are a number of requirements. There must be no 
contaminant or interfering signal between those being studied as this adds 
uncertainty with respect to the determination of the coalescence temperature. It must 
also be possible to reach a temperature where the separated signals are fully resolved 
in order to determine the maximum signal separation. The two species being studied 
must also have equal populations and the signals must be uncoupled. This method 
has been used on hydrogens which are coupled, but this can only be assumed to yield 
an approximation as one of the simplifications that yields this equation is that the 
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signals are not coupled. Unfortunately, one of the major drawbacks of this method is 
that it is only possible to calculate the rate and ∆G‡ at the coalescence temperature. 
This is because there is no way of extracting ∆H‡ and ∆S‡ using this method and 
therefore it cannot be corrected to a standard temperature such as 298 K or the same 
coalescence temperature of another compound. Because of this, comparisons must be 
made with care. If ∆S‡ is small, as might be expected in a unimolecular inversion 
process, then comparisons can be made as the T∆S‡ term should have a negligible 
effect on ∆G‡.  
 
Equation 1.1. Rate at coalescence 
Where : k is the rate constant in s
-1
 and υAB is the separation in Hz of the exchanging signals A and B. 
Equation 1.2. ∆G‡ at coalescence 
Where ∆G‡ is the Gibbs free energy of activation, R is the gas constant, Tc is the coalescence 
temperature in Kelvin and ∆v is the shift separation in Hz of the fully resolved exchanging signals. 
1.1.7.2 Complete Line Shape Fitting 
When signals begin to exchange on a time scale similar to that of an NMR 
experiment, they start to broaden due to Heisenberg uncertainty broadening. The 
additional broadening of the signals has a direct relationship with the rate of the 
exchanging spin states. The half height, half width is needed for the calculations, as 
shown in Equations 1.3 and 1.5, from which the reference broadness is subtracted. 
This is almost impossible to accurately measure manually from the multiple NMR 
spectra required. The most reliable technique is to generate spectra based on these 
parameters until it is possible to map the generated signal onto the real spectra. This 
is called line shape fitting and the values used to generate the simulated signal can 
then be used in the relevant equations to extract the activation parameters.  
ABk 

2

)]ln(23[‡


Tc
RTcG
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Equation 1.3. Below coalescence 
 
Equation 1.4. At coalescence 
 
Equation 1.5. Above coalescence 
Where: k is the rate constant in s
-1
, ∆v peak width at half height of exchanging singlet in Hz, ∆vref 
peak width at half height of non exchanging singlet in Hz, vAB is the fully resolved peak separation of 
exchanging signals A and B in Hz. 
  
Importantly, because the fitting can be done over a wide range of temperatures, it is 
possible to extract ∆H‡ and ∆S‡ using an Eyring plot (Equation 1.6), which can then 
give ∆G‡ at any temperature (Equation 1.7). The primary benefits of this method are 
that full activation data can be extracted and, due to the large number of values 
taken, greater confidence can be placed in the results. As this method is not 
dependent on the coalescence temperature, it can be used when the coalescence 
temperature may be partially obscured by similar signals. However, as the position 
of υA and υB are still required, sufficient datapoints are still needed in the slow 
domain to predict their positions at higher temperatures.  
 
Equation 1.6. 
 
Equation 1.7. 
Where: k is the rate constant in s
-1
, T is the temperature in Kelvin, kB is the boltzman constant, h is 
planks constant, R is the gas constant, ∆G‡ is the Gibbs free energy of activation, ∆H
‡
 is the enthalpy 
energy of activation, ∆S‡ is the entropy of activation. 
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1.1.7.3 EXSY Spectra 
If two NMR signals are undergoing exchange on a time scale similar to T1 of the 
NMR experiment, then it is possible to gather quantitative rate data using the EXSY 
(EXchange SpectroscopY) experiment. One of the signals is selectively saturated 
and then the spectra observed after the delay period. If the signals are exchanging 
within this time domain, then enhancement of the other signal is observed. This 
looks similar to NOE experimental data, however, the physical process is completely 
different because NOE experiments saturate a signal, which allows T1 relaxation 
through dipole – dipole interactions of other hydrogens close in space. In EXSY 
spectra, it is the excited hydrogen switching spin state during the delay period which 
causes enhancement. The intensity change, in conjunction with the delay time, 
allows the rate of the process to be measured. This experiment can be done over a 
range of temperatures which allows the same thermodynamic data to be obtained as 
with line shape fitting. 
 
1.1.8 Control of Pyramidal Inversion using Chemical Inputs 
Previous research at Warwick has shown that control over nitrogen pyramidal 
inversion is possible with external chemical inputs, through investigation of a 
number of aziridine and azetidine based systems. Small nitrogen rings are ideal to 
study as the ring strain slows the rate of inversion such that it is similar to the NMR 
time domain. Aziridines and azetidines are also well studied, with a large body of 
research on which to draw for the synthesis of the target systems.
43,44
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1.1.8.1 Hydrogen Bonding System 
Shipman has previously shown that the rate of inversion can be reversibly controlled 
by turning a ground state hydrogen bond with the aziridine nitrogen on or off. 
Naphthoquinone 16 was synthesized and the inversion barrier measured using VT 
NMR. Reduction to the hydroquinone yielded a hydrogen bond donor in close 
proximity to the aziridine hydrogen bond acceptor (Scheme 1.4). When the inversion 
barrier was measured for 17 under the same conditions, the inversion barrier was 
found to have risen 11 kJ mol
-1
. This value is in line with the expected strength of a 
hydrogen bond, reaffirming the assumption that the hydrogen bond must be broken 
before inversion can occur. This process could be cycled numerous times by mild 
oxidation and reduction, however the continued addition of chemical reagents 
eventually caused dilution and degradation. This system allows one to indirectly 
measure the strength of hydrogen bonds in situ and non-destructively.
45
  
 
 
Scheme 1.4. Redox control of nitrogen pyramidal inversion.
45
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1.1.8.2 Metal Binding System 
If nitrogen pyramidal inversion could be slowed by a hydrogen bond interaction, 
then the next logical step was to use a stronger bonding interaction which would 
completely halt inversion (Scheme 1.5). Compound 18 was developed as a bidentate 
ligand for metals and a number of metal salts were then screened. [PdCl2(MeCN)2] 
was found to have the strongest interaction. Repeated cycles involving addition of 
metal and competitive phosphine ligand, allowed the inversion process to be stopped 
and restarted several times. Again, after a few cycles, the addition of supplementary 
chemicals caused degradation of the system.
46
  
 
 
Scheme 1.5. Control of pyramidal inversion using lone pair metal binding.
46
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1.1.8.3 Transition State Hydrogen Bonding  
Compound 20 was designed to form a hydrogen bond between the pyridyl hydrogen 
bond acceptor and the amide hydrogen bond donor. Unexpectedly, the inversion 
barrier measured was actually lower in the hydrogen bonding system than in a 
control system 21, incapable of hydrogen bonding. A double mutant cycle was used 
to ensure that the structural modifications were not responsible for changes to the 
inversion barrier. Detailed computational modelling identified that the only viable 
hydrogen bond was between the amide NH and pyridyl nitrogen. However, this 
could only occur in the transition state and not in the ground state (Scheme 1.6). This 
causes stabilization of the transition state relative to the ground state and therefore a 
reduction in the inversion barrier. This is remarkable as it is one of the few examples 
of synthesized small molecules which allows for controlled, measurable interactions 
with a transition state.
47
 
 
 
Scheme 1.6. Hydrogen bond only detected in TS by change to inversion barrier and supported by ab 
initio calculations. 
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1.2 Results and Discussion 
1.2.1 Introduction 
Small, strained nitrogen rings such as aziridines and azetidines are ideal subjects 
with which to study nitrogen pyramidal inversion because their inherently high ring 
strain energy slows the inversion rate sufficiently to be measured by VT-NMR 
techniques.
46
 Our research group has developed a large amount of experience in the 
organic synthesis and application of complex strained nitrogen ring systems.
48,49
 We 
have previously had success developing systems along these lines where nitrogen 
inversion can be controlled using chemical inputs.
45-47
 Our aim with this project was 
to extend this knowledge to the design and synthesis of systems which will only 
require physical inputs such as light and heat to alter rates of pyramidal motion. 
 
To respond to these physical inputs, several design criteria are needed. Firstly, the 
ability to modify one of the fundamental properties that affect inversion rates, such 
as angular constraint and orbital hybridization. Secondly, a photochemical “handle” 
is required which, when activated, will cause a reversible change to the above 
properties. The systems we chose to study are based on the well-established 
photodimerisation of anthracene, and separately the photoisomerisation of 
azobenzenes. Specifically, the heterocyclic systems 22 – 29 (Scheme 1.7) were 
targeted whose rate of pyramidal motion might respond to light through dimerisation 
(22 – 27) or isomerisation (28 – 29). Fuller details of what led to the selection of 
each system is described in the following sections. 
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Scheme 1.7. The systems chosen for study. 
 
1.2.2 Ring Strain Induced by Macrocycle Formation 
We postulated that when a small secondary macrocycle is fused with a nitrogen 
heterocycle, the degree of angular strain in the heterocycle would increase due to a 
greater deviation from the ideal bond angles.
50
 This small change in ring strain 
energy was expected to have a significant effect on the rate of pyramidal inversion, 
as it is extremely sensitive to this parameter.
51
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We were interested in forming a secondary macrocycle on the lower portion of the 
aziridine ring, between the two carbon substituents. Anthracene has previously been 
used to photochemically form macrocycles that can be broken by a thermal reverse 
reaction.
52
 Therefore, we decided to incorporate two anthracene moieties into the 
molecule which would allow control over macrocyclic formation using physical 
inputs. We focused on the synthesis of compounds related to 22 that fulfil a number 
of further criteria. The compound is symmetric to ensure equal invertomer 
populations, which simplifies calculation of the inversion barrier. We chose to use 
the dimerisation of anthracene as a photochemical means of forming the macrocycle, 
as the reaction is reversible and it has been successfully applied in similar 
contexts.
52-54
 
 
1.2.2.1 Anthracene Photochemistry 
Anthracene photodimerisation was amongst the first observed photochemical 
reactions in 1867.
55
 It was noted that incident solar radiation on a saturated solution 
of anthracene in benzene resulted in the formation of microscopic crystals coating 
the sides of the vessel. The crystals were found to be inert but almost insoluble in 
organic solvents. Remarkably it was observed that these crystals reverted entirely to 
their original state thermally (Scheme 1.8). It was later shown that the crystals were 
an anthracene dimer which did not retain the fluorescent properties of anthracene and 
was formed by a photoinduced [4π+4π] cycloaddition, which was possible due to the 
low aromatic nature of the central anthracene ring.
55
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Scheme 1.8. Anthracene dimerization. 
 
The use of anthracene as a photochemical means of controlling molecular and 
biological properties has been previously demonstrated.
52,54,56
 Anthracene would 
appear to be an ideal photochrome for our studies on pyramidal inversion as its 
photochemistry has been well studied,
57,58
 thus aiding in the design and synthesis of 
molecules which fulfil our requirements.  
1.2.2.2 Towards the Synthesis of Macrocyclic Precursor 22 
Ether 33 was synthesised using a known procedure
59
 and isolated in 50% yield. 
Dimerisation of this alkene was achieved by intermolecular Grubbs olefin metathesis 
leading to 34 in 59% yield as an inseperable 3:1 mixture of trans and cis isomers, the 
assignment of which was based on comparison to literature 
1
H NMR values of 
related compounds (Scheme 1.9). Grubbs first generation catalyst provided a clean 
reaction, as long as reaction temperatures did not exceed 55 
o
C, presumably because 
higher temperatures can deactivate the catalyst through vessel wall reactions.
60,61
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Scheme 1.9. Synthesis of 34. 
Next, we wanted to undertake direct aziridination of olefin 34. Metal-catalyzed 
direct aziridination of alkenes by nitrenes is a reaction that has received a large 
amount of interest and seemed well-suited to our needs.
62
 PhINTs is a well-
documented nitrene source,
63,64
 which shows high levels of stereoselectivity. Using 
PhINTs as the nitrene source, it is possible to aziridinate substrates such as styrene 
and trans-stilbene in CH2Cl2 under mild conditions.  
 
The PhINTs reagent has a number of limitations. It must be prepared, using a low 
yielding laborious process, immediately prior to the reaction as PhINTs displays 
poor stability. PhINTs is hard to characterize, so to ensure the synthesised PhINTs 
was of sufficient quality, concurrent aziridinations of styrene were run as controls. 5 
eq of the olefin are typically required and with only limited quantities of 34 available 
we were unable to fully explore this reaction. However, using reported conditions, 
the reaction proved unsuccessful (Scheme 1.10).  
 
 
Scheme 1.10. Attempted aziridination of 34. 
 
A closely related method has recently been established,
65
 which addresses a number 
of these problems. 36 was successfully synthesised using the reported procedure in 
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29% yield. Whilst the use of acetonitrile as the solvent worked in this instance, 
experience has shown that it is ineffective in anthracene systems due to their poor 
solubility in polar solvents. CH2Cl2 has proven to be a good solvent choice for 
anthracene systems and therefore the reaction was repeated in CH2Cl2. Surprisingly, 
the yield of this reaction was increased to 36%, possibly due to the improved 
solubility of the aromatic compounds (Scheme 1.11).  
 
 
Scheme 1.11. Aziridination of trans-stilbene. 
 
Whilst the yield of this transformation is lower than with PhINTs, the nitrenoid is 
produced in situ, removing the need for a separate synthesis. This reaction also only 
requires 1.2 equivalents of olefin, making it much more appropriate for use within a 
multi-step synthesis. Olefin 34 was exposed to these modified aziridination 
conditions in the hope of yielding the N-sulfonyl aziridine 37. Unfortunately, 
aziridination of 34 using these modified in situ conditions were unsuccessful, 
resulting only in recovery of unreacted starting material.  
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Scheme 1.12. Attempted aziridination of 34. 
 
We made further attempts to functionalize the central alkene of 34 using a range of 
reactions which would introduce functionality that could eventually lead to aziridine 
ring formation (Scheme 1.13). Attempts to brominate 34 resulted in decomposition 
with no trace of bromine addition. mCPBA epoxidation and Upjohn dihydroxylation 
were also unsuccessful, with only starting material being recovered. 
 
 
Scheme 1.13. Attempted functionalization of 34. 
 
1.2.2.3 Synthesis of Macrocyclic Precursor 44 
An alternative strategy to 22 was considered. We decided to preform the aziridine 
nucleus and introduce the anthracene groups later in the synthesis. Using well-
documented procedures,
66,67
 diol 43 was produced in 6 steps (Scheme 1.14). 
Treatment of 43 with NaH in DMF, followed by addition of 9-
(bromomethyl)anthracene yielded 48 in 48% yield, providing a substrate with which 
to explore how macrocyclisation might impact pyramidal motion. 
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Scheme 1.14. Synthesis of 44.
66-68
 
 
The photodimerisation of this compound was investigated in collaboration with 
James Tucker at the University of Birmingham. A small amount of 44 (0.28 µM) in 
CH2Cl2 was extensively degassed by freeze pump thaw cycles under high vacuum. 
This oxygen-free solution was then irradiated with a 125 W medium pressure Hg 
lamp through a coated glass band-pass filter centred on 365 nm ± 2 nm 
(Edmundoptics P/N: NT65-130). A range of reaction times (30 min – 4 h) were 
investigated, but unfortunately all attempts to photodimerise 44 resulted in 
degradation (Scheme 1.15). Even though the solvents were extensively degassed, 
during the longer reaction times, oxidation of the anthracene rings to anthraquinone 
was observed, along with fragmentation of the compound. This illustrates the 
sensitivity of anthracene photochemistry to oxidation, and the destructive effect this 
has on the molecules.
69
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Scheme 1.15. Attempted photoisomerisation of 44. 
 
We were concerned that the aziridine ring might be the origin of the photochemical 
instability. To test this idea, aziridine 42 and anthracene were dissolved in benzene. 
Irradiation under the same conditions used previously, produced anthracene dimer 
and recovered aziridine 42, as judged by 
1
H NMR, indicating that aziridines are 
stable under these conditions. There are a number of reports
70
 to suggest that benzyl 
groups can cleave and rearrange under high energy UV conditions. Successful 
alkylation of NH aziridine 41 has been reported only using benzyl bromide and ethyl 
iodide, with numerous other electrophiles reported to be ineffective.
67
 Therefore 
alkylation of aziridine 41 with ethyl iodide was investigated. Alkylation of 41 with 
ethyl iodide, freshly filtered through alumina, yielded 46 in 32%. Reduction with 
lithium aluminium hydride was found to be extremely problematic, with extraction 
of diol 47 from the aluminium salts formed during the workup proving very difficult. 
Repeated sonication of these salts with diethyl ether allowed 47 to be extracted, 
however, the yield remained low (49%).
71
 Further alkylation of diol 47 was 
achieved, providing 48 in a very modest 15% yield (Scheme 1.16).  
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Scheme 1.16. Synthesis of 48. 
 
The photochemical experiments were carried out using the same methods as for 
compound 44 (Scheme 1.15) with the assistance of James Tucker and Luciana 
Giordano at the University of Birmingham. Disappointingly, degradation of 48 was 
again seen, even when photoirradiation was limited to 30 minutes. Presumably 44 
and 48 are not able to access a conformation where it is possible for the two 
anthracene rings to align and isomerise to form the macrocycle once in a 
photoexcited state. This may be because the macrocycle to be formed is rather small. 
However, if the size of the linking arms was increased to help allow the 
photochemical reaction to proceed, it is doubtful any significant increase in aziridine 
ring strain would arise, and hence no detectable change in the nitrogen inversion rate 
would be observed.  
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1.2.2.4 Forming Macrocycles via Grubbs Metathesis 
The synthesis and purification of the anthracene systems was difficult, primarily 
because of the poor solubility of the compounds. We wished to verify the effect of 
macrocycle formation on the rate of pyramidal inversion on a simpler synthetic 
system. We postulated that the dihedral angle of a cis double bond was a good 
representation of the bridgehead connection of an anthracene dimer (Figure 1.10). 
Grubbs metathesis was chosen as a reliable synthetic means to form a comparable 
macrocycle. 
 
 
Figure 1.10. Comparison of anthracene (left) and alkene (right) systems. 
 
Treatment of 43 with NaH in DMF, followed by addition of allyl bromide produced 
50 in 51% yield (Scheme 1.17). A low concentration of this compound (~2 mM) and 
10 mol% Grubbs I catalyst were stirred overnight in dry CH2Cl2, however, ESI-MS 
indicated no product had been formed. An additional 10 mol% of catalyst was added 
and the reaction heated to 50 ºC to give 51. This compound was difficult to separate 
from catalyst decomposition products. Grubbs
72
 has reported the removal of spent 
catalyst via a water soluble tridentate phosphine, P(CH2OH)3. 
 
The reaction was repeated and the ligand was prepared
73
 then used as described, by 
addition of 20-30 eq of ligand in IPA relative to catalyst, following the metathesis 
reaction. After an aqueous work-up this reaction mixture was more easily purified to 
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give 51 in 14% yield, consisting of an inseparable mixture of both geometric isomers 
in an approximately 7 : 3 ratio (trans : cis). Ideally, the cis isomer was desired to 
emulate the anthracene bridgehead. However, comparison with literature 
1
H NMR 
shifts of similar products
74
 and the usual Grubbs I ratio indicated the major product 
was most likely the trans isomer.
75
 Unfortunately, the product was not very stable 
and decomposed during further NMR experiments to confirm this assumption. 
 
 
Scheme 1.17. Synthesis of 51 via Grubbs metathesis. 
 
It was expected that Grubbs II catalyst might be a more appropriate catalyst, leading 
to improved yields of alkene 51.
76
 However, attempts using this catalyst led only to 
recovery of starting material. 
 
Further problems were encountered when VT-NMR spectra were recorded using 51. 
The aziridine hydrogens, from which the inversion barrier is calculated, were 
coupled to the adjacent methylene hydrogens, making the spin system too complex 
for coalescence temperature calculations
33
 or line shape analysis using WinDNMR.
77
 
Data that was collected using approximate Tc calculations based on the coupled 
1
H 
shifts (50, Tc = 358 K, ∆G
‡
 = 71.1 kJ mol
-1
; 51, Tc = 338 K, ∆G
‡
 = 67.8 kJ mol
-1
), 
indicated that there may indeed be a difference in the rate of pyramidal inversion, but 
in the opposite direction to that anticipated. The original hypothesis was that 
increasing the angular constraint by forming a fused ring system would raise the 
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barrier, but this data suggests that ring closure may destabilise the ground state, 
possibly by steric interactions.  
 
In order to obtain better quality data, we decided to synthesise d4-50, which would 
have a simple AB aziridine spin system (Scheme 1.18). Reduction of 43 with lithium 
aluminium deuteride yielded diol 52 in 38% yield with 99% deuterium incorporation 
as determined by 
1
H NMR. Encouragingly, the 
1
H NMR spectrum showed the 
aziridine hydrogens to be a simple uncoupled AB system. Diol 52 was allylated to 
give 53 in 74% yield. Unfortunately, ring closing metathesis using deuterated 53 did 
not lead to macrocycle 54 despite several attempts. Repeating of the Grubbs reaction 
for the initial bis-alkene 50 also failed to give consistent results. Indeed, this 
metathesis reaction proved to be very unreliable, most likely due to the difficulty of 
forming a strained ring via ring closing metathesis. 
 
 
Scheme 1.18. Attempted synthetic route towards 54. 
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1.2.2.5 Conclusions 
The synthesis of bis-anthracene containing aziridines 44 and 48 was achieved in 7 
steps in acceptable yields. We were able to demonstrate that aziridine 42 is stable to 
anthracene photochemical conditions, but we were unable to photoisomerise bis-
anthryl aziridines 44 and 48 to macrocycles. 
 
To model their behaviour, diene 50 was made in 7 steps and its ring closing 
metathesis to 51 achieved. There is some indication from Tc calculations that this 
ring closure produces a change in the inversion barrier. However, the unreliability of 
this reaction, and the failure with the photochemical reactions led us to abandon this 
avenue of research. 
 
1.2.3 Ring Strain Induced by Small Ring Formation 
1.2.3.1 Introduction 
To maximise the probability of successful photochemistry with our systems, we 
moved towards simplified structures that were closely related to carbocyclic systems 
already established to undergo photodimerisation. Specifically, Bergmark
78
 has 
shown that 55 can be reversibly transformed into 56, containing 3 – 5 membered 
carbocycles (Scheme 1.19).
58
 The photochemistry of these carbocyclic compounds is 
reported to be very efficient due to the anthracene rings being held in close 
proximity, although in the case of the one carbon linker, the cyclisation is postulated 
to proceed in a stepwise process rather than a single concerted step due to the 
differing planes of the anthracene rings.
58
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Scheme 1.19. Bis-anthryl amine based systems related to known carbocyclic systems.
58
 
 
In an analogous manner, we envisaged that 57 could be photoisomerised to aziridine 
or azetidine containing 58. Large changes in N-inversion barriers would be expected 
between 57 and 58 as a result of introduction of ring strain.  
 
1.2.3.2 Synthesis of Bis Anthryl Amines 61, 68 and 70 
Our initial attempts focused on an amine linker which, upon dimerisation, would 
yield aziridine 58 (n = 0). We attempted a Buchwald amination
79
 of 9-
aminoanthracene 59 with 9-bromoanthracene 60. 9-Aminoanthracene was easily 
prepared using reported methods,
80
 but unfortunately early attempts were hindered 
by the difficulty in following the reaction by 
1
H NMR spectroscopy and were 
unsuccessful using Fu’s highly reactive tri-tert-butylphosphine ligand. To make 
reaction analysis easier, a range of published Buchwald conditions were applied to a 
model system involving the use of amine 62 (Scheme 1.20).
79
 In this way, we 
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identified xphos as the preferred ligand and NaO
t
Bu as the best base for the synthesis 
of 63. 
 
Scheme 1.20. Buchwald amination. 
 
Once the conditions had been optimised, they were then applied to the bis-anthryl 
system (Scheme 1.21). The reaction did not proceed as cleanly as the model reaction, 
but the product was clearly visible by ESI-MS and 
1
H NMR. Disappointingly, 
attempts to isolate 61 by chromatography using silica gel or alumina, or by 
crystallisation as either the free base or as the corresponding hydrochloride salt, were 
unsuccessful. Attempts were also made to alkylate the crude product with methyl 
iodide or tosyl chloride, neither of which gave any indication of the desired products.  
 
 
Scheme 1.21. Optimised Buchwald amination conditions applied to the synthesis of 61. 
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Attempts to undertake a second Buchwald amination on 63 led to the unexpected 
formation of 64 (Scheme 1.22). This was indicated by the 
1
H NMR signal (δ = 8.69 
ppm) corresponding to the H-10 anthracene integrating to one hydrogen, and a lack 
of equivalence in the remaining anthracene signals. This gave an insight into the 
reactivity of these compounds, which was further confirmed by the attempted 
methylation of 59 and 61, which rapidly underwent multiple methylations (up to 
four) by mass spectrometry. In general, all of the unsubstituted aminoanthracenes 
prepared showed poor stability and even 9-aminoanthracene itself oxidises and 
degrades rapidly in solution. 
 
 
Scheme 1.22. Unexpected formation of 64 under Buchwald amination conditions. 
 
9-Aminoanthracenes are rare, however, N-acetylaminoanthracene is a well-known 
compound.
81
 This was prepared according to the literature method, in the hope that it 
could be reduced with lithium aluminium hydride, to form N-ethyl aminoanthracene. 
The stability of N-ethyl aminoanthracene was again found to be poor, however, the 
observed stability of the N-acetyl aminoanthracene compared to the parent 
aminoanthracene was interesting. Unfortunately N-carbonyl aziridines are not useful 
for this project, as the strong overlap of the nitrogen lone pair into the carbonyl 
system causes the ground state to be planar or near planar, therefore exhibiting very 
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little pyramidal character. The stability of 65 is presumably due to some degree of 
delocalisation of the nitrogen lone pair away from the anthracene ring system.  
 
 
Scheme 1.23. Acetylation of 9-aminoanthracene.
81
 
 
Based on these observations, we decided to target N-sulfonyl amines which we 
hoped would yield stable compounds yet retain some pyramidal character. 
Unfortunately, it was anticipated that aziridine systems could only be readily 
synthesised using Buchwald amination reactions, which are unsuitable for producing 
N-sulfonyl amine linked anthracenes. Thus, we decided to target the related azetidine 
precursors (68 and 70), allowing different synthetic routes to be employed. 
Tosylation of 59 was achieved using standard conditions yielding 67 (Scheme 1.24), 
which had only been reported previously as a photochemical side product.
82
 Using 
catalytic potassium iodide and potassium carbonate in acetone, and heating to reflux 
for two days with bromomethyl anthracene, bis-anthracene 68 was obtained in a 
pleasing 77% yield. Using the same procedure, 70 was also synthesised using 4-
methoxybenzenesulfonyl chloride as the electrophile to form sulfonamide 69 in 45% 
yield. Alkylation was explored under microwave conditions (300 W, 110 
o
C, 15 
min.). The yield of 48% is lower than the thermal conditions used for 68, but the 
reaction time is much shorter. The intention of adding the p-methoxy group was to 
improve solubility, which was causing difficulty when purifying by chromatography. 
However, there was no noticeable difference in the solubility of 68 and 70. 
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Scheme 1.24. The synthesis of 68 and 70. 
 
A suitable crystal for X-ray analysis of 68 was grown using the solvent diffusion 
method from dichloromethane and diethyl ether. This not only revealed the near 
planar nature of the nitrogen substituents (Φ = 162o, measured as the angle of the N – 
R3 plane relative to the R1 – N – R2 plane) in this compound, but also how well the 
anthracene rings were set for dimerisation, being only 2.8 Å apart. The barely 
pyramidal nature of the nitrogen centre is disappointing, as any inversion process 
would be extremely rapid and very difficult to measure.  
 
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 57 - 
 
 
Figure 1.11. X-ray crystal structure of 68. 
 
1.2.3.3 Photoisomerisation of 68 
The photochemistry of 68 was initially investigated at the University of Birmingham 
with the assistance of James Tucker and Luciana Giordano. Irradiation of 68 (1.86 
µM in degassed CH2Cl2) using a 125 W medium pressure Hg lamp through a glass 
bandpass filter centred on 365 nm ± 2 nm (Edmundoptics P/N: NT65-130) for one 
hour, yielded photodimer 71 in an encouraging 58% yield. The ring closure was 
supported by the appearance of two strongly coupled AB doublets at 4.5 ppm in the 
1
H NMR, and no change in molecular ion mass indicated that intramolecular 
isomerisation was occurring.  
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Scheme 1.25. Irradiation of 68 to form 71. 
 
Low temperature VT-NMR data for 71 was collected in d2-dichloromethane. A 
coalescence temperature of 80 oC was measured but, unfortunately, the freezing 
point of dichloromethane is at 95 oC and the operational limit of a standard NMR 
probe is 100 oC. Because of this, it was not possible to obtain sufficient data in the 
slow inversion regime to determine the maximum separation of the resolved signals. 
Hence, complete line shape analysis was not possible as the true position of υA and 
υB could not be plotted. However, using the Equation 1.7 it was possible to estimate 
G for 71 at coalescence, G‡ = 35 kJ mol-1 at 193 K. This is higher than that 
reported for N-tosyl azetidine, which has a reported inversion barrier of 26 kJ mol
-1
 
at 123 K in CHClF2.
33
  
 
Equation 1.7. G‡ at coalescence. 
 
One might expect a decrease in the inversion barrier rather than the increase 
observed due to the large number of steric interactions in 71 in the ground state when 
compared with N-tosyl azetidine. Such interactions would be expected to destabilize 
the ground state relative to the transition state thereby reducing the required energy 
to progress from the ground to the transition state. Presumably 71 has increased ring 
strain compared with N-tosyl azetidine.  
)]ln(23[‡


Tc
RTcG
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1.2.3.4 Conclusions 
Although our efforts towards the synthesis of the aziridine family were unsuccessful 
due to poor stability, we were able to successfully synthesise members of the N-
sulfonyl azetidine family. Azetidine 71 was synthesised in five high yielding steps, 
which included an efficient anthracene photoisomerisation. Unfortunately, the crystal 
structure of 68 showed it was very close to being planar at the nitrogen centre, and 
had very little pyramidal character. The pyramidal inversion of 71 was fast enough to 
be at the limit of VT-NMR investigation, however we were able to calculate 
activation parameters through coalescence. This azetidine proved to have a higher 
pyramidal inversion barrier than N-tosyl azetidine, an observation that merits further 
investigation by computational modeling. 
 
This system did not possess all the ideal attributes to allow us to demonstrate 
photocontrol of pyramidal inversion and hence we decided to examine alternate 
systems. However, because the photochemical isomerization in these molecules was 
found to be very efficient, we went forward to modify these systems to form light-
activated β-lactam antimicrobial agents. This subject is discussed in detail 
throughout Chapter 2. 
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1.2.4 Using Light to Disrupt Hydrogen Bonds 
1.2.4.1 Introduction 
Shipman has shown that hydrogen bonds can be used to modify the rate of pyramidal 
inversion. In 2006, ground state hydrogen bonds were used to slow pyramidal 
motion.
46
 More recently, transition state stabilising hydrogen bonds were used to 
accelerate N-inversion (Schemes 1.4 – 1.6).47 We wanted to combine this established 
hydrogen bonding aziridine fragment with the ability to form a large macrocycle 
through photochemistry. In this way, the hydrogen bond could be disrupted by 
macrocycle formation. We chose to attempt this using bis-anthracene so that this 
process could be controlled using light / heat. 
 
 
Scheme 1.26. Control of inversion via macrocycle formation to disrupt hydrogen bonding. 
 
1.2.4.2 Towards the Synthesis of Precursor 72 
Aziridine 75 was synthesised in 2 steps from epoxide 39 (Scheme 1.27). Initial ring 
opening with 2-picolylamine occurred in a 99% yield. Ring closure of 74, under 
standard Mitsunobu conditions using DEAD, was achieved with difficulty and 
problems were encountered in isolating 75 from the reduced DEAD (EtO2CNH-
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NHCO2Et). A low yield of 19% was obtained, which still contained some minor 
contaminants.  
 
 
Scheme 1.27. Synthesis of aziridine 75.
47
 
 
Anthryl amine 78 was synthesised via nitrile 77 (Scheme 1.28). Commercial 9-
chloromethyl anthracene 76 was treated with sodium cyanide at 140 
o
C to give 77 in 
71% yield. Reduction of nitrile 77 using lithium aluminium hydride under forcing 
conditions produced a mixture of compounds with 78 being isolated in just 27% 
yield. Large quantities of sodium cyanide must be used in order to produce usable 
amounts of amine 78 and, additionally, both compounds are very insoluble, therefore 
making isolation difficult. 
 
 
Scheme 1.28 Reported synthesis of amine 78.
83
 
 
In order to safely and effectively produce sufficient amine, a new route was required, 
which is shown in Scheme 1.29. It has previously been shown that lithiated 9-
bromoanthracene can effectively ring open oxirane to yield alcohol 81.
84
 
Commercial oxirane is expensive due to the cost of containment, but can be easily 
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prepared, although it does require special precautions due to its toxicity. 9-
Bromoanthracene was lithiated using n-butyllithium at 78 oC, then warmed to 0 oC 
and reacted with excess oxirane to give alcohol 81 in 50% yield. 
 
Mesylation of 81 was achieved using standard conditions in 86% yield, followed by 
substitution with a sodium azide in 93% yield. Final reduction of azide 83 using 
hydrogenation catalyzed by palladium on activated carbon was quantitative. This 
new route employs a greater number of steps, but each of the steps are easier to 
accomplish, especially in terms of purification and can be more readily scaled up. 
 
 
Scheme 1.29. Improved synthetic route towards amine 78. 
 
With the required amine in hand, attempts were made to react it with aziridine 75 
(Scheme 1.30). Previously, this substrate had been reacted with a large excess of 
methylamine (20 eq) in methanol.
47
 However, because of the limited availability and 
solubility of 78, we attempted the reaction using 2.5 eq of 78. After 1 week, there 
was no indication of any conversion to amide 84. In the initial research for this 
reaction no attempts were made to optimize the reaction conditions as methylamine 
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is highly soluble and was used in a large excess as a solution in methanol with 
chloroform as co-solvent.
47
 
 
 
Scheme 1.30. Attempted amide formation. 
 
As pyridine 75 and amine 78 were in short supply, a model reaction was 
investigated. n-Propylamine was chosen as the amine and aziridine 42 was used in 
place of 75 as it is much easier to make (Scheme 1.31). The reaction was conducted 
with 5, 10, 20 and 40 eq of amine in an 0.18 M solution of aziridine using 
chloroform as the solvent. The 40 eq reaction was found to be complete within 2 
days, whereas the 20 eq reaction required 5 days. The 10 eq reaction was much 
slower and, after 1 week, there was mainly starting material (62%), monosubstituted 
product 86 (38%) and trace amounts of the required di-substituted product 85. The 5 
eq reaction showed no indication of any conversion after 1 week, which supports the 
earlier disappointing result obtained using the anthryl amine 78 (Scheme 1.30). 
 
 
Scheme 1.31. Optimization of amide formation. 
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Further attempts were made using the anthryl ethylamine 78, however, when the 
quantity of this compound was increased, it was found to not fully dissolve in the 
available solvent. The maximum that was possible to dissolve was about 5 eq, which 
is far from the ideal 20 eq required for the reaction, and therefore it was not possible 
to drive this amidation reaction to completion.  
 
1.2.4.3 Conclusions 
Unfortunately, our efforts to make 72 were primarily thwarted by the poor solubility 
of the anthracene derivatives. The key amide forming step of this synthesis requires a 
high concentration of amine in order to force the reaction to completion, but it was 
not possible to obtain these high concentrations using anthryl ethylamine 78. 
Alternative amide coupling reactions were briefly explored, however, they were 
unsuccessful and limited by the presence of the aziridine ring. On the positive side, 
an improved synthesis of 78 has been developed compared to literature methods as 
well as optimization of the amide forming step using n-propylamine. 
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1.2.5 Azobenzene Photoisomerisation Based Systems 
1.2.5.1 Introduction 
Azobenzenes have been widely used in rotaxane and catenane chemistry to make 
photoresponsive systems.
85
 They have also been widely used in molecular rotors and 
meshed gear systems,
86
 and to control biological processes.
87
 The photochemistry of 
azobenzenes is well understood,
88,89
 and the interconversion of the cis to trans 
isomers can be achieved in high conversion and cycled many times without 
significant degradation (Scheme 1.32). The synthesis of such molecules is also well-
documented due to their extensive use as dyes.
90
 
 
 
Scheme 1.32. Isomerisation of azobenzenes. 
 
Trans azobenzenes 88a are completely planar with extensive delocalization 
throughout the ring system.
91
 For azobenzene, irradiation causing a symmetry 
allowed π → π* transition (λmax = 320 nm) or a very weak unresolved n → π
*
 
transition (λmax = 450 nm), causes an isomerisation of the azo bond to occur, forming 
cis azobenzene 88b. Two mechanistic pathways have been reported for the 
isomerisation. Firstly, rupture of the N=N π bond followed by either rotation or, 
alternatively, inversion of one nitrogen centre, leads to the cis-isomer. It is likely a 
combination of both the bond rotation and inversion pathways that is responsible for 
isomerisation in most cases.
88
 Due to steric interactions, it is necessary for one of the 
aromatic rings to twist out of the plane, reducing conjugation in the cis product.
92,93
 
This twist restricts the aromatic orbital overlap and therefore the degree of 
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conjugation between the two rings. The cis isomer can be converted back to the trans 
isomer by irradiation. For azobenzene, the cis π → π* transition (λmax = 270 nm) is 
weaker but the n → π* transition (λmax = 450 nm) absorbs much more strongly than 
the trans isomer. There is also a thermal pathway from the cis isomer towards the 
thermodynamically more stable trans isomer, the barrier to which is dependent on 
the aromatic substituents. 
 
 
Scheme 1.33. Conversion of azobenzene cis and trans isomers. 
 
We hypothesised that the different electronic structures of the cis and trans 
azobenzene isomers could be used to modify the rate of pyramidal inversion. We 
have described earlier how sensitive the rate of inversion can be to the p character of 
the nitrogen lone pair, which is influenced by the nature of any adjacent π systems. 
Andose
41
 has compiled data that shows there is approximately a difference of 12.5 kJ 
mol
-1
 in ∆G‡ between the inversion energies of N-phenyl and N-p-nitro phenyl 
aziridines (Figure 1.12).  
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Figure 1.12. Inversion barrier of aryl aziridines from line shape fitting (a & b) and Tc calculations 
(c).
41
 
 
Based on this evidence, it seemed reasonable to propose that azobenzene 
isomerisation could significantly alter the nature of an attached N-aryl π-system, and 
have a measurable effect on the inversion parameter. We selected aziridines 89 and 
90 as suitable systems to test these ideas (Figure 1.13). For VT-NMR analysis, 89 is 
most attractive as the aziridine hydrogens are a simple AB system. However, 
synthetically, 90 appeared most attractive, especially as it has been made previously 
by Hallas.
94
  
 
 
Figure 1.13. Aziridine targets 89 and 90. 
 
For this work, we restricted ourselves to aziridine based systems. This is because 
reported values for analogous phenyl and p-NO2 phenyl azetidines, place the 
inversion rate beyond the limits of study by VT-NMR spectroscopy.
33
 It is known 
that azobenzenes with appended N-heterocycles of four membered rings and higher 
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are planar, whereas aziridine rings were determined to be mainly tetrahedral at the 
nitrogen centre.
95
 Research by Hallas et al
94,96
 has, for a number of years, focused on 
the construction of azobenzenes functionalized with small, strained terminal nitrogen 
rings intended as modified azo dyes. It was expected, and demonstrated in a series of 
papers,
97,98
 that with adequate ring strain it was possible to forcibly alter the orbital 
character of the terminal nitrogen, which in turn affected the electronic structure of 
the azobenzene due to differing orbital contributions from the nitrogen lone pair. 
 
 
Figure 1.14. Cyclic terminal groups in azobenzenes.
99
 
 
Hallas made various derivatives from three to six membered rings (Figure 1.14), 
however, only those based on aziridines exhibited unusual properties whereby the 
ring strain was sufficient to force the nitrogen to be pyramidal. The unique 
hypsochromic properties of the aziridyl azobenzenes are dependent on solvent and 
lend credence to the idea that nitrogen delocalization into the azobenzene system is 
occurring. 
 
Both of our target systems have an aziridine ring connected directly to a fairly simple 
azobenzene. To maximize the effect of conjugation with the second aromatic ring, 
we chose to introduce a nitro group in the para position of the second ring. 
 
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 69 - 
 
The synthesis of 90 has previously been reported
94
 by Hallas during his 
investigations. Hydrobromide salt 92 was synthesised using a procedure developed 
by Pearlman, although the reported details were sketchy (Scheme 1.34).
100
 Heating 
of β-hydroxy ethylaniline (91) in concentrated aqueous hydrogen bromide resulted in 
displacement of the hydroxyl group and formation of hydrobromide salt 92. Azo 
coupling of 92 with p-nitroaniline was reported with only small amounts of the 
hydrolysis side product being observed. Finally, the aziridine ring was closed by 
treatment of 93 with sodium amide in DMSO. 
 
 
Scheme 1.34. Reported synthesis of 90.
94
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1.2.5.2 Towards the Synthesis of Aziridine 89 
α,β-Unsaturated esters have been aziridinated using the required amino azobenzene 
system with lead tetraacetate (Scheme 1.35).
101
 The role of the 
dimethylaminobenzene group on the olefin in this reaction was uncertain. For our 
requirements, this substituent needed to be removed. 
 
 
Scheme 1.35. Literature example of Pb(OAc)4 aziridinations.
101
 
 
Diethylmalonate was condensed with paraformaldehyde then immediately trapped 
by [4+2] cycloaddition with anthracene. The isolated adduct was then heated to 
225 
o
C to encourage a thermal retrocyclisation and the olefin isolated by distillation 
according to published methods.
102
 A solution of olefin and Disperse Orange 3 
(Aldrich) in dichloromethane was treated with lead tetraacetate, however, 
disappointingly no aziridine products were observed (Scheme 1.36).  
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Scheme 1.36. Synthetic route towards 89.
102
 
 
There have been reports
103
 of forming aryl aziridines from similar compounds via the 
dibromide. Olefin 99 was brominated in 56% yield using bromine in carbon 
tetrachloride (Scheme 1.37). Further reactions of 100 with Disperse Orange 3 101 in 
acetonitrile clearly showed substitution of one bromine by mass spectrometry (m/z = 
493 [
79
BrM+H]
+
, 495 [
81
BrM+H]
+
, however no conditions were found that promoted 
the second displacement to form the aziridine ring. At this juncture, we decided to 
focus on the synthesis of known aziridine 90. 
 
 
Scheme 1.37. Attempted alternate synthesis of 101. 
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1.2.5.3 Synthesis of Aziridine 90 
The synthesis of 90 has previously been reported by Hallas
94
 (Scheme 1.34). 
However the synthesis of 90 used a procedure first reported by Pearlman.
100
 
Unfortunately, in our hands it was not possible to isolate 92 and the best outcome 
was a 1:1 mixture of 92 and alcohol 102. Attempts to purify this mixture by 
fractional crystallisation were unsuccessful (Scheme 1.38).  
 
 
Scheme 1.38. Attempted synthesis of 92. 
 
Next, we attempted to modify the published route by attempting the diazo coupling 
using aniline 91. First, p-nitro aniline was treated with sodium nitrite to form the 
diazonium salt, which was then slowly added to β-hydroxyethylaniline (91). A deep 
red solid, 103, was collected in 87% yield. In an attempt to intercept the developed 
synthesis, azobenzene 103 was treated with phosphorous tribromide. Unfortunately, 
this was unsuccessful, most likely due to the high water solubility of the product salt. 
Basification of the mixture with sodium hydroxide after work-up led to the isolation 
of 103, presumably as a result of displacement of the bromide by hydroxide. 
 
 
Scheme 1.39. Diazo coupling of 91. 
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In order to introduce an alternate electrophile for ring closure, we attempted the 
tosylation of 103 using 1 eq of purified tosyl chloride at room temperature. However, 
the result was not encouraging as the major product was the unwanted N-tosylated 
isomer, although trace amounts of the O-tosylate were detected. Assigning the 
products was challenging due to the IR spectral similarities. The O-tosylated product 
is characterised by a widening separation of the CH2 signals and a downfield shift of 
these methylenes (3.35 and 3.85 ppm) to 3.50 and 4.20 ppm. The NH signal also 
moves upfield from 4.70 ppm to 4.50 ppm. The N-tosylated product is characterised 
by the CH2 signals moving closer together, forming a multiplet centred around 3.65 
ppm. Selective tosylation of the oxygen of amino alcohols such as 104 is possible 
when the aryl substituent is strongly electron withdrawing (Scheme 1.40).
104
 
 
 
Scheme 1.40. Literature method for selective tosylation.
104
 
 
These conditions were then examined using aminoalcohol 103. Using 1.1 eq of 
purified tosyl chloride and the reaction cooled to 5 oC (ice / salt water), resulted in a 
mixture of compounds but predominantly O-tosylation was observed with a large 
proportion of starting material remaining (103:OTs:NTs, 10:5:2) (Scheme 1.41).  
 
 
Scheme 1.41. Selective tosylation of 103. 
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To try and improve the selectivity, mesyl chloride was tried at 78 oC, however, only 
the unwanted sulphonamide was observed. Treatment of 103 with 1.25 equivalent of 
tosyl chloride and 10 mol% DMAP in pyridine between 15 and 20 oC showed low 
conversion but increased selectivity for 106 (103:OTs:NTs, 10:5:1). Stirring the 
mixture for longer did not result in further conversion and warming the mixture to 
r.t. overnight led to a loss of selectivity. The reaction was repeated but, after 4 hours, 
a second addition of tosyl chloride (1 eq) and catalytic DMAP was added and the 
mixture stirred at 20 oC for a further 4 hours to give a 70% conversion, as indicated 
by crude 
1
H NMR. Whilst the additional equivalents of tosyl chloride helped force 
the reaction towards completion, it also brought about the appearance of a di-
tosylated product, characterised by CH2 signals at 4.10 and 3.80 ppm.  
 
To make the reaction method more convenient the procedure was further modified 
and a solution of 103 was cooled to 20 oC before 10 equivalents of tosyl chloride 
and 1 equivalent of DMAP were added. The mixture was strictly temperature 
controlled such that it never warmed above 15 oC and stirred for 6 h. The mixture 
was quenched at 20 oC by the addition of methanol to trap the excess tosyl chloride. 
Chromatography, followed by crystallisation of the corresponding HCl salt, provided 
107 in 8% yield. The yield was unfortunately significantly impacted due to the 
difficulty in removing 103 from the product mixture, as the crude ratio was much 
better (103:OTs:NTs:di-tosylate, 1:6:2:2). 
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Scheme 1.42. Modified synthesis of 107 salt. 
 
Hallas et al
96
 had reported the effective ring closure of bromide 93 using sodium 
amide in dimethyl sulfoxide, however this was found to be ineffective in this 
instance. Other reports indicated the use of sodium hydride in DMSO as also being 
effective.
104
 Whilst the reaction in DMSO did produce some aziridine, the 
conversion was limited to 44%. Treatment of 107 with sodium hydride in dimethyl 
formamide, on the other hand, proceeded rapidly with a high conversion (84%). 
Some ring opening of the aziridine occurred during purification, causing 
contamination and a reduced yield, but treatment of the chromatography silica with 
triethylamine and base washing all glassware prevented such ring opening reactions, 
yielding aziridine 90 in 70% yield. At this junction, the stage was set to explore the 
impact of light on rates of pyramidal motion. 
 
 
Scheme 1.43. Ring closure of 107with sodium hydride. 
 
1.2.5.4 Computational Modeling 
Through collaboration with Dr Walsh, an Associate Professor of BioNanotechnology 
at Deakin University, Australia, it has been possible to calculate the lowest energy 
ground state structures and transition state structures for both the cis and trans 
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azobenzene isomers in a solventless environment and also using an implicit solvent 
model (toluene). A high level of theory, MP2/6-31G*, was used to optimize the 
geometry of the minima and corresponding transition state. Single-point energies 
(SPE) for these optimized structures were then calculated at the higher MP2/aug-cc-
pVDZ level. The ground and transition state structures of the trans isomer were 
relatively straightforward to calculate due to the restricted degrees of freedom 
(Figure 1.15). Conversely, because of the anticipated twist between the aromatic 
systems in the cis isomer, the minimum structure proved more difficult to locate. 
 
 
Figure 1.15. Computed ground (Left) and transition (Right) state structures for the trans (Top) and cis 
(Bottom) isomers in the gas phase. 
 
The relative energies of these structures were calculated both without solvent and 
using toluene as an implicit solvent, in order to better model the experimental VT-
NMR conditions. The calculated values are shown in Table 1.1 which also shows the 
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difference in the calculated inversion barriers between the cis and trans isomers to be 
3.6 kJ mol
-1 
at the highest level of theory.  
 
 
No Solvent Implicit Solvent (toluene) 
 E-GS 
(au) 
E-TS 
(au) 
∆E  
(au) 
∆G‡ 
(kJ mol
-1
) 
E-GS 
(au) 
E-TS 
(au) 
∆E  
(au) 
∆G‡ 
(kJ mol
-1
) 
Trans -907.545 -907.526 0.0198 52.0 -907.355 -907.337 0.0188 49.3 
Cis -907.530 -907.509 0.0206 56.3 -907.339 -907.319 0.0201 52.9 
∆∆G‡    4.3    3.6 
 
Table 1.1. Calculated activation energies for cis- and trans-90. 
 
Importantly, the computed structures of cis-90 and trans-90 validate our initial 
hypothesis that the trans isomer would be planar and highly conjugated, and that the 
cis isomer requires the rings to twist slightly out of plane to each other. Such a 
twisting clearly disrupts the character of the π system, which is evidenced in the 
calculated difference in the inversion barriers for the two isomers. 
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1.2.5.5 Photochemical Isomerization of 90 
Photoisomerisation of trans azobenzenes can proceed via two distinct pathways, 
either a higher energy, sharper π → π* symmetry allowed transition, or a lower 
energy, symmetry disallowed and broader n → π* transition. For azobenzene, these 
transitions are well resolved from each other. Cis azobenzene has two weaker π → π* 
bands at a higher energy than the trans isomer, but a strong n → π* transition in 
approximately the same region as the trans isomer. 
 
 
Scheme 1.44. Azobenzene photoisomerisation
88,105
 with quantum yields.
106
 
 
The UV/VIS spectrum of aziridine trans-90 was poorly resolved, indicating overlap 
of electronic transitions. Many substituted azobenzenes have very similar UV/VIS 
spectra to azobenzene.
88
 The π→π* trans → cis is at a longer wavelength, separated 
from π→π* cis → trans. Also, the π→π* and n→π* transitions for both isomers are 
well separated, allowing for the selective excitation of either the cis or trans isomer. 
Typically, the broad n→π* transitions above 400 nm overlap, but normally favour 
formation of the trans isomer due to the significantly higher quantum yields and a 
stronger absorbance. Narrow ranges of wavelengths can be used to selectively target 
the π→π* transition of either isomer, allowing control over the direction of the 
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 79 - 
 
isomerisation and achieving high photostationary ratios. Unfortunately, it has been 
reported that in 2- and 4-amino azobenzenes, the π→π* transition shifts to longer 
wavelengths and overlaps with the n→π* transition.107 This is clearly the case for 
compound trans-90, as the spectra shown in Figure 1.16 is very broad and poorly 
resolved. 
 
 
Figure 1.16. UV trace of compound 90. 
 
Aziridine trans-90 was dissolved in deuterated dichloromethane in an NMR tube and 
irradiated using a 125 W medium pressure Hg lamp, initially using a <355 nm cutoff 
filter (0.0012 M BiCl3 in 4.8 M HCl) and then separately with a >360 nm cut off 
filter (0.8 M NiSO4 + 1.0 M CoSO4).
108
 Both reactions were irradiated at room 
temperature for 1 h. Following irradiation the sample was kept in the dark and 
immediately studied by 
1
H NMR spectroscopy (within 5 min), however, no cis 
isomer was detected. 
 
A subclass of azobenzenes are the push-pull azobenzenes and are characterized by an 
electron withdrawing group on one of the aromatic rings and an electron donating 
group on the other. These molecules have been shown to have very thermally 
unstable cis isomers compared to other azobenzenes. One explanation is that 
delocalisation of the electron density by resonance for isomer cis-90, leads to a 
higher degree of N-N single bond character. The extreme case is shown in Scheme 
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1.45. This allows for rotation to occur, leading to the thermodynamically more stable 
trans isomer. Whilst the partial isolation of the π systems in the cis isomer would 
limit this delocalisation, some degree of N-N π-bond disruptive character probably 
exists.
88
 
 
 
Scheme 1.45. Delocalisation of electron density in azobenzenes. 
 
In such push-pull systems, use of solvents with a small dielectric constant are found 
to significantly increase the lifetime, up to a 10,000 fold, of the cis isomer. 
Presumably this is due to a reduction in stabilization of the polarised resonance form 
109 through solvent interactions.
93,109
 
 
Toluene-d8 is an ideal solvent, with a useable NMR range down to 95 
o
C and, at the 
same time, is known to be amongst the best at extending the lifetime of diazo cis 
isomers. 
 
When trans-90 was dissolved in benzene-d6 and irradiated (room temperature, 1h) 
using the >360 nm cut off filter (0.8 M NiSO4 + 1.0 M CoSO4), a small amount of 
cis-90 was observed (trans : cis; 90 : 10). When the experiment was repeated using 
the < 355 nm filter (0.0012 M BiCl3 in 4.8 M HCl), this conversion increased (trans : 
cis; 81 : 19). A more complicated bandpass filter has been reported using 0.75% w/v 
iodine in carbon tetrachloride,
110
 which has a modest transmission of ~ 40%, but is 
highly selective for λmax = 390 nm (λ1/2 max = 350, 410 nm). Irradiation of trans-90 in 
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 81 - 
 
toluene (room temperature, 1 h or 2 h) through this filter resulted in further 
improvement of the conversion (trans : cis; 73 : 27). The thermally induced back 
reaction could be inhibited by use of lower photoirradiation temperatures. Indeed, 
photoirradiation of trans-90 and keeping the surrounding filter solution at <10 C 
(ice-water bath) for 3 h, improved the isomerisation such that cis-90 was the major 
product (trans : cis; 44 : 56), (48 : 52, toluene-d8). No further improvements were 
seen lowering the temperature to 20 C. 
 
Next, we explored the effect of increasing the intensity of the light source. The 
Schott FSQ-UG1 UV bandpass filter has transmission properties almost identical to 
the iodine/carbon tetrachloride solution filter, but with a much higher maximum 
transmission of 75%.
111
 Using a box around the lamp, and this glass as a window, 
the sample was irradiated under the same conditions in toluene with cooling in 
ice/water. However, no improvement in the conversion was observed. 
 
At room temperature, cis-90 isomerised to trans-90, according to the expected first 
order kinetics, t1/2 = 90 min ± 10 min in toluene with k = 0.0002 s
-1 
(see Appendix 3). 
This is significantly slower than values reported for classical push-pull 
azobenzenes,
93
 demonstrating the effect of ring strain on the ability of the nitrogen to 
delocalise into the -system. Below 10 oC, the cis isomer was observed to be 
thermally stable, which importantly simplified low temperature VT-NMR 
experiments as the cis-90 isomer did not revert to trans-90 during the long 
experiment time. 
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The photoisomerisation of 90 was optimised, however only a maximum ratio of 
trans : cis; 44 : 56 was achieved using a λmax = 390 nm filter, 125 W Hg lamp, 
temperature <10 
o
C, irradiated for 4 h. This is imperfect, but is most likely close to 
the achievable limit for this compound with the thermal instability of cis-90, and 
overlapping excitation wavelengths of the isomers, making further improvement 
difficult. The cis → trans isomerisation was easily achieved thermally by placing the 
sample in a 60 
o
C oil bath for 10 min. 
 
 
Scheme 1.46. The optimised isomerisation of 90. 
 
1.2.5.6 Determination of Activation Parameters for Pyramidal Inversion 
The four hydrogens of an unsubstituted aziridine are all magnetically non-equivalent, 
resulting in a highly second order AA’BB’ spin system. WinDNMR and the 
equations method are not suitable for simulating such complex spin systems.
77
 These 
spin systems have been observed for a number of aziridines, including simple NH 
aziridine.
39,112,113
 Fortuitously, when low temperature 
1
H NMR spectra for trans-90 
were acquired, the aziridine signals were observed as two singlets of a simple A2B2 
spin system, coalescing to one singlet at higher temperatures. Presumably JAB = JAB’ 
making A and A’ both chemically and magnetically equivalent.  
 
The activation parameters of trans-90 and cis-90 were calculated using the aziridine 
1
H signals in two ways. Firstly, using the simple coalescence method, and later using 
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the more accurate line shape analysis. Equation 1.2 only requires accurate 
determination of the coalescence temperature (Tc) and the maximum separation of 
the fully resolved signals. At the lowest possible VT-NMR temperature, the signals 
for both isomers were still somewhat broad, however this was more pronounced for 
trans-90. For cis-90, determination of Tc was more difficult due to the presence of 
both isomers in the sample and overlapping of some signals. Attempts were made to 
electronically subtract the spectra of trans-90 from the spectra of the mixture but 
without success. These issues somewhat increase the uncertainty of values calculated 
using this method. 
 
 
Equation 1.2. Where R is the gas constant and ∆v is the maximum separation of resolved signals. 
 
A major limitation of the equation method is the inability to calculate ∆G‡ at 
temperatures other than Tc. Commonly, systems to be compared have different Tc 
values which makes comparison difficult. In the case of pyramidal inversion, the 
entropy term is normally small, making variations over temperature ranges smaller, 
and more manageable. 
 
 
Tc (K) ∆G
‡
 at Tc (kJ mol
-1
) 
Trans-90 207 38.9 
Cis-90 223 42.2 
 
Table 1.2. Calculated activation parameters at coalescence using the Tc equation method. 
 
Using this method, ∆∆G‡  3.3 kJ mol-1 was determined with the cis isomer having a 
higher barrier to inversion. Data was consistent with that predicted, and in line with 
)]ln(23[‡

 cc
T
RTG
Photocontrol of Molecular Motion  Alexander J Hough 
 
- 84 - 
 
values computed previously. Complete line shape analysis is commonly regarded as 
a superior method to derive activation parameters. Line shape fitting calculates the 
rate of a process from Heisenberg uncertainty broadening. This is done over a wide 
range of temperatures, thus allowing ∆H‡ and ∆S‡ to be determined from a plot of 
the Eyring equation. Spectra were acquired from 219 to 188 K, and the measured 
spectra fitted to line shape analysis using the A2B2 spin system with WinDNMR.
77
  
 
  (1.8) 
 
  (1.9) 
 
Figure 1.17. The Eyring equation (1.8) and its linear form (1.9). 
 
 
Figure 1.18. Correlation of actual (left) and simulated (right) spectra were excellent for the trans 
isomer allowing the rate of inversion to be calculated for a range of temperatures. 
 
Processing the VT-NMR data for cis-90 was more difficult. Once the photochemical 
reaction was complete, the sample was wrapped in foil and stored in dry ice/acetone 
then transported to the NMR spectrometer, which was precooled to 188 K. 
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Unfortunately, cis-90 contained trans-90 (56 : 44), complicating the analysis. Upon 
warming the sample, it was clear that cis-90 coalesced at a higher temperature, 
however, close to Tc, the broad signals overlapped, therefore making simulation 
difficult. These temperatures were omitted from the Eyring plot in order to reduce 
the uncertainty. However, as can be seen, the data above and below this region are 
very good, allowing H‡ and S‡ to be determined. 
 
 
Figure 1.19. Correlation of actual (left) and simulated (right) spectra for the cis isomer, allowing the 
rate of inversion to be calculated for a range of temperatures. 
 
Because the Eyring plots 1.1 and 1.2 give ∆H‡ and ∆S‡ as functions of the gradient 
and intercept it is possible to calculate ∆G‡ at any temperature. Table 1.3 shows that 
the line shape data has been calculated for each coalescence temperature, allowing 
for comparison with the data compiled from the equations method. This shows that 
whilst the absolute values for ∆G‡ are smaller when extracted from line shape fitting, 
the relative difference between the two isomers is similar, but about 1 kJ mol
-1
 less 
than when comparing coalescence temperature calculations.  
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Graph 1.1. Eyring plot generated from rate data obtained by line shape fitting of trans-90. 
 
 
Graph 1.2. Eyring plot generated from rate data obtained by line shape fitting of cis-90. 
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 ΔG‡ (207K) 
(kJ mol
-1
) 
ΔG‡ (223K) 
(kJ mol
-1
) 
ΔG‡ (298K) 
(kJ mol
-1
) 
ΔH‡ 
(kJ
 
mol
-1
) 
ΔS‡ 
(J K
-1
 mol
-1
) 
 
(Tc = 207) 
37.7 38.0 39.2 34.4 -16.3 
  
(Tc = 223) 
39.7 40.1 41.7 35.3 -21.4 
 
Table 1.3. Calculated activation parameters based on line shape fitting data. 
 
At 298 K, there is a 2.5 kJ mol
-1
 difference in the inversion barrier between trans-90 
and cis-90. Using the Eyring equation, this equates to a ~ 2.8 fold difference in the 
inversion rate (k = 8.3 x 10
5
 vs 3 x 10
5
 s
-1
). This represents a significant change in 
the rate of pyramidal inversion, which results from the photochemically induced 
isomerisation. Aziridine 90 is very robust when kept away from sources of acid. It 
can be rapidly cycled to cis-90 with light and back to trans-90 by heating it in an oil 
bath at 60 
o
C for 10 minutes. Three complete cycles were completed without any 
sign of degradation. 
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1.2.5.7 Conclusions 
Azobenzene containing aziridine 90 has been successfully synthesized via a 
modified synthetic pathway in 3 steps from 91. The photoisomerisation of 90 has 
been optimised to the following conditions. Irradiation for 4 h with a 125 W Hg 
lamp through a λmax = 390 nm filter with the solution cooled to <10 
o
C (ice/water). 
The thermal isomerisation of cis- 90 has also been optimised to 10 min at 60 
o
C.  
 
Scheme 1.47. Synthetic route to 90 and photochemistry. 
 
It has been demonstrated that it is possible to modify the pyramidal inversion rate of 
this molecule using only the physical inputs of light and heat. This process proceeds 
without degradation and can be cycled at least three times sequentially. This 
represents the first example of photocontrolled pyramidal inversion. The standard 
Gibbs free energy of activation for trans-90 (39.2 kJ mol
-1
) and cis-90 (41.7 kJ mol
-
1
) has been determined using complete line shape fitting. A difference in the Gibbs 
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free energy of activation between the two isomers equal to 2.5 kJ mol
-1
 has been 
determined with the cis isomer having a higher activation barrier. This equates to 
>2.8 fold difference in the rate at 298 K. The experimental values are supported by 
computational methods, which slightly overestimated the difference in the activation 
barrier (G‡  = 3.6 kJ mol-1) 
 
However, there is still significant scope for development since the cis isomer is less 
thermally stable (t1/2 = 90 min at 298 K) than hoped, due to the push – pull nature of 
this azobenzene. Only a relatively low conversion to the cis isomer can be achieved 
(ca 56%). Whilst the cis isomer appears to be stable below 10 
o
C, at room 
temperature it is found to rapidly revert to the trans isomer. It may be possible to 
solve these problems by moving to a push – push azobenzene system (Scheme 1.48), 
which could result in a change to the pyramidal inversion for the same reasons. 
These molecules have been reported to be more thermally stable,
88
 however 
reports,
104
 and our own experiments, suggest that an alternative synthetic pathway 
would be required. This is because it is only possible to complete the selective 
tosylation step 103 – 107 when there is a directly conjugated and strongly electron 
withdrawing group in the ring system. 
 
Scheme 1.48. Potential Push-Push azobenzene system. 
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2.1 Introduction 
2.1.1 Antimicrobial Agents 
2.1.1.1 History 
β-Lactams are one of the largest families of antibacterial compounds, along with 
macrolides and fluoroquinolones (Figure 2.1).
114
 The serendipitous observations of 
an apparent bacterial exclusion zone around the fungus Penicillium rubens by 
Fleming in 1928
115
 led to the discovery of penicillin. This in turn led to the 
development of a variety of penicillins and cephalosporins for use as antibiotics.
116
  
 
 
Figure 2.1. Important antibiotic families. 
 
 
Figure 2.2. Families of commercial β-lactam antibiotics.117 
 
In order to combat the growing rise of antibiotic resistant bacteria, the cephamycins 
were developed in the 1970s and were found to be more resistant to β-lactamases, 
which are the origin of bacterial resistance. There followed an explosion in new 
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classes of β-lactams discovered from natural sources, which proved to be both potent 
and relatively resistant to β-lactamases. This prompted further synthetic 
investigations, which allowed the diversification of existing families and the creation 
of new ones that were not derived from natural sources, such as the monobactams, 
carbapenems, cephabacins and formadicins (Figure 2.2).
118
 
 
 
Figure 2.3. Families of commercial β-lactam antibiotics.117 
 
2.1.1.2 Importance in Modern Medicine 
At the time of their discovery, penicillin based β-lactams were the first drugs capable 
of treating previously serious bacterial infections from Syphilis, Staphylococci and 
Streptococci. Since then the diversity of β-lactams has greatly increased and 
subsequently so have the number of infections that can be treated. However, 
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alongside the increased use of β-lactams, the number of bacteria developing 
resistance to them has also multiplied.
119
 
 
During the boom years of β-lactam development, huge numbers of antibiotics were 
developed, along with new methodologies to synthesise them. As the number of new 
antimicrobial compounds grew, and the number of approved treatments became 
comprehensive, interest in further development faded. 
 
However, due to the prevalent rise of bacteria resistance to all but a few current 
products, scientific interest has returned to focus on known and novel families of 
antibiotics in order to diversify their structures and combat the growing resistance. 
Recent novel antimicrobial families include the Pleuromutilins 122
120
 and 
Lipopeptides 123
121
 (Figure 2.4). However, development is very expensive with a 
low return for the pharmaceutical companies since the new antibiotic families are 
being reserved as a last line of defence. The introduction of structurally unique β-
lactams is another method
122,123
 which might help in the fight against antimicrobial 
resistance, but may also expand the applications of β-lactams into new areas. To go 
alongside this, new synthetic strategies must be investigated that will allow for facile 
access to structures quite distinct from common β-lactams.124-126 
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Figure 2.4. Members of the Pleuromutilins (left) and Lipopeptides (right); both new approved 
treatments against Gram-positive skin infections.  
 
β-lactams are also an important class of compounds beyond their application as 
antibiotics. The functional β-lactam moiety is found in many more biological 
applications and is a feature of some herbicides
127
 as well as showing activity against 
certain cancer cells.
128
 Their high ring strain energy makes them much more reactive 
than normal amides, making them useful intermediates in the synthesis of more 
complex products.
129,130
 Therefore the development of methodologies towards new 
classes of β-lactams is an important contribution to the knowledge base of organic 
synthesis.  
 
2.1.1.3 Mechanism of Action 
β-lactams work by disrupting the action of transpeptidase enzymes, which cross-link 
the bacterial cell wall. The rigid cell wall is comprised of alternating N-
acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) units. Each NAM unit 
has a pentapeptide attached to it, which contains a D-alanine subunit. Two of these 
D-alanine residues are then cross-linked by the transpeptidase enzyme. These 
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enzymes, also known as penicillin binding proteins (PBPs), are responsible for the 
final cross-linking step in the formation of the peptidoglycan layer of the cell wall, 
which makes it rigid and gives osmotic stability (Figure 2.5).
131
  
 
 
Figure 2.5. Cross-linking of bacterial cell wall. 
 
Without this cross-linking event, the cell wall ruptures, resulting in cell death. The 
penicillin binding proteins have a high affinity for the β-lactams, because the lactam 
closely mimics the D-alanine – D-alanine region of the NAM pentapeptide. The PBP 
mistakenly recognises the β-lactam molecule as another building block in the cross-
linking process, and binds to it. However, once bound, the lactam ring is irreversibly 
opened causing acylation of the PBP, thereby blocking its function and leaving the 
bacterial cell wall in a weak state (Figure 2.6).
132
  
 
 
Figure 2.6. Mechanism of action of penicillin. 
 
Infections caused by Gram-positive bacteria are most commonly treated using β-
lactams because the peptidoglycan layer is the outer, most crucial, layer in the cell 
wall. Gram-negative bacteria, however, have a second membrane outside of the 
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peptidoglycan layer, which consists of lipopolysaccharides and proteins. This 
additional membrane means that Gram-negative bacteria are much less susceptible to 
β-lactam antibiotics because the peptidoglycan layer is less crucial to the stability of 
the cell wall.
133
   
 
2.1.1.4 Resistance to β-lactams 
The growing resistance of many bacteria to β-lactam antibiotics is of increasing 
concern and raises fears of untreatable common infections, similar to those seen 
before the invention of modern antibiotics. The major causes of resistance to 
antibiotic medication are largely preventable, however, on a global scale this is 
proving very difficult to manage. Once drug treatment has been initiated, it is 
imperative that the treatment is continued until the bacteria are eradicated. If 
treatment is terminated early, even if symptoms have been alleviated, the surviving 
bacteria can develop resistance.
134
 
 
It is a stark reminder of the power of evolution that bacteria are able to mutate so 
effectively over a relatively short amount of time.
135
 There are four modes of 
resistance observed in bacteria.
136
 Firstly, it is possible that the penicillin binding 
protein can be modified so that it is less susceptible to binding with β-lactam 
containing antibiotics, thereby significantly reducing the effectiveness of some 
drugs. An example of this mode is found in the bacteria Streptococcus pneumonia, 
where natural transformation and recombination of DNA from other organisms has 
led to PBPs with a low binding affinity for β-lactams and therefore a high level of 
resistance. Horizontal gene transfer has led to a spread of resistance to other related 
organisms such as MRSA (Methicillin-resistant Staphylococcus aureus) bacteria. In 
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most cases, resistance evolves against specific β-lactam families, which still allows 
successful treatment with structurally different β-lactams.137  
 
Another mode of resistance is the production by the bacteria of other proteins with 
the express purpose of destroying the β-lactams by hydrolysis. This is one of the 
most common modes of defence, especially amongst Gram-negative bacteria, which 
are the hardest to treat. These so-called β-lactamases can be very efficient at 
hydrolysing the β-lactam ring before the drug is able to act. This can be overcome by 
delivering the antibiotic with a β-lactamase inhibitor such as clavulanic acid, 
Sulbactam, Tazobactam and Aztreonam (Figure 2.7).
138
 Azetreonam was originally 
developed as a stand alone antibiotic, however, it was found to be an efficient 
inhibitor as it is readily ring opened by some β-lactamases and has been found to be 
especially effective at fighting cephalosporinases. These inhibitors are also β-
lactams, but the interaction with β-lactamases must be different in order to be 
effective. Most β-lactamases are able to quickly hydrolyse many molecules of 
antibiotic without being deactivated, but an effective inhibitor, often called a 
“suicide inhibitor,” must either permanently bind with the β-lactamase, or remain in 
the active site for a prolonged period. 
 
 
Figure 2.7. Effective β-lactamase inhibitors.139 
 
Towards Light-Activated Antimicrobial Agents  Alexander J Hough 
 
- 98 - 
 
For β-lactams to be effective they must diffuse through the outer membrane of the 
bacterial cell wall in order to access PBPs on the inner plasma membrane. This 
diffusion is aided by outer membrane proteins on the surface of the bacteria cell. 
Some bacteria such as Escherichia coli have developed resistance to carbapenems by 
reducing the expression of these outer membrane proteins.
140
  
 
Finally, some bacteria have developed efflux pumps in the cell wall that are capable 
of removing β-lactams from inside the cell. This can be very effective in Gram-
negative bacteria where the additional outer cell membrane already makes it difficult 
for drug molecules to permeate into the cell.
141
 
 
2.1.2 Photoactivation in Medicine 
Radiation has long been used for treatment and diagnosis in medicine. The use of 
visible or near visible light is a treatment field called phototherapy and is already 
used to directly treat vitamin D deficiency, neonatal jaundice, autoimmune diseases 
and bipolar disorder. Indirect phototherapy is an emerging field where an 
administered molecule absorbs light and the photoexcited molecule undergoes a 
subsequent range of processes that provide biological activity. This may be a 
photochemical reaction of the molecule, a photoreaction with surrounding 
biomolecules or an energy/electron transfer. 
142
 Vitamin D3 formation is an excellent 
example of a biologically active molecule being formed in vivo through the action of 
light
143
 (Scheme 2.1). 
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Scheme 2.1. Photochemical formation of vitamin D3. 
 
The technology allows for temporal and spacial control of an active compound with 
the use of a light source. A non-toxic prodrug can be delivered, which ideally bio-
accumulates in the target region and can then be activated at the required time using 
light. Light penetration of human tissue is dependent on a number of factors such as 
pigmentation, adsorption by haemoglobin and myoglobin, and light scattering. Light 
of longer wavelength (600-700 nm) penetrates 1.5 - 3 times further than shorter 
wavelengths (400-500 nm).
144
 The prodrug can be activated locally, either topically 
(in the skin) with broad spectrum lamps, or internally using laser light sources 
attached to fibre optics.  
 
Cancer treatment is an area of great interest as many anti-cancer agents are also toxic 
to normal human cells and processes, as well as the targeted cancer cells. If the 
treatment is confined to the area of the tumour cells, the adverse effects on the rest of 
the body are more limited.
145
 Photodynamic therapy (PDT) is becoming an 
increasingly important line of anti-cancer research. Where phototherapy uses a 
prodrug and light, photodynamic therapy relies on a non-toxic sensitizer molecule 
and a third element, oxygen.
146
 Sensitizers are commonly based on porphyrins, 
147
 a 
range of which have been approved for clinical use to treat a variety of abnormalities 
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(Figure 2.8). The sensitizer molecule is excited, commonly with long wavelength 
(620-850 nm), this energy is then transferred to triplet oxygen, promoting it to 
cytotoxic singlet oxygen. Singlet oxygen then causes DNA and protein disruption to 
surrounding cells leading to tumour death. Unfortunately, PDT treatments can be 
hindered by low oxygen concentrations (common in rapidly growing tumour cells), 
causing damage to blood components (from singlet oxygen) and poor compound 
solubility.
148
 
 
 
Figure 2.8. Clinically approved PDT sensitizers.
149-151
 
 
More recently, metal-porphyrin complexes have addressed some of these restrictions 
with strong adsorptions at longer wavelengths (600-900 nm) and higher quantum 
yields. Lutetium texaphyrin is a Lu
3+
 porphyrin that is approved for PDT treatment 
of cervical, prostrate and brain tumours.
152
 More significantly, organometallic 
complexes are being developed that interact directly with DNA without the need for 
supplementary high oxygen concentrations.
153
 Photocleavage of DNA with Rh
3+
 
arene complexes have been shown to weakly bind to DNA in the dark and, on 
excitation (320-440 nm),
154
 LMCT causes a hydrogen abstraction from a 
deoxyribose sugar ring of the DNA ultimately causing cleavage.
155
 Pt
2+
 anticancer 
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agents such as oxaliplatin, satraplatin and picoplatin have proven themselves as 
lifesaving therapeutics. However, there are problems with intrinsic resistance and 
general toxicity.  
 
Pt
4+
 azide compounds 132 offer greater points of structural diversity, better aqueous 
solubility and lower toxicity. The area to be treated can then be irradiated with light 
(~400 nm) to induce a photoreduction to form aggressive Pt
2+
 complexes that are 
concentrated only in the locale of the affected areas (Scheme 2.2).
156
 
 
 
Scheme 2.2. Irradiation of Pt
4+
 compounds to form Pt
2+
 complexes. 
 
In the treatment of bacterial infections, some of the same advantages of phototherapy 
are still applicable. Infections on the exterior of the body or those that can be easily 
accessed with fibre optics, such as those of skin, eyes or oral, would allow for either 
targeted or time delayed treatment.
157
 There is also a large interest in the 
development of surface coatings that have antimicrobial properties for use in 
hospitals and other high risk areas, in order to combat the spread of life-threatening 
infections. Some researchers have demonstrated materials where the antimicrobial 
properties are continually being renewed through the action of light.
158
 
 
Another mode of phototherapy is the photochemical interconversion of an inactive 
compound into a bioactive one. A relevant attempt at this has been demonstrated by 
Capps et al,
159
 who used light induced electrocyclisations of 2-pyridones to make 
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cephalosporin derivative 135. Unfortunately, 135 proved unstable and readily 
transformed back into pyridone 134. This was postulated as being due to the sulfur 
appendage donating electron density into the β-lactam ring system, causing ring 
cleavage (Scheme 2.3).
160
 However, small molecule prodrugs such as these remain 
an attractive target. Photoisomerisation of these prodrugs to biologically relevant 
molecules may be important in future medicinal treatments. 
 
 
Scheme 2.3. Light induced electrocyclisations by Capps et al.
159
  
 
Indeed, phototherapy in general continues to be a relevant area of research, and a 
growing mode of treatment for a variety of ailments, especially in view of increasing 
antibacterial resistance. 
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2.2 Results and Discussion 
2.2.1 Introduction 
In light of the prominence of β-lactams as antimicrobial agents, we set out to explore 
whether such compounds could be generated by photochemical methods, with a view 
to the development of novel, light-activated antimicrobial agents. 
 
Ideally, the precursor must be highly stable, non-toxic and biologically inactive, but 
easily synthesised using high yielding reactions and purifications. Preferably, the 
precursor would readily undergo a high yielding, photochemical transformation upon 
irradiation with low energy visible / near visible light. This would yield a significant 
biological functional group, region or shape, which then gives the molecule a high 
level of biological activity.  
 
The β-lactam ring is a key functional group in a large and diverse family of 
antibiotics, which are also finding applications in other medicinal treatments. A wide 
range of structurally diverse β-lactams are known to be highly effective 
antimicrobial agents but, with rising levels of resistance, new and unusual structures 
are still relevant.
161
 Additionally, there are a number of possible photochemical 
routes to β-lactams. 
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2.2.2 Anthracene Isomerisations 
 
 
Scheme 2.4. β-lactam formation from the isomerisation of anthracenes.162 
 
In 1968 Appelquist et al
162
 made 137 as part of their extensive investigations focused 
on the development of a reliable synthesis of 138. The formation of 137 was found 
to be very slow, requiring 14 days of intense irradiation to achieve a 50% yield. 
Presumably this was due to the rotamer populations being unfavourable for the 
photochemical reaction to proceed (Scheme 2.5). Whilst β-lactam 137 was isolated, 
limited data was provided and no studies of its bioactivity were reported. We 
reasoned that this chemistry could provide an interesting way to generate potentially 
new antimicrobial agents through photoactivation.  
 
 
Scheme 2.5. Proposed rotamer populations. 
 
We reasoned that it would be possible to functionalize 136 by alkylating the nitrogen 
with a number of substituents, which would hopefully improve solubility, enhance 
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biological activity and, importantly, push the rotamer population towards the right 
hand side, improving the photochemical isomerisation (Scheme 2.5). 
2.2.2.1 β-Lactam Synthesis 
Our investigations comprised of a number of aims. Firstly, to develop a family of 
simply derived β-lactams by alkylation and photocyclisation of 136. This family of 
β-lactams and their precursors could then be screened in biological tests against 
simple Gram-positive and Gram-negative bacteria. Ideally, a compound could be 
found that exhibits good antimicrobial activity whilst its precursor displayed little or 
no biological activity. 
 
Additionally, the reaction time documented for the conversion of 136 to 137 is long 
and low yielding. We postulated that this was most likely due to the population of 
amide rotamers in the secondary amide (vide supra). We hoped to establish the 
benefit of N-substitution on the propensity of the photoreaction to occur. 
 
9-Aminoanthracene 59 was synthesised following published procedures
80
 (Scheme 
2.6). First, 9-nitroanthracene 140 was prepared by nitration of anthracene in 70% 
yield and then reduced using tin (II) chloride in concentrated hydrochloric acid to 
give 59 in 76% yield. 9-Aminoanthracene 59 was found to oxidize easily and 
required storage at 10 oC, away from sources of light.  
 
 
Scheme 2.6. Synthesis of 9-aminoanthracene 59. 
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Carboxylic acid 141 was converted to the acid chloride 142 by refluxing in thionyl 
chloride, with the reaction confirmed by a shift in the C=O IR vibration from 1678 to 
1779 cm
-1
. Due to its instability, acid chloride 142 was used immediately in the next 
step. Acid chloride 142 was directly heated with amine 59 in toluene, in the presence 
of pyridine, giving amide 136 in 32% yield (Scheme 2.7). Purification of this amide 
by recrystallisation from benzene, as reported in the literature,
162
 proved difficult due 
to its extremely poor solubility. More worryingly, attempts to isomerise 136 to 137 
using a 125 W medium pressure Hg lamp and Pyrex filter during laboratory working 
hours for 5 days (lit. 14 days
162
) were completely unsuccessful, with no indication of 
isomerisation by 
1
H NMR. This supports the assertion that the secondary amide is 
particularly difficult to isomerise due to unfavourable rotamer populations.  
 
 
Scheme 2.7. Synthetic route towards 137. 
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Treatment of secondary amide 136 with sodium hydride, followed by addition of an 
electrophile, was successful in producing a wide range of tertiary amides 143 – 147 
(Table 2.1). Methylation, mesylation and tosylation were carried out with good 
conversions, as evidenced by crude 
1
H NMR. Sulfonamides 144 and 145 were made 
because N-sulfur containing lactams are very effective antibiotics.
163
 However, 
during purification of these materials, lower than expected recovery of material was 
obtained. In the case of mesylated compound 144, the product was obtained cleanly 
but in a significantly lower yield than the crude conversion indicated. Tosylated 
product 145 and methylated 143 were also obtained in much lower than expected 
yields, however, they were also contaminated with significant quantities of 
isomerised products 150 and 148. The presence of the dimerised anthracene unit was 
clearly indicated by the appearance of an AB system in the 
1
H NMR spectrum 
around 4.6 ppm, which was not observed in the initial crude 
1
H spectrum (Table 2.1, 
entries 1-3). The alkylated tertiary amides also displayed secondary signals in the 
1
H 
NMR, these were determined to be rotomer signals and not isomers by noting a 
change in the relative integrals of these peaks in different NMR solvents for 
compound 152. 
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Scheme 2.8. Amide substitution. 
 
Entry R-X R Yield Compound
 
1 MeI Me Isolated
*
 143 
2 MsCl Ms 32% 144 
3 TsCl Ts Isolated
*
 145 
4 
  
Not isolated
‡
 
146 
5 
  
Not isolated
‡
 
147 
 
Table 2.1. Amide substitution. 
*
Product was purified by chromatography, however further 
spontaneous isomerisations occurred. 
‡
No attempts were made to isolate these products due to 
spontaneous isomerisations. 
 
Ethyl bromoacetate was used as an electrophile to provide lactam 152. Firstly, the 
ester itself was an interesting target, but this compound could also be hydrolysed to 
give the corresponding carboxylic acid, which is a common fragment of many highly 
active antibiotics and might be expected to improve solubility in aqueous media. p-
Methoxybenzyl bromide was also used as an electrophile in order to produce the 
related lactam 151. This compound gave the opportunity of removing the PMB 
group in the final lactam, using CAN to yield the parent β-lactam, which we had 
been unable to synthesise using the reported photochemical method.  
 
Alkylated compounds 146 and 147 were also observed to quickly isomerise in 
ambient conditions. Due to the low recovery of compounds 143 – 145 and because 
Towards Light-Activated Antimicrobial Agents  Alexander J Hough 
 
- 109 - 
 
the crude 
1
H NMR spectroscopy data showed that the reaction was relatively clean, 
we decided to circumvent these problems by directly photoisomerising the alkylated 
products after a standard aqueous work-up. 
 
Substituted amides 143 – 147 were much more soluble, particularly in the case of the 
N-methyl derivative. Importantly, the observed spontaneous isomerisation of the 
crude mixtures of 143 - 147 strongly suggested that the substitution had a direct 
impact on the amide rotamer populations and made the photoisomerisation much 
more facile, even under low energy light conditions. 
 
 
Scheme 2.9. Photoisomerisation of tertiary amides. 
Entry Method R Yield Compound 
1 A Me 10% over 2 steps
* 
148 
2 A Ms 65% 149 
3 A Ts 10% over 2 steps
* 
150 
4 B 
 
37% over 2 steps 151 
5 A 
 
33% over 2 steps 152 
 
Table 2.2. Photoisomerisation reactions. Method A: Irradiation with 125 W medium pressure Hg 
lamp for 1 h in benzene. Method B: a solution of the tertiary amide in chloroform was stirred in direct 
sunlight for 4 h. 
*
 The yield may have been significantly improved by not attempting to isolate the 
tertiary amide. 
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Initially, photoisomerisation was achieved using Method A, irradiating the sample 
with a 125 W medium pressure mercury lamp and quartz cooling jacket purchased 
from Photochemical Reactors Limited. A dilute sample of amides 143 – 145, 147 
(approx. 0.0012 M) was prepared in anhydrous benzene and thoroughly degassed by 
freeze pump thaw under high vacuum. Anthracene photoisomerisations are very 
sensitive to dissolved oxygen in the solvent
164
 which quickly fragments the 
compounds via the formation of anthraquinone. In order to obtain results with 
minimal oxidation observed, the solution had to undergo five freeze pump thaw 
cycles with argon being bubbled through the melted solution between cycles. The 
required high dilution of the reaction solution and the careful degassing made the 
process lengthy and limited the quantity of material that could be prepared. 
 
To filter the broad output spectrum of the Hg lamp, we opted to use solution based 
filters, which allowed for greater control of the wavelengths of light that were to be 
filtered out, than individual multi coated glass filters. Zimmerman has reported
108
 a 
number of highly effective, long lasting filters which can be used on their own or 
together to form bandpass filters. Many anthracene isomerisations are known to 
proceed well with irradiation at 360 nm. Higher energy irradiation can cause retro 
[4π + 4π] cycloaddition, degradation and oxidation. To avoid these problems, a < 
355 nm cut-off filter using bismuth chloride in dilute hydrochloric acid (0.0012 M 
BiCl3 in 2:3 conc. HCl:H2O), as reported by Zimmerman, was optimal since 
transmission below 355 nm was negligible and effectively filtered out by the Pyrex 
reaction vessels.
111
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Method B was based on observations of how efficiently and cleanly the tertiary 
amides isomerised under ambient light. Crude NMR samples that were exposed to 
sunlight were analysed over a number of hours by 
1
H NMR spectroscopy and 
indicated that the transformation was relatively fast and efficient. Importantly, even 
though the solvent was not degassed, there were very minimal traces of any 
anthracene oxidation occurring. 
 
It was found that by dissolving the crude mixture of 146 in chloroform and exposing 
the stirred solution to direct sunlight under a normal atmosphere for 4 hours, the 
compound would isomerise almost completely with minimal oxidation. This method 
was found to be very effective as it completely negates the need for lengthy 
degassing and was not limited by solvent volumes which was a major drawback with 
Method A. The ability of these compounds to isomerise under these milder 
conditions heightened our interest, as the potential to be activated under such 
conditions made their medicinal use much more plausible in a similar fashion to the 
in vivo synthesis of vitamin D3.
165
 
 
Successful photoisomerisation of these compounds was quickly determined by the 
appearance of two coupled AB doublets around 4.6 ppm in the 
1
H NMR spectrum 
and the disappearance of characteristic aromatic anthracene signals. The formation 
of a β-lactam ring was confirmed by the presence of a strong IR stretch at 
approximately 1745 cm
-1
. This was supported by the x-ray crystal structure of 154 
(Figure 2.9), obtained from a single crystal grown using the solvent diffusion method 
(CHCl3, Et2O). 
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Figure 2.9. X-ray crystal structure of 154. 
 
A common motif in many β-lactam antibiotics is an N-acetic acid derivative (Scheme 
2.10). Treatment of 152 with sodium hydroxide in a THF / water (1:1) solution 
yielded the product which was initially isolated as the sodium salt 153 and used for 
preliminary biological testing. The free acid 154 was also prepared cleanly using an 
acidic aqueous work-up. 
 
 
Scheme 2.10. Hydrolysis of 152. 
 
The spontaneous photoisomerisation was a welcome effect of the substitution of 
secondary amides 143 - 147, and had had a much greater effect than anticipated. 
Unfortunately, it made the isolation of the amide precursors extremely difficult. It 
was necessary to isolate a clean sample of an amide precursor to validate that any 
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observed biological activity was solely due to the β-lactam and to demonstrate that 
an inactive compound could be converted to an active one using light. To achieve 
this, it was necessary to complete the synthetic and purification steps with the 
exclusion of ambient light. Amide 136 was alkylated and purified to form 147 using 
the same conditions as before but in a darkened room and isolated in 20% yield. 
Attempts to hydrolyse 147 using the established conditions (Scheme 2.11) were 
unsuccessful, but heating the reaction mixture to reflux for 6 h, followed by an acidic 
aqueous work-up yielded carboxylic acid 155 in 44% yield. 
 
 
Scheme 2.11. Synthesis of amide precursor 155. 
 
Even though we had been unable to access the unsubstituted β-lactam 137 through 
the reported photochemical route, the compound was still a desirable target. 
Treatment of 151 with cerium ammonium nitrate, however, was not successful in 
removing the p-methoxybenzyl group (Scheme 2.12). 
 
 
Scheme 2.12. Attempted alternative synthesis of 137. 
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2.2.2.2 Biological Testing 
Lactam 148 was the first compound tested for antimicrobial activity against two 
common bacteria using the Kirby-Bauer method of agar diffusion.
166
 Bacillus 
subtilis was chosen as the Gram-positive bacteria and Escherichia coli as the Gram-
negative. They are commonly reported bacteria that are easy and relatively safe to 
use. Ampicillin was used as a positive control as it has a high activity against both 
strains. Loadings of the test compound 148 (10, 50, 200 & 500 μg) were dissolved in 
20 μL of dimethylsulfoxide and adsorbed onto filter pads which were then placed, 
along with a DMSO blank and ampicillin control, on an agar plate inoculated with 
each bacteria. Each experiment was carried out in duplicate and incubated overnight 
to allow a bacterial lawn to develop. 
 
It was possible to clearly identify the zones of inhibition around the filter pads after 
bacterial lawn growth. Importantly, the DMSO control did not retard the growth of 
bacteria, confirming it was an acceptable solvent for the loading of the compounds. 
Unfortunately, there was no evidence of inhibition around any of the pads loaded 
with the prepared β-lactam 148. 
 
At this juncture, we decided to screen the remaining lactams 149 – 153 at the highest 
previous loading of 500 µg. Encouragingly, carboxylate salt 153 displayed a small 
zone of inhibition against B. Subtilis (Figure 2.10a). We were concerned that because 
this carboxylate salt had been used without purification (Scheme 2.10), impurities 
from the reaction could be providing a false positive result. To reassure ourselves 
that excess NaOH was not the active antibacterial agent, the impact of sodium 
hydroxide on the bacterial strains was investigated. Based on estimations of any 
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possible unreacted sodium hydroxide, loadings of 10, 50 and 100 µg were tested. At 
these levels sodium hydroxide was not found to affect the bacterial growth in any 
way.   
 
 
Figure 2.10a. (B. Subtilis)                                               Figure 2.10b. (E. Coli) 
Biological testing, 500 μg loading. 
1 = DMSO, 2 = 150, 3 = 149, 4 = 152, 5 = 151, 6 = 153, 7 = Ampicillin 20 μg 
 
We wanted to test the carboxylic acid to compare its activity against the sodium salt. 
Compound 154 was synthesised using the same method, however, during workup, 
the mixture was acidified and extracted to yield the clean carboxylic acid. This acid 
was tested as before with loadings of 31, 63, 125, 250, 500 µg. The highest four 
loadings showed approximately the same zone of inhibition against Gram-positive B. 
Subtilis. The lowest loading displayed a very slight reduction in this zone (Figure 
2.11a). No activity against the Gram-negative E. Coli was observed (Figure 2.11b). 
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Figure 2.11a. (B. Subtilis)                                               Figure 2.11b. (E. Coli) 
Biological testing of 154. 1 = DMSO, 2 = 31 μg, 3 = 63 μg, 4 = 125 μg, 5 = 250 μg, 6 = 500 μg, 7 = 
Ampicillin 20 μg 
 
The observation that the extent of the zone of inhibition does not increase with 
increased concentration, suggests that diffusion in the agar media may be restricted 
by poor solubility. 
 
At this juncture we had established that lactam 154 is a weak antimicrobial agent. 
The next step was to confirm that the β-lactam ring was responsible for this activity. 
Amide 155 was carefully prepared and purified in a dark room, to avoid 
contamination with β-lactam formed by spontaneous photoisomerisation in ambient 
light.  
 
Amide 155, along with lactam 154 as a comparison, were loaded onto agar plates 
inoculated with B. Subtilis and E. Coli in a dark room. Once all the plates had been 
loaded they were wrapped in foil to protect from light sources, and transferred to an 
incubator overnight. To our surprise and disappointment, amide 155 was found to be 
several times more active than its lactam isomer against B. Subtilis (Figure 2.12a) 
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and even displayed activity against E. Coli (Figure 2.12b). It therefore seems 
probable that the anthracene rings are important for the antimicrobial activity. 
Indeed, many drugs contain anthracene moieties
167
 and this functional group could 
disrupt DNA replication by mechanisms such as intercalation.
168
  
 
 
Figure 2.12a. (B. Subtilis)                                               Figure 2.12b. (E. Coli) 
Biological testing of 155. 
1 = DMSO, 2 = 60 μg, 3 = 125 μg, 4 = 500 μg, 5 = 154 500 μg, 6 = Ampicillin 20 μg 
 
2.2.2.3 Conclusions 
By substituting the nitrogen atom of amides 143 - 147, the rate of [4π+4π] 
cycloaddition has been markedly increased, reducing the reaction time from 14 days 
to 1 hour and allowing the reactions to proceed using low energy natural light. This 
cyclisation process is very clean, with little competitive oxidation of the anthracenes 
in deoxygenated solvent.  
 
Towards Light-Activated Antimicrobial Agents  Alexander J Hough 
 
- 118 - 
 
 
Scheme 2.13. Summary. 
 
A family of tertiary amides were synthesised which were easily isomerised into 
highly functionalised β-lactams on irradiation with a UV lamp or natural sunlight, 
for which the structures were confirmed by x-ray crystallography. The lactams were 
tested for antimicrobial activity against an example of a Gram-positive (B. Subtilis) 
and Gram-negative (E. Coli) bacteria. Unfortunately, only compound 154 displayed 
a modest activity against B. Subtilis with the remaining compound family proving to 
be ineffective (Scheme 2.13).  
 
The zone of inhibition was small but may be limited by two factors. It may be 
limited by poor solubility and diffusion of the compounds, which is supported by the 
extent of inhibition being unchanged at different compound loadings. Alternatively, 
the activity may be limited due to restricted reactivity of the compound. We 
postulate that the steric bulk of the di-anthracene rings prevents nucleophilic attack 
on the lactam ring, even though this ring system is highly strained (Figure 2.13). 
This is supported by the x-ray structure, which indicates approach at the Bürgi-
Dunitz angle is blocked by the facing aromatic rings, and also by the fact that 
hydrolysis of the ester (Scheme 2.10) can be achieved without significant ring 
opening of the lactam nucleus. 
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Figure 2.13. The Bürgi-Dunitz approach super-imposed on the crystal structure of 154. 
 
The intention was that the tertiary amide would serve as a prodrug to be converted to 
the active compound with light. Isolation of this compound was challenging due to a 
spontaneous isomerisation in ambient light, however, this was achieved in a dark 
room. To our consternation, when the corresponding uncyclised derivative 155 was 
evaluated biologically, it demonstrated considerably higher activity than lactam 154. 
In view of these disappointing results we decided to explore an alternative approach 
based on 2-pyridones. 
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2.2.3 2-Pyridone Isomerisations 
It is widely known that when 2-pyridones 156 are exposed to ultraviolet light, an 
isomerisation occurs to yield bicyclic β-lactam 157 (Scheme 2.14). In comparison to 
our earlier work on anthracene based systems, these lactams are less sterically 
crowded and, without the two anthracene rings, potentially more soluble.  
 
 
Scheme 2.14. Photochemical isomerisation of 2-pyridones. 
 
In section 2.2.2, we demonstrated that β-lactams can be synthesised through the 
action of light in an efficient manner. However, these anthracene based systems were 
hampered by poor solubility and steric overcrowding, which together hampered their 
ability to display useful antimicrobial activity. 2-Pyridones such as 156 are well-
known for electrocyclic ring closure upon irradiation with ultraviolet light to form 
fused β-lactams. This interconversion was first demonstrated by Corey.169 As 
previously noted, Capps et al has attempted to form β-lactam antibiotics in this way, 
focussing on lactams fused with sulfur containing rings, which are common in many 
commercial antibiotics such as the penicillins and cephalosporins (Scheme 2.3). 
Begley et al
170
 synthesised a family of related compounds, derived from the 
photoisomer of N-benzyl-oxycarbonylmethylene-2-pyridone (Scheme 2.15). 
Lactams 159 – 163 were tested for biological activity against a range of Gram-
positive and -negative bacteria. Unfortunately, no activity was detected for these 
simple derivatives.
170
 However, we believed further structural diversification based 
on known β-lactam antibiotics may lead to biological activity. 
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Scheme 2.15. Derivatives by Begley et al.
170
 
 
We reasoned that this interconversion could provide an attractive alternative solution 
to the anthracene based systems. Key advantages include better solubility and 
increased ring strain energy that is derived from the fused bicyclic structure. 
Additionally, the lactam ring opening should be easier due to a less hindered 
nucleophilic approach, in turn leading to higher activity against bacteria. The 2-
pyridone structure also offers many more sites for functionalisation to fine tune the 
structure in order to optimise activity. 
 
2.2.3.1 Synthesis of 2-Pyridones and Photoisomers 
We started our investigations by targeting 4-methoxy-2-pyridones, as it has been 
reported that the 4-methoxy group greatly increases the efficiency of the 
photochemical isomerisation.
171
 4-Methoxypyridine-N-oxide 165 was synthesised by 
nucleophilic aromatic substitution of 4-nitropyridine-N-oxide in 90% yield. 
Isomerisation of this compound to pyridine 167 using acetic anhydride was achieved 
in 39% yield by first forming ester 166, which was subsequently cleaved through 
stirring in methanol/water to form 167 (Scheme 2.16).  
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Scheme 2.16. Synthesis of 167.  
 
A solution of 167 in acetonitrile was degassed by freeze pump thaw cycles, then 
irradiated with a 125 W medium pressure Hg lamp and a bismuth chloride <355 nm 
cut-off filter (0.0012 M BiCl3 in 2:3 conc. HCl: H2O).
108
 This isomerisation was 
found to be much slower than with anthracene systems 143 - 147, and required 
irradiation for 24 h to achieve complete conversion to 168. Nevertheless, the reaction 
was very clean with no observed side products. The isomerisation was confirmed by 
an upfield shift of aromatic resonances in the 
1
H NMR and the appearance of a 
strong shift at 1740 cm
-1
 in the IR spectrum, indicative of a β-lactam ring. 
 
 
Scheme 2.17. Isomerisation of 167 to 168. 
 
Confident that this chemistry worked well, we set out to produce a range of β-
lactams that might more closely map onto the structures of known antibiotics. In this 
way, we hoped to make some derivatives that should possess good levels of 
biological activity. Nocardicin A was chosen as a basis for structural mapping as it is 
a naturally produced monobactam that possesses good activity against Gram-
negative bacteria, notably against Pseudomonas
172,173
 (Figure 2.14). Substitution of 
the 4-methoxy group with 4-benzyloxy would hopefully allow for a better structural 
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mapping over the 3’-6’ aromatic ring of Nocardicin A. It was then hoped that 
alkylation of the pyridine nitrogen would lead us to a wide range of simple targets 
that could be tested for biological activity. The electrophiles were chosen based on 
previous success with the anthracene systems and common antibiotic functionality. 
 
 
Figure 2.14. β-lactams  based on Nocardicin A.174 
 
4-Benzyloxypyridine-N-oxide was prepared using a modification of the earlier 
procedure. Benzyl alcohol was deprotonated with sodium, then reacted with 4-
nitropyridine-N-oxide in 52% yield. The isomerisation was achieved in the same 
manner with acetic anhydride in an improved 50% yield (Scheme 2.18). 
 
 
Scheme 2.18. Synthesis of 170. 
 
  
Towards Light-Activated Antimicrobial Agents  Alexander J Hough 
 
- 124 - 
 
Alkylation of 2-pyridones 167 and 170 was achieved with electrophiles ethyl 
bromoacetate and 174, using potassium carbonate and dimethyl formamide to give 
the desired products in moderate yields (Table 2.3). Electrophile 174 was prepared 
following a reported procedure in comparable yields (Scheme 2.19).
175
 Hydrolysis of 
esters 175 - 176 using lithium hydroxide proved to be unsuccessful, yielding a 
complex mixture of products. 
 
 
Scheme 2.19. Synthesis of electrophile 174. 
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Scheme 2.20. Alkylation of 167 and 170. 
Entry R1 R2 Yield Compound 
1 Me 
 
73% 175 
2 Bn 
 
55% 176 
3 Bn 
 
53% 177 
 
Table 2.3. Results for the alkylation of 167 and 170. 
 
Compounds 175 - 177 were irradiated using a 125 W medium pressure Hg lamp with 
a concentration of 1mM in acetonitrile. In the case of the NH pyridones 167 and 170, 
the reaction was high yielding and very clean (Table 2.4). Pyridone 176 was 
successfully electrocyclised, however, significant side products were also produced, 
reducing the yield to 57%.  
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Scheme 2.21. Irradiation of 2-pyridones. 
 
Entry R1 R2 Time Yield Compound 
1 Me H 1 day Quant 168 
2 Bn H 1 day 79% 178 
3 Bn 
 
2 days 57% 179 
 
Table 2.4. Electrocyclisations of 167, 170 and 176. 
 
Substituted pyridones 175 and 177 proved more challenging as the electrocyclisation 
was a minor photochemical product which could not be effectively separated from 
the impurities. Therefore a different approach was required. As both NH pyridones 
isomerised cleanly, it was possible to gain access to lactam 180 via alkylation of the 
NH β-lactam. β-Lactam 167 was alkylated with ethyl bromoacetate using potassium 
carbonate in DMF (Scheme 2.22). The yield was moderately low (38%), but gave 
access to the compound for biological testing. However, repeating this reaction with 
electrophile 174 and lactam 170 was unsuccessful, possibly due to the increased 
steric crowding around the electrophilic centre. 
 
 
Scheme 2.22. Alternative route to β-lactam 180. 
Towards Light-Activated Antimicrobial Agents  Alexander J Hough 
 
- 127 - 
 
2.2.3.2 Biological Testing 
Four lactams 168, 178 - 180 were subjected to testing against B.Subtilis and E. Coli 
using the Kirby Bauer test. All four compounds were loaded on to the same plate at 
500 μg, along with DMSO and 20 μg ampicillin as negative and positive controls 
respectively. 
 
After incubation overnight, it was clear to see that there was no zone of growth 
inhibition around any of the test compounds. However, there was clearly a reddish 
discolouration of the agar, extending in a large radius around the compounds, 
especially noticeable around compounds 179 and 180 (Figure 2.15). One possible 
explanation is that the compounds are far more soluble and diffuse much more 
readily than the anthracene systems. However, this most likely indicates that these 
compounds are too reactive and are possibly subject to destructive reactions from the 
aqueous agar media. This leaves two potential problems, either the compounds are 
ineffective antimicrobial agents or they are being rapidly deactivated before any 
interaction with the bacteria could occur, thereby resulting in no observed activity. 
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Figure 2.15a. (B. Subtilis)                                               Figure 2.15b. (E. Coli) 
Testing results of lactams 500 μg loading. 
301 = 179, 308 = 178, 310 = 168, 312 = 180. 
 
2.2.3.3 Conclusions 
A small family of highly strained β-lactams derived from photochemical 
electrocyclisation of 2-pyridones were prepared. These compounds addressed our 
concerns regarding poor solubility, diffusion and hindered nucleophilic approach 
vectors. The lactam interconversion was very clean and effective with the NH 
pyridones, but more challenging with N-alkylated pyridones as the efficiency of the 
photochemical reaction dropped markedly. 
 
Unfortunately none of the tested compounds (168, 178 – 180) were found to have 
any antimicrobial activity. This may be a result of being too reactive, as high ring 
strain energy may make the β-lactam ring very prone to nucleophilic opening. 
Alternatively, these compounds may not be compatible treatments for the selected 
bacteria, and more encouraging results may be encountered by screening against a 
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broader spectrum of bacteria, or through further modification of the pyridone 
substituents to enhance binding to the penicillin binding protein. 
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Chapter 3: 
Experimental  
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3.1 General Procedures 
All reactions were performed under an atmosphere of dry nitrogen or argon in flame 
or oven dried glassware unless otherwise stated. Anhydrous solvents were purchased 
from Sigma-Aldrich or Fisher Scientific in Sure-Seal™ bottles for use as reaction 
solvents. All other solvents were reagent grade, used as received or purified by 
standard protocols where stated. Petrol refers to the petroleum ether fraction which 
boils in the range 40-60 
o
C for column chromatography or 60-80 
o
C for 
recrystallisations. 
 
Commercially available starting materials were used without further purification 
unless otherwise stated. Thin layer chromatography was performed on pre-coated 
aluminium-backed plates (Merck Silicagel 60 F254), visualised by UV 254 nm then 
stained with potassium permanganate or ceric ammonium molybdate solution. Flash 
chromatography was performed using Matrex silica 60. Melting points were 
recorded on a Gallenkamp MPD350 apparatus and are reported as observed. Single 
crystal X-ray diffraction data were obtained using a Siemens SMART XRD system 
or an Oxford Diffraction Gemini XRD system.  
 
Nuclear magnetic resonance (NMR) spectra were recorded on Bruker DPX (300, 
400, 500 or 600 MHz) spectrometers. VT NMR measurements were performed on a 
500 or 600 MHz spectrometer. Chemical shifts are reported in parts per million 
relative to the standard tetramethylsilane. The peak multiplicities were specified as 
singlet (s), doublet (d), triplet (t), quartet (q), quintet (quint). Coupling constants (J) 
are reported in Hertz.  
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Low resolution mass spectra were recorded on an Esquire 2000 platform with 
electrospray ionisation. High resolution mass spectra were obtained using a Bruker 
MicroTOF spectrometer. 
 
3.1.1 Photochemical Procedures 
All experiments carried out using a laboratory light source were done using 
equipment purchased from Photochemical Reactors Ltd (Berkshire, UK). The lamp 
used was a 125 W medium pressure mercury, high intensity discharge lamp (model: 
3010) supported by a 125 W power supply (Model: 3110). The lamp was cooled 
using an immersion quartz water jacket (Model: 3210). 
 
A variety of experimental setups and filters were used, which are detailed in 
Appendix 2. 
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3.2 Control of Molecular Motion Experimental 
9-Allyloxymethyl-anthracene (33) 
 
A known compound
59
 synthesized using a modified reported 
procedure.
176
 A solution of anthracene-9-yl methanol (1.00 g, 4.80 
mmol, 1.0 eq) in dry DMF (10 mL) was placed under nitrogen, 
stirred and cooled to 0 
o
C. Sodium hydride (60% in mineral oil, 210 mg, 5.30 mmol, 
1.1 eq) was then added, followed by allyl bromide (580 mg, 4.80 mmol, 1.0 eq) 
added dropwise. The resulting mixture was stirred for 1 h at 0 
o
C then allowed to 
warm and stirred for 1 h at room temperature. The reaction was then quenched with 
water (30 mL) and extracted with EtOAc (3 x 20 mL). The combined organics were 
washed with water (2 x 10 mL), sodium bicarbonate (10 mL) and brine (10 mL), 
dried (MgSO4) and concentrated in vacuo. The yellow solid was purified by flash 
chromatography (3% EtOAc in petrol), then recrystallised (petrol) to give 33 as light 
yellow crystals (594 mg, 50%). Rf = 0.47 (5% EtOAc in petrol); m.p. = 65 – 67 
o
C 
(petrol); IR (thin film) 2871, 1677, 1644, 1622, 1592, 1523, 1126, 727 cm
-1
; 
1
H 
NMR (400MHz, CDCl3) δ 4.17 (2H, d, J = 5.8, OCH2), 5.24 (1H, dd, J = 10.4, 1.3, 
CH=CHH), 5.35 (1H, dd, J = 17.3, 1.3, CH=CHH), 5.44 (2H, s, ArCH2O), 5.96 - 
6.07 (1H, m, CH=CH2), 7.42 (2H, dd, J = 8.8, 7.4, ArH), 7.51 (2H, dd, J = 8.4, 7.4, 
ArH), 7.97 (2H, d, J = 8.4, ArH), 8.36 (2H, d, J = 8.8, ArH), 8.41 (1H, s, ArH); 
13
C 
NMR (100 MHz, CDCl3) δ 64.2 (CH2), 71.5 (CH2), 117.7 (CH2), 124.4 (CH), 125.0 
(CH), 126.2 (CH), 128.4 (CH), 128.8 (C), 129.1 (CH), 131.1 (C), 131.5 (C), 135.0 
(CH). 
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(2E) and(2Z)-1,4-Bis(9-anthryloxy)but-2-ene (34) 
 
A novel compound synthesized using a modified 
procedure.
177
 Dry dichloromethane (8 mL) was 
deoxygenated by repeated freeze pump thaw cycles 
under nitrogen, and transferred to a flask containing 9-
allyloxymethyl-anthracene (400 mg, 1.60 mmol, 1.0 
eq) via cannula. Grubbs I catalyst (66 mg, 8.02 x 10
-5
 mol, 5 mol%) was added and 
the solution slowly warmed to 50 
o
C so that the oil bath temperature did not exceed 
60 
o
C. After 5 h the solution was concentrated in vacuo yielding a dark brown oil. 
Purification by flash chromatography (10% EtOAc in petrol) produced a light brown 
solid which was recrystallised (50% EtOAc in petrol), yielding small beige crystals 
(238 mg, 59%) as a 3:1 inseperable mixture of trans and cis isomers. m.p. 106-108 
o
C (50% EtOAc in petrol); Rf = 0.24 (10% EtOAc in petrol); IR (thin film) 2868, 
1674, 1647, 1590, 1526, 1118, 727 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ major: 4.21 
- 4.23 (4H, m, OCH2), 5.47 (4H, s, ArCH2), 5.97 - 6.01 (2H, m, =CH), 7.42 – 7.52 
(8H, m, ArH), 7.99 (4H, d, J = 8.0, ArH), 8.37 (4H, d, J = 8.7, ArH), 8.45 (2H, s, 
ArH); minor: 4.21 - 4.23 (4H, m, OCH2), 5.37 (4H, s, ArCH2), 5.90 (2H, br t, J = 
3.9, =CH), 7.42 – 7.52 (8H, m, ArH), 7.99 (4H, d, J = 8.0, ArH), 8.31 (4H, d, J = 
8.7, ArH), 8.45 (2H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 64.3 (CH2), 66.0 
(CH2), 70.4 (CH2), 124.3 (CH), 124.4 (CH), 125.0 (CH), 126.2 (CH), 128.4 (CH), 
129.0 (CH), 130.1 (CH), 128.7 (C), 131.0 (C), 131.5 (C); MS (ES
+
) m/z 469 
[M+H]
+
; HRMS (ES
+
) calcd for C34H29O2, 469.2959 [M+H
+
], found 469.2955. 
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(2S
*
, 3S
*
)-2,3-Diphenyl-1-(toluene-4-sulfonyl)-aziridine (181) 
 
A known compound synthesized using a reported procedure.
62
 To 
a solution of trans-stilbene (965 mg, 5.35 mmol, 5.0 eq) in 
dichloromethane (5 mL) was added PhINTs (400 mg, 1.07 mmol, 
1.0 eq). Cu(acac)2 (28 mg, 0.1 mmol, 10 mol%) was added 
forming a dark green mixture. This was stirred for 3 h under nitrogen until all of the 
suspended PhINTs had been dissolved. The solution was then filtered through a plug 
of celite which was washed with dichloromethane and concentrated in vacuo. 
Purification by flash chromatography (10 – 20% EtOAc in petrol) furnished a white 
solid. This solid was recrystallised (50% EtOAc in petrol) to give 81 as fluffy white 
crystals (135 mg, 36%). Rf = 0.24 (10% EtOAc in petrol); 
1
H NMR (CDCl3, 
400MHz) δ 2.38 (3H, s, CH3), 4.26 (2H, s, CH), 7.20 (2H, d, J = 8.2, TsArH), 7.31 - 
7.38 (6H, m, ArH), 7.39 - 7.44 (4H, m, ArH), 7.62 (2H, d, J = 8.2, TsArH); 
13
C 
NMR (CDCl3, 100 MHz) δ 21.6 (CH3), 50.4 (CH), 127.6 (CH), 128.3 (CH), 128.5 
(CH), 128.7 (CH), 129.4 (CH), 133.1 (C), 137.1 (C), 142.0 (C); MS (ES
+
) m/z 350 
[M+H
+
], 372 [M+Na
+
]. 
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(2S
*
, 3S
*
)-2-(2,3-Diphenyl-aziridine-1-sulfonyl)-5-methyl-pyridine (36) 
 
A novel compound synthesized using a modified procedure.
65
 
dichloromethane (1 mL) was added to a flask containing 4 Å 
powdered molecular sieves (500 mg), trans stilbene (108 mg, 0.60 
mmol, 1.2 eq), iodobenzene diacetate (161 mg, 0.50 mmol, 1.0 
eq), 5-methyl-2-pyridinesulfonamide (86 mg, 0.50 mmol, 1.0 eq) and Cu(acac)2 (7 
mg, 0.025 mmol, 5 mol%) and the mixture stirred for 20 h at room temperature. The 
resulting light green mixture was filtered through a plug of celite and washed with 
dichloromethane then concentrated in vacuo. Purification by flash chromatography 
(25 – 30% EtOAc in petrol) yielded 36 as a white powder (62 mg, 36%). m.p. 148-
149 
o
C (powder 25 – 30% EtOAc in petrol); Rf = 0.14 (30% EtOAc in petrol); IR 
(thin film) 3034, 1571, 1450, 1319, 1168, 902, 765, 688 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 2.38 (3H, s, CH3), 4.42 (2H, s, NCH), 7.28 - 7.38 (6H, m, ArH), 7.43 - 
7.49 (4H, m, ArH), 7.51 (1H, d, J = 8.0, PyH), 7.62 (1H, d, J = 8.0, PyH), 8.48 (1H, 
s, PyH); 
13
C NMR (100 MHz, CDCl3) δ 18.6 (CH3), 50.7 (CH), 122.0 (CH), 128.3 
(CH), 128.5 (CH), 128.7 (CH), 133.1 (CH), 137.5 (C), 137.9 (C), 150.4 (CH), 154.6 
(C); MS (ES
+
) m/z 351 [M+H
+
]; HRMS (ES
+
) calcd. for C20H18N2O2NaS, 373.0981 
[M+Na
+
], found 373.0990; Anal. Calcd. For C20H18N2O2S: C, 68.55; H, 5.18; N, 
7.99; S, 9.15%. Found: C, 68.63; H, 5.20; N, 7.92; S, 9.01%. 
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9-Bromomethylanthracene (182) 
 
A known compound synthesized using a reported procedure.
178
 A 
suspension of anthracene-9-yl methanol (1.00 g, 4.80 mmol, 1.0 eq) 
was dissolved in toluene (26 mL) and cooled to 0 
o
C, PBr3 (761 mg, 2.80 mmol, 1.2 
eq) was then added dropwise via syringe. The solution was stirred for 1 h at 0 
o
C 
then warmed to room temperature. Saturated Na2CO3 solution (5 mL) was added 
slowly and the mixture allowed to return to room temperature. The organic phase 
was separated and washed with water (4 mL), brine (4 mL) then dried (MgSO4) and 
concentrated in vacuo. The crude product was recrystallised (50% EtOAc in petrol), 
yielding 182 as yellow needle-like crystals (560 mg, 86%). Rf = 0.16 (10% EtOAc in 
petrol); 
1
H NMR (400 MHz, CDCl3) δ 5.52 (2H, s, CH2), 7.50 (2H, dd, J = 8.9, 7.5, 
ArH), 7.63 (2H, dd, J = 8.4, 7.5, ArH), 8.03 (2H, d, J = 8.4, ArH), 8.30 (2H, d, J = 
8.9, ArH), 8.47 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 27.0 (CH2), 123.5 
(CH), 125.4 (CH), 126.8 (CH), 127.9 (C), 129.22 (C), 129.3 (CH), 129.7 (CH), 
131.6 (C). 
 
Diethyl (2S,3S)-2-bromo-3-hydroxysuccinate (38) 
 
A known compound synthesized using a reported procedure.
66
 A 
solution of 40% HBr in acetic acid (100 mL) was added dropwise 
to stirred diethyl-L tartrate (26.0 g, 0.126 mol, 1.0 eq) at 0 
o
C over 30 minutes. The 
solution was stirred for a further 15 minutes at 0 
o
C then allowed to warm to room 
temperature and stirred for 10 h. The reaction mixture was then poured into ice (500 
g) and transferred to a 1 L separating funnel. The mixture was extracted with diethyl 
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ether (4 x 80 mL) and the combined organics washed with water (3 x 60 mL), brine 
(100 mL), dried (MgSO4) then concentrated in vacuo to a yellow / orange oil. To this 
oil was added ethanol (140 mL) and the flask equipped with a condenser capped with 
a silica containing drying tube. Acetyl chloride (4.42 g, 56.3 mmol) was carefully 
added and the solution heated to reflux for 7 h, then concentrated in vacuo. The 
crude product was purified by vacuum distillation (120 
o
C, 4 mbar) yielding 38 as a 
very pale yellow oil (26.7 g, 79%). 
1
H NMR (400 MHz, CDCl3) δ 1.30 (6H, t, J = 
7.1, CH3), 4.19 - 4.31 (4H, m, CH2), 4.65 (1H, d, J = 4.1, CH), 4.70 (1H, d, J = 4.3, 
CH); 
13
C NMR (100 MHz, CDCl3) δ 13.7 (CH3), 13.8 (CH3), 47.5 (CH), 62.3 (CH2), 
62.6 (CH2), 72.4 (CH), 166.5 (C=O), 170.1 (C=O); MS (ES
+
) m/z 269 [
79
BrM+H]
+
, 
271 [
81
BrM+H]
+
, 291 [
79
BrM+Na]
+
, 293 [
81
BrM+Na]
+
. 
 
Diethyl (2R, 3R)-2,3-epoxysuccinate (39) 
 
A known compound synthesized using a reported procedure.
66
 A 
solution of sodium ethoxide was prepared by addition of sodium 
(2.99 g, 130 mmol, 1.3 eq) to dry ethanol (11 mL). This solution was then added by 
means of a large bore cannula to a solution of 38 (26.7 g, 99.0 mmol, 1 eq) in dry 
ethanol (72 mL) at 0 
o
C over a period of 2 h. Following addition, the solution was 
stirred for a further 30 minutes then quenched by the addition of acetic acid (1.43 
mL). The solution was diluted with water (450 mL) and extracted with 
dichloromethane (4 x 50 mL). The combined organics were washed with brine (50 
mL), dried (MgSO4) and concentrated in vacuo. The pale yellow crude oil was 
purified by vacuum distillation (89 
o
C, 1 mbar) yielding 39 as a highly mobile, 
colourless oil (13.2 g, 71%). Rf = 0.6 (20% EtOAc in petrol); IR (thin film) 2984, 
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1737, 1467, 1446, 1370, 1327, 1276, 1192, 1094, 1024 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 1.32 (6H, t, J = 7.2, CH3), 3.67 (2H, s, NCH), 4.21 - 4.29 (4H, m, CH2); 
13
C NMR (100 MHz, CDCl3) 13.9 (CH3), 51.9 (CH), 62.1 (CH2), 166.7 (C=O). 
 
Diethyl (2S, 3R)-2-azido-3-hydroxysuccinate (40) 
 
A known compound synthesized using a reported procedure.
66
 To a 
solution of DMAP (584 mg, 4.80 mmol, 0.3 eq) in dry DMF (3 
mL), was added dry ethanol (0.33 mL, 5.6 mmol). The resulting mixture was stirred 
and cooled to 0 
o
C before azidotrimethylsilane (2.39 g, 21.0 mmol, 1.3 eq) was 
added dropwise via syringe. The resulting homogeneous mixture was allowed to 
warm to room temperature and stirred for an additional 15 minutes. A solution of 39 
(3.00 g, 16.0 mmol, 1.0 eq) in dry chloroform (8.4 mL) was added rapidly by syringe 
and stirred for 30 h at room temperature. The cooled mixture was diluted with water 
(60 mL) and extracted with 1:1 hexane:ether (4 x 12 mL), dried (MgSO4) then added 
to a solution of hydrogen chloride in ethanol (6 mL, 2.3 N solution) and stirred for 
30 minutes. The mixture was washed with water (4 x 2 mL), sodium bicarbonate (2 
mL) and brine (2 mL), dried (MgSO4) and concentrated in vacuo to give 40 as a pale 
yellow oil which was used without further purification (3.01 g, 81%). IR (thin film) 
3482, 2115, 1737 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.31 (3H, t, J = 7.2, CH3), 
1.32 (3H, t, J = 7.2, CH3), 3.26 (1H, d, J = 5.5, CH), 4.18 - 4.33 (4H, m, CH2), 4.63 
(1H, dd, J = 5.5, 2.7, CH); 
13
C NMR (100 MHz, CDCl3) δ 14.21(CH3), 14.24 (CH3), 
62.4 (CH), 62.8 (CH2) 64.5 (CH2), 72.0 (CH), 168.9 (C=O), 170.9 (C=O). 
 
  
Experimental  Alexander J Hough 
 
- 140 - 
 
(2S, 3S)-Aziridine-2,3-dicarboxylic acid diethyl ester (41) 
 
A known compound synthesized using a reported procedure.
67
 To a 
solution of 40 (5.60 g, 24.0 mmol, 1.0 eq) in DMF (93 mL) at 0 
o
C, 
was slowly added PPh3 (6.40 g, 24.0 mmol, 1.0 eq) portion wise. This solution was 
stirred at room temperature for 1.5 h then heated to 100 
o
C overnight. The crude 
mixture was diluted with water (10 mL) and extracted with EtOAc (4 x 5 mL). The 
organic extracts were combined and washed with water (6 x 5 mL) and brine (5ml) 
then dried (MgSO4) and concentrated in vacuo. Purification by flash chromatography 
(20 – 30% EtOAc in petrol) yielded 41 as a pale yellow oil (2.42 g, 60%). Rf = 0.22 
(20% EtOAc in petrol); IR (thin film) 2983, 1724, 1446, 1336, 1258, 1179, 1030, 
746 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.29 (6H, t, J = 7.1, CH3), 1.78 (1H, s, NH), 
2.85 (2H, s, NCH), 4.16 – 4.28 (4H, m, CH2); 
13
C NMR (100 MHz, CDCl3) δ 13.9 
(CH3), 35.1 (CH), 36.0 (CH), 61.4 (CH2), 62.0 (CH2), 168.6 (C=O), 170.3 (C=O); 
MS (ES
+
) m/z 188 [M+H
+
]. 
 
(2S, 3S)-1-Benzyl-aziridine-2,3-dicarboxylic acid diethyl ester (42) 
 
A known compound synthesised using a reported procedure.
67
 To a 
solution of 41 (644 mg, 3.40 mmol, 1.0 eq) in dry acetonitrile (5 mL) 
was added potassium carbonate (952 mg, 6.90 mmol, 2.0 eq) and 18-
crown-6 (10 mg, 10 mol%). The solution was stirred at 0 
o
C and 
benzyl bromide (589 mg, 3.40 mmol, 1.0 eq) was added dropwise and the solution 
heated to 50 
o
C for 24 h. The solution was cooled and additional benzyl bromide 
(471 mg, 2.80 mmol, 0.8 eq) added dropwise. The solution was again heated to 
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50 
o
C for 24 h. The salts were removed by filtration and the solution concentrated in 
vacuo. The crude yellow oil was purified by flash chromatography (5 – 10% EtOAc 
in petrol) to give 42 as a very pale yellow oil (658 mg, 70%). Rf = 0.69 (20% EtOAc 
in petrol); IR (thin film) 2979, 1726, 1496, 1454, 1179, 736, 695 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 1.24 (3H, m, CH3), 1.29 (3H, m, CH3), 3.00 (1H, br s, NCH), 3.13 
(1H, br s, NCH), 4.00 (1H, d, J = 13.8, NCHH), 4.15 – 4.24 (4H, m, CH2), 4.20 (1H, 
d, J = 13.8, NCHH), 7.25 – 7.38 (5H, m, ArH); 13C NMR (125 MHz, CDCl3) δ 14.1 
(CH3), 41.1 (CH3), 44.2 (CH), 54.7 (NCH2), 61.6 (CH2), 127.2 (CH), 128.1 (CH), 
128.2 (CH), 138.4 (C), 167.3 (C=O), 169.0 (C=O); MS (ES
+
) m/z 278 [M+H
+
]. 
 
(2S, 3S)-(1-Benzyl-3-hydroxymethyl-aziridin-2-yl)-methanol (43) 
 
A known compound synthesised using a reported procedure.
67
 Lithium 
aluminium hydride (1.00 g, 26.2 mmol, 8.0 eq) was suspended in THF 
(28 mL) and cooled to -10 
o
C. A solution of 42 (908 mg, 3.28 mmol, 
1.0 eq) in THF (6.4 mL) was added dropwise via syringe and the 
mixture stirred at -10 
o
C for 4 h. EtOAc (10 mL) was carefully added, followed by 
50% EtOAc in water (20 mL). The resulting gel was carefully washed with EtOAc 
and the filtrate dried (MgSO4) and concentrated in vacuo. Purification by flash 
chromatography (5% MeOH in dichloromethane) gave 43 as a white solid (378 mg, 
60%). Rf = 0.09 (5% MeOH in dichloromethane); 
1
H NMR (400 MHz, MeOD) δ 
2.03 (1H, m, NCH), 2.25 (1H, dt, J = 7.4, 3.7, NCH), 3.51 (1H, dd, J = 11.7, 5.5, 
CHH), 3.56 (1H, dd, J = 11.7, 5.8, CHH), 3.63 (1H, d, J = 13.7, NCHH), 3.88 (1H, 
dd, J = 12.6, 7.8, CHH), 4.00 (1H, dd, J = 12.6, 3.9, CHH), 4.02 (1H, d, J = 13.7, 
NCHH), 7.28 (1H, t, J = 7.3, ArH), 7.36 (2H, t, J = 7.4, ArH), 7.45 (2H, d, J = 7.2, 
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ArH); 
13C NMR (100 MHz, MeOD) δ 43.6 (CH), 45.7 (CH), 56.0 (CH2Ph), 59.1 
(CH2OH), 64.3 (CH2OH), 128.2 (CH), 129.3 (CH), 129.5 (CH), 140.7 (C); MS (ES
+
) 
m/z 194 [M+H
+
]. 
 
(2S, 3S)-2,3-Bis-(anthracen-9-ylmethoxymethyl)-1-benzyl-aziridine (44) 
 
A novel compound synthesised using a standard 
alkylation procedure. 60% sodium hydride in 
mineral oil (22 mg, 0.54 mmol, 2.2 eq) was washed 
with dry n-pentane (2 x 1 mL) and dried under 
vacuum. Dry DMF (0.4 mL) was added, followed 
by 15- crown-5 (6 mg, 10 mol%) and the suspension cooled to 0 
o
C. A 0 
o
C solution 
of 43 (50 mg, 0.25 mmol, 1.0 eq) in DMF (0.4 mL) was added dropwise via syringe 
and the mixture stirred at 0 
o
C for 30 minutes. Then a solution of 9-
(bromomethyl)anthracene (155 mL, 0.57 mmol, 2.3 eq) in DMF (0.4 mL) was added 
dropwise, before the mixture was allowed to warm to room temperature and stirred 
for 2 days. The reaction mixture was quenched with water (5 mL) and extracted with 
EtOAc (2 mL). An emulsion formed during extraction so the mixture was diluted 
with brine (10 mL), then extracted with EtOAc (4 x 5 mL). The combined organic 
extracts were washed with water (6 x 2 mL), brine (2 mL) dried (MgSO4), then 
concentrated in vacuo to give a light yellow solid. Purification by flash 
chromatography (20 – 30% EtOAc in petrol), followed by further flash 
chromatography (10% Acetone, 10% diethyl ether in petrol) yielded 44 as a light 
green/yellow solid (721 mg, 48%). m.p. 140 
o
C (dec); Rf = 0.08 (30% EtOAc in 
petrol); 
1
H NMR (400 MHz, CDCl3) δ 1.74 - 1.79 (1H, m, NCH), 2.18 - 2.24 (1H, 
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m, NCH), 3.23 (1H, d, J = 14.0, NCHH), 3.51 (1H, dd, J = 10.6, 5.1, CHCHHO), 
3.57 (1H, dd, J = 10.6, 5.9, CHCHHO), 3.64 - 3.67 (1H, m, CHCHHO), 3.71 (1H, d, 
J = 14.1, NCHH), 3.79 (1H, dd, 11.2, 3.2, CHCHHO), 5.32 (2H, q, J = 11.2, 
OCH2Ar), 5.40 (2H, q, J = 11.8, OCH2Ar), 7.04 - 7.15 (5H, m, ArH), 7.30 - 7.42 
(8H, m, ArH), 7.88 (2H, d, J = 7.7, ArH), 7.91 (2H, d, J = 8.5, ArH), 8.23 (2H, d, J = 
8.8, ArH), 8.27 (2H, d, J = 8.5, ArH), 8.32 (1H, s, ArH), 8.36 (1H, s, ArH); 
13
C 
NMR (100 MHz, CD2Cl2) δ 40.0 (CH), 42.9 (CH), 55.5 (CH2), 65.1 (CH2), 65.4 
(CH2), 66.8 (CH2), 73.1 (CH2), 124.7 (CH), 124.9 (CH), 125.4 (CH), 125.4 (CH), 
126.5 (CH), 126.6 (CH), 126.9 (CH), 128.1 (CH), 128.4 (CH), 128.6 (CH), 128.8 
(CH), 129.1 (C), 129.3 (CH), 129.4 (CH), 129.6 (C), 131.3 (C), 131.4 (C) 140.5 (C); 
MS (ES
+
) m/z 574 [M+H
+
]; HRMS (ES
+
) calcd. For C41H36NO2, 574.2741 [M+H
+
], 
found 574.2745. 
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(2S, 3S)-1-Ethyl-aziridine-2,3-dicarboxylic acid diethyl ester (46) 
 
A known compound synthesised using a reported procedure.
67
 60% 
sodium hydride in mineral oil (1.29 g, 32.2 mmol, 2.1 eq) was washed 
with dry petrol (2 x 5 mL) then dried in vacuo. Ethyl iodide was 
prepared by passing it through a plug of neutral activated alumina (brockman grade 
I). A solution of 41 (2.87 g, 15.3 mmol, 1.0 eq) in DMF (14.1 mL) was added to the 
sodium hydride and stirred at 0 
o
C for 15 minutes then the ethyl iodide (4.79 mg, 
30.6 mmol, 2.0 eq) added and stirred for 12 h at room temperature. The reaction was 
quenched with ammonium chloride (20 mL) and extracted with diethyl ether (3 x 40 
mL). The combined organics were then washed with water (60 mL), brine (200 mL), 
dried (MgSO4) and concentrated in vacuo leaving a light yellow oil. Purification by 
flash chromatography (10 – 15% EtOAc in petrol) yielded 46 as a colourless oil 
(1.36 g, 32%). Rf = 0.33 (15% EtOAc in petrol); 
1
H NMR (400 MHz, CDCl3) δ 1.12 
(3H, t, J = 7.2, NCH2CH3), 1.24 – 1.25 (6H, m, CH3), 2.74 – 2.83 (2H, m, NCHH, 
CH), 2.95 – 3.02 (2H, m, NCHH, CH), 4.22 (4H, m, CO2CH2); 
13
C NMR (100 MHz, 
CDCl3) δ 14.2 (CH3), 14.4 (CH3), 41.0 (CH), 43.7 (CH), 45.8 (CH2), 61.6 (CH2), 
quaternary carbon not observed; MS (ES
+
) m/z 216 [M+H]
+
, 238 [M+Na]
+
. 
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(2S, 3S)-1-Ethyl-3-hydroxymethyl-aziridin-2-yl)-methanol (47) 
 
A novel compound synthesised using a modified procedure
180
 and 
work-up.
71
 A suspension of LiAlH4 (106 mg, 2.80 mmol, 3.0 eq) in 
diethyl ether (5 mL) was cooled to 0 
o
C. A solution of 46 (200 mg, 
0.90 mmol, 1.0 eq) in diethyl ether (2 mL) was first cooled to 0 
o
C then added 
dropwise. The mixture was stirred for 2 h at 0 
o
C then allowed to warm to room 
temperature and stirred for 3 h. The reaction was quenched by the careful dropwise 
addition of water (0.11 mL) followed by 10% NaOH (0.16 mL) then water (0.26 
mL) and stirred vigorously for 20 minutes at 0 
o
C before being filtered. The filter 
cake was then washed well with warm ether (200 mL) and the filtrate then 
concentrated in vacuo yielding 47 as a white solid requiring no further purification 
(57 mg, 49%). m.p. 88 – 91 oC (powder, Et2O); 
1H NMR (400 MHz, MeOD) δ 1.22 
(3H, t, J = 7.2, CH3), 1.74 (1H, m, CH), 2.13 (1H, dt, J = 8.3, 3.7, CH), 2.49 (1H, dq, 
J = 12.0, 7.2, NCHH), 2.81 (1H, dq, J = 12.0, 7.2, NCHH), 3.45 (1H, dd, J = 11.6, 
6.5, CHHOH), 3.57 (1H, dd, J = 11.6, 5.1, CHHOH), 3.76 (1H, dd, J = 12.6, 8.3, 
CHHOH), 3.92 (1H, dd, J = 12.6, 3.7, CHHOH); 
13C NMR (100 MHz, MeOD) δ 
15.0 (CH3) 43.4 (CH), 45.1 (CH), 46.4 (CH2), 58.8 (CH2), 64.6 (CH2); MS (ES
+
) m/z 
132 [M+H]
+
; HRMS (ES
+
) calcd. For C6H14NO2, 132.1016 [M+H]
+
, found 
132.1021. 
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(2S, 3S)-2,3-Bis-allyloxymethyl-1-benzyl-aziridine (50) 
 
A novel compound synthesised using standard alkylation 
conditions. 60% sodium hydride in mineral oil (37 mg, 0.93 
mmol, 2.3 eq) was washed with n-pentane (2 x 1 mL) and 
dried in vacuo. DMF (0.5 mL) was added and the suspension 
cooled to 0 
o
C. A solution of 43 (78 mg, 0.40 mmol, 1.0 eq) in DMF (0.5 mL) was 
cooled to 0 
o
C then added dropwise. The mixture was stirred at 0 
o
C for 30 minutes 
before neat allyl bromide (122 mg, 1.01 mmol, 2.5 eq) was added dropwise and the 
mixture allowed to warm to room temperature and stirred overnight. The reaction 
was quenched with water (5 mL) and extracted with EtOAc (4 x 2 mL). The 
combined organic extracts were then washed with water (8 x 2 mL) and brine (2 
mL), dried (MgSO4) and concentrated in vacuo leaving a yellow oil. Purification by 
flash chromatography (20% EtOAc in petrol) yielded 50 as a colourless oil (56 mg, 
51%). Rf = 0.22 (20% EtOAc in petrol); IR (thin film) 2848, 1646, 1496, 1452, 1351, 
1263, 1097, 991, 920, 817, 731, 696 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.79 - 1.85 
(1H, m, NCH), 2.20 (1H, dt, J = 7.6, 3.5, NCH), 3.35 (1H, dd, J = 10.6, 6.0, 
CHCHHO), 3.40 (1H, dd, J = 10.6, 5.2, CHCHHO), 3.48 (1H, d, J = 13.8, NCHH), 
3.62 (1H, dd, J = 11.3, 7.6, CHCHHO), 3.73 (1H, dd, J = 11.3, 3.7, CHCH2O), 3.86 
(1H, d, J = 13.5, NCHH), 3.83 – 3.94 (4H, m, CH2), 5.08 (2H, dd, J = 20.0, 10.4, 
CH=CHH), 5.16 (2H, dd, J = 27.6, 17.2, CH=CHH), 5.73 – 5.82 (2H, m, CH=CHH), 
7.15 (1H, t, J = 7.2, ArH), 7.23 (2H, t, J = 7.3, ArH), 7.32 (2H, d, J = 7.3, ArH); 
13
C 
NMR (100 MHz, CDCl3) δ 39.8 (CH), 42.2 (CH), 55.5 (CH2Ph), 66.2 (CH2), 71.7 
(CH2), 71.8 (CH2), 72.2 (CH2), 116.9 (=CH2), 117.2 (=CH2), 126.8 (CH), 128.0 
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(CH), 128.3 (CH), 134.5 (HC=), 134.7 (HC=), 139.8 (C); MS (ES
+
) m/z 274 
[M+H
+
]; HRMS (ES
+
) calcd. For C17H24NO2, 274.1802 [M+H
+
], found 274.1809. 
 
(1S, 5E, 10S) and (1S, 5Z, 10S)-11-Benzyl-3,8-dioxa-11-aza-bicyclo[8.1.0]undec-
5-ene (51) 
 
A novel compound synthesised using a modified procedure.
179
 Dry 
DCM (70 mL) was degassed by freeze thaw under vacuum, and a 
solution of 50 (44 mg, 0.16 mmol, 1.0 eq) in dry dichloromethane (10 
mL) was degassed in the same way before it was added via cannula to 
the main solution. Grubbs I catalyst (13 mg, 10 mol%) was added and the violet 
solution stirred at room temperature overnight. Additional Grubbs I catalyst (11 mg, 
8.5 mol%) was added and the solution heated slowly to 50 
o
C. After 5 h the solution 
was concentrated in vacuo leaving a dark brown oil. Purification by flash 
chromatography (30 – 50% gradient EtOAc in petrol) then further flash 
chromatography (2% MeOH in dichloromethane) yielded 51 as an off white solid of 
moderate purity (6 mg, 14%). Full data was not obtained due to decomposition of the 
sample under NMR conditions. Rf = 0.31 (2% MeOH in dichloromethane); 
1
H NMR 
(400 MHz, CDCl3) δ 1.43 – 1.57 (1H, m, NCH), 1.75 – 1.84 (1H, m, NCH), 2.94 
(1H, dd, J = 12.5, 8.4, CHH), 3.34 (1H, d, J = 13.7, NCHH), 3.41 – 3.48 (1H, m, 
CHH), 3.68 (1H, d, J = 13.7, NCHH), 3.66 – 3.75 (2H, m, CH2), 4.11 (1H, d, J = 
12.8, CHH), 4.27 – 4.38 (3H, m, CH2, CHH), 5.93 – 6.06 (2H, m, CH=), 7.14 – 7.28 
(5H, m, ArH); MS (ES
+
) m/z 246 [M+H]
+
. 
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(2S, 3S)-(1-Benzyl-3-hydroxy(
2
H2)methyl-aziridin-2-yl)-(
2
H2)methanol (52) 
 
A novel compound synthesised using standard reduction conditions. 
Lithium aluminium deuteride (606 mg, 14.4 mmol, 8.0 eq) was 
suspended in THF (14 mL) and cooled to -10 
o
C. A solution of ester 
43 (500 mg, 1.81 mmol, 1.0 eq) in THF (3.2 mL) was added dropwise 
via syringe and the mixture stirred at -10 
o
C for 4 h. EtOAc (8 mL) was carefully 
added followed by 50% EtOAc in water (16 mL). The resulting gel was carefully 
washed with EtOAc (75 mL) and the filtrate dried (MgSO4) then concentrated in 
vacuo. Purification by flash chromatography (5% MeOH in dichloromethane) gave 
52 as a white solid (135 mg, 38%). m.p. 109 – 111 oC (powder, 5% MeOH in 
dichloromethane); Rf = 0.39 (10% MeOH in dichloromethane); IR (thin film) 3267, 
3031, 2752, 2581, 2081, 1431, 1354, 1260, 1156, 969, 726, 692 cm
-1
; 
1
H NMR (400 
MHz, MeOD) δ 2.02 (1H, d, J = 3.6, NCH), 2.24 (1H, d, J = 3.6, NCH), 3.62 (1H, d, 
J = 13.8, NCHH), 4.01 (1H, d, J = 13.7, NCHH), 4.94 (2H, s, OH), 7.23 – 7.30 (1H, 
m, ArH), 7.36 (2H, t, J = 7.7, ArH), 7.45 (2H, d, J = 7.2, ArH); 
13
C NMR (100 MHz, 
MeOD) δ 43.5 (CH), 45.6 (CH), 56.0 (CH2Ph), 58.5 (CD2OH), 63.7 (CD2OH), 128.2 
(CH), 129.3 (CH), 129.5 (CH), 140.7 (C); MS (ES
+
) m/z 198 [M+H]
+
, 220 [M+Na]
+
; 
HRMS (ES
+
) calcd. For C11H12D4NO2, 198.1427 [M+H]
+
, found 198.1426. 
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(2S, 3S)-2,3-Bis-allyloxy(
2
H2)methyl-1-benzyl-aziridine (53) 
 
A novel compound synthesised using standard alkylation 
conditions. 60% sodium hydride in mineral oil (52 mg, 1.30 
mmol, 2.3 eq) was washed with n-pentane (2 x 1 mL) and 
dried in vacuo. DMF (0.5 mL) and 15-crown-5 (12 mg, 10 
mol%) were added and the suspension cooled to 0 
o
C. A solution of 52 (111 mg, 
0.56 mmol 1.0 eq) in DMF (0.5 mL) was cooled to 0 
o
C then added dropwise. The 
mixture was stirred at 0 
o
C for 30 minutes before neat allyl bromide (170 mg, 1.41 
mmol, 2.5 eq) was added dropwise and the mixture allowed to warm to room 
temperature and stirred overnight. The reaction was quenched with water (5 mL) and 
extracted with EtOAc (4 x 2 mL). The combined organic extracts were then washed 
with water (8 x 2 mL) and brine (2 mL), dried (MgSO4) then concentrated in vacuo 
leaving a yellowish oil. Purification by flash chromatography (20% EtOAc in petrol) 
gave 53 as a colourless oil (115 mg, 74%). Rf = 0.32 (20% EtOAc in petrol); IR (thin 
film) 2848, 1495, 1452, 1357, 1188, 1095, 1046, 921, 730, 696 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 1.80 (1H, d, J = 3.0, NCH), 2.18 (1H, d, J = 3.0, NCH), 3.47 (1H, d, 
J = 13.8, NCHHPh), 3.87 (5H, m, NCHHPh, OCH2), 5.03 – 5.22 (4H, m, CH=CH2), 
5.72 – 5.84 (2H, m, CH=CH2), 7.15 (1H, t, J = 7.3, ArH), 7.23 (2H, t, J = 7.3, ArH), 
7.32 (2H, d, J = 7.3, ArH); 
13
C NMR (100 MHz, CDCl3) δ 39.6 (CH), 42.1 (CH), 
55.5 (CH2Ph), 65.5 (m, CD2), 71.5 (m, CD2), 71.6 (CH2), 71.7 (CH2), 116.8 (=CH2), 
117.2 (=CH2), 126.8 (CH), 128.0 (CH), 128.3 (CH), 134.6 (HC=), 134.8 (HC=), 
139.8 (C); MS (ES
+
) m/z 278 [M+H]
+
; HRMS (ES
+
) calcd. For C17H20D4NO2, 
278.053 [M+H]
+
, found 278.2057. 
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9-Nitro-anthracene (140) 
 
A known compound synthesised using a reported procedure.
80
 
Anthracene (10.0 g, 56.0 mmol, 1.0 eq) was suspended in glacial 
acetic acid (40 mL) and the temperature kept below 30 
o
C by use of a water bath. 
Concentrated nitric acid (4 mL) was added dropwise to the vigorously stirred 
mixture then stirred vigorously for 1 h until homogeneous. Concentrated HCl (50 
mL) in glacial acetic acid (50 mL) was added slowly, forming a pale yellow 
precipitate which was filtered and washed with glacial acetic acid (3 x 24 mL) then 
water until neutral. The solid was collected and treated with a warm (60 – 70 oC) 
solution of 10% NaOH (100 mL), filtered and washed with water until neutral then 
air dried. The solid was recrystallised from hot glacial acetic acid to yield 140 as 
yellow needles (8.73 g, 70%). m.p. 146 – 148 oC (AcOH) (Lit 146 oC); 1H NMR 
(400 MHz, CDCl3) δ 7.52 (2H, tm, J = 7.4, ArH), 7.62 (2H, tm, J = 7.4, ArH), 7.92 
(2H, dd, J = 8.8, 0.8, ArH), 8.00 (2H, d, J = 8.6, ArH), 8.54 (1H, s, ArH); 
13
C NMR 
(100 MHz, CDCl3) δ 121.4 (CH), 122.6 (C), 126.2 (CH), 128.4 (CH), 128.9 (CH), 
130.4 (CH), 130.8 (C), 144.3 (C). 
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Anthracen-9-ylamine (59) 
 
A known compound synthesised using a reported procedure.
80
 9-
nitroanthracene 140 (3.16 g, 14.2 mmol, 1.0 eq) was suspended in 
glacial acetic acid (63 mL) and heated with stirring to 80 
o
C for 1.5 h until 
homogeneous. A slurry of SnCl2 (13.4 g, 70.8 mmol, 5.0 eq) in concentrated HCl 
(47.5 mL) was added dropwise, the mixture was stirred for 30 minutes at 80 
o
C then 
allowed to cool to room temperature. The light yellow precipitate was filtered off 
and washed with concentrated HCl (3 x 5 mL). After drying the solid was treated 
with 5% NaOH solution (75 mL) for 15 minutes with occasional manual stirring. 
The dark mustard solid was filtered and washed with water until neutral then air 
dried to give 59 as a dark orange solid (2.09 g, 76%). m.p. 116 
o
C (dec.); IR (thin 
film) 3366, 1620, 1427, 1364, 857, 813, 717, 622 cm
-1
; 
1
H NMR (300 MHz, CDCl3) 
δ 4.86 (2H, br s, NH2), 7.38 – 7.47 (4H, m, ArH), 7.89 (1H, s, ArH), 7.93 – 7.98 
(4H, m, ArH); 
13
C NMR (100 MHz, CDCl3) δ 116.3 (CH), 118.3 (C), 121.1 (CH), 
123.8 (CH), 125.3 (CH), 129.0 (CH), 132.1 (C), 137.9 (C); MS (ES
+
) m/z 194 
[M+H]
+
, 216 [M+Na]
+
. 
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Di-anthracen-9-yl-amine (61) 
 
A novel compound synthesised using a modified procedure.
79
 9-
aminoanthracene 59 (97 mg, 0.50 mmol, 1.0 eq), 9-
bromoanthracene (129 mg, 0.50 mmol, 1.0 eq), sodium tert-
butoxide (67 mg, 0.70 mmol, 1.4 eq), palladium acetate (3 mg, 2 
mol%) and xphos (10 mg, 4 mol%) were placed in a microwave tube flushed with 
nitrogen. Toluene (1 mL) was added and the tube sealed. Irradiation for 30 minutes 
(150 
o
C, 250 W) resulted in a black suspension which, when concentrated in vacuo, 
yielded a black tar. Purification by column chromatography (15% dichloromethane 
in petrol + 0.5% triethylamine) resulted in slow degradation allowing a yellow solid 
to be collected containing minor impurities (60 mg, ~32%). Obtained data is limited 
due to poor stability. Rf = 0.2 (20% dichloromethane in petrol + 1% triethylamine); 
1
H NMR (400 MHz, C6D6) δ 6.60 (1H, s, NH), 6.96 (4H, dd, J = 9.0, 6.7, ArH), 7.23 
(4H, dd, J = 8.4, 6.7, ArH), 7.91 (4H, d, J = 8.4, ArH), 8.02 (4H, d, J = 9.0, ArH), 
8.15 (2H, s, ArH); MS (ES
+
) m/z 370 [M+H]
+
, 392 [M+Na]
+
.  
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9-(Anthracen-10-yl)-N-(3,5-dimethoxyphenyl)anthracen-10-amine (64) 
 
A novel compound synthesised using modified Buchwald 
amination conditions.
79
 N-(3,5-dimethoxyphenyl)anthracen-10-
amine 63 (50 mg, 0.15 mmol, 1.0 eq), 9-bromoanthracene (40 
mg, 0.15 mmol, 1.0 eq), sodium tert-butoxide (20 mg, 0.21 
mmol, 1.4 eq), palladium acetate (1.2 mg, 2 mol%) and xphos (4 
mg, 4 mol%) were placed in a dry microwave tube under nitrogen. Toluene (0.4 mL) 
was added and the mixture irradiated with microwaves (250 W, 150 
o
C) for 30 
minutes. The crude mixture was filtered through celite which was washed with 
dichloromethane (10 mL) and the filtrate concentrated in vacuo. Purification by flash 
chromatography (10% EtOAc in petrol) yielded 64 as a yellow solid (76 mg, 38%). 
Rf = 0.17 (10% EtOAc in petrol); 
1
H NMR (400 MHz, CDCl3) δ 3.76 (6H, s, CH3), 
5.95 (2H, d, J = 2.2, ArH), 6.01 (1H, t, J = 2.2, ArH), 6.16 (1H, br s, NH), 7.10 – 
7.20 (8H, m, ArH), 7.40 – 7.48 (4H, m, ArH), 8.16 (2H, d, J = 8.6, ArH), 8.36 (2H, 
d, J = 8.6, ArH), 8.69 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 55.2 (CH3), 90.4 
(CH), 93.4 (CH), 124.0 (CH), 125.4 (CH), 125.91 (CH), 125.96 (CH), 126.02 (CH), 
126.9 (CH), 127.3 (CH), 127.4 (CH), 128.6 (CH), 129.3 (C), 131.6 (C), 131.7 (C), 
132.1 (C), 132.4 (C), 132.8 (C), 150.2 (C), 161.9 (C), 1 x (C) not observed; MS 
(ES
+
) m/z 506 [M+H]
+
, 228 [M+Na]
+
; HRMS (ES
+
) calcd. For C36H27NNaO2 = 
528.1934 [M+Na]
+
 found 528.1936. 
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N-Anthracen-9-yl-4-methyl-benzenesulfonamide (67) 
 
A novel compound synthesised using a modified procedure.
181
 
9-aminoanthracene 59 (200 mg, 1.04 mmol, 1.0 eq), p-
toluenesulfonyl chloride (197 mg, 1.04 mmol, 1.0 eq) and 
DMAP (20 mg, 0.17 mmol, 0.16 eq) were placed in a round bottom flask and 
pyridine added (5 mL). The mixture was stirred at room temperature overnight. The 
reaction mixture was quenched with 2N HCl (2 mL) and extracted with 
dichloromethane (3 x 5ml), dried (MgSO4) and concentrated in vacuo to give a 
yellow solid which was recrystallised (ethanol) to give 67 as cream crystals (211 mg, 
58%). m.p. 244 – 246 oC (ethanol); IR (thin film) 3274, 2970, 1380, 1330, 1157 cm-
1
; 
1
H NMR  (400 MHz, CDCl3) δ 2.37 (3H, s, CH3), 6.72 (1H, s, NH), 7.11 (2H, d, J 
= 8.2, ArH), 7.33 (2H, dd, J = 7.6, 8.4 ArH), 7.42 (2H, dd, 7.6, 8.2 ArH), 7.49 (2H, 
d, J = 8.2, ArH), 7.95 – 8.03 (4H, m, ArH), 8.45 (1H, s, ArH); 13C NMR (100 MHz, 
CD2Cl2) δ 21.6 (CH3), 124.1 (CH), 125.8 (CH), 126.6 (CH), 127.7 (C), 128.4 (CH), 
128.7 (CH), 130.0 (CH), 130.6 (CH), 132.2 (C), 134.5 (C), 137.2 (C), 144.5 (C); MS 
(ES
+
) m/z 348 [M+H]
+
, 370 [M+Na]
+
, 386 [M+K]
+
; HRMS (ES
+
) calcd. For 
C21H17NNaO2S 370.0872 [M+Na]
+
 found 370.0873.  
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N-Anthracen-9-yl-N-anthracen-9-ylmethyl-4-methyl-benzenesulfonamide (68) 
 
A novel compound synthesised using a modified 
procedure.
182
 Acetone was dried by standing over activated 
4 Å molecular sieves overnight. To a flask containing N-
tosyl amino anthracene 67 (400 mg, 1.20 mmol, 1.0 eq), 9-
bromoanthracene (890 mg, 3.50 mmol, 3.0 eq), potassium carbonate (479 mg, 3.50 
mmol, 3.0 eq) and potassium iodide (191 mg, 1.20 mmol, 1.0 eq) was added the 
dried acetone (22 mL) and the mixture heated to reflux for 3 days. The reaction 
mixture was filtered through celite which was washed with dichloromethane (200 
mL). The filtrate was concentrated in vacuo and purified by flash chromatography 
(50% dichloromethane in petrol) followed by trituration (diethyl ether) to give 68 as 
a light yellow powder (497 g, 77%). m.p. 242 – 244 oC (powder, Et2O); UV 
(dichloromethane) λmax, nm: 353, 372, 394; IR (thin film) 2970, 1349, 1158, 731, 
662 cm
-1
; 
1
H NMR (700 MHz, CDCl3) δ 2.48 (3H, s, CH3), 6.23 (2H, s, CH2), 6.88 
(2H, dd, J = 7.7, 8.5 ArH), 6.96 (2H, dd, J = 7.7, 8.4 ArH), 7.13 – 7.19 (4H, m, 
ArH), 7.27 (2H, dd, J = 8.2, 7.5 ArH), 7.51 (2H, dd, J = 8.9, 7.5 ArH), 7.64 (2H, d, J 
= 8.4, ArH), 7.66 (2H, d, J = 8.5, ArH), 7.79 (2H, d, J = 8.2, ArH), 7.91 (2H, d, J = 
8.9, ArH), 8.03 (1H, s, ArH), 8.08 (1H, s, ArH); 
13
C NMR (176 MHz, CDCl3) δ 21.6 
(CH3), 46.3 (CH2), 123.8 (CH), 124.1 (CH), 124.3 (CH), 124.6 (CH), 125.3 (CH), 
125.5 (CH), 125.8 (C), 128.1 (CH), 128.2 (CH), 128.4 (CH), 128.5 (CH), 129.6 
(CH), 129.7 (C), 130.6 (C), 131.36 (C), 131.42 (C), 131.9 (C), 137.6 (C), 143.6 (C), 
1 x (CH, Ar) not observed; MS (ES
+
) m/z 560 [M+Na]
+
; HRMS (ES
+
) calcd. For 
C36H27NNaO2S = 560.1655 [M+Na]
+
, found 560.1653. 
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N-Anthracen-9-yl-4-methoxy-benzenesulfonamide (69) 
 
A novel compound synthesised using a modified procedure.
181
 
9-aminoanthracene 59 (500 mg, 2.60 mmol, 1.0 eq), 4-
methoxybenzenesulfonyl chloride (537 mg, 2.60 mmol, 1.0 
eq) and DMAP (50 mg, 0.42 mmol, 0.16 eq) were placed in a round bottom flask 
and pyridine added (12.5 mL). The mixture was stirred at room temperature 
overnight, then quenched with 2N HCl (50 mL) and extracted with dichloromethane 
(3 x 15ml). The combined organics were washed with 5% HCl (4 x 15 mL) then 
dried (MgSO4) and concentrated in vacuo leaving a yellow solid, which was 
recrystallised twice (ethanol) to give 69 as pale cream crystals (429 mg, 45%). m.p. 
208 – 210 oC (ethanol); IR (thin film) 3265, 1594, 1577, 1496, 1383, 1329, 1302, 
1262, 1151, 828, 730 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.79 (3H, s, CH3), 6.76 
(2H, d, J = 9.0, ArH), 6.82 (1H, s, NH), 7.34 (2H, dd, J = 8.9, 7.6, ArH), 7.42 (2H, 
dd, J = 8.4, 7.6, ArH), 7.51 (2H, d, J = 9.0, ArH), 7.96 (2H, d, J = 8.4, ArH), 8.00 
(2H, d, J = 8.9, ArH), 8.43 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 55.6 (CH3), 
114.1 (CH), 123.7 (CH), 125.4 (CH), 126.3 (CH), 128.0 (CH), 128.4 (CH), 129.6 
(CH), 130.2 (C), 131.3 (C), 131.8 (C), 147.7 (C), 163.2 (C); MS (ES
+
) m/z 386 
[M+Na]
+
; HRMS (ES
+
) calcd. For C21H17NNaO3S = 386.0821 [M+Na]
+
, found 
386.0824. 
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N-Anthracen-9-yl-N-anthracen-9-ylmethyl-4-methoxy-benzenesulfonamide (70) 
 
A novel compound synthesised using a modified 
procedure.
182
 69 (150 mg, 0.41 mmol, 1.0 eq), 9-
bromomethylanthracene (106 mg, 0.41 mmol, 1.0 eq), 
potassium iodide (7 mg, 0.041 mmol, 0.1 eq) and 
potassium carbonate (86 mg, 0.62 mmol, 1.5 eq) were placed in a microwave tube 
and flushed with nitrogen gas. Acetonitrile (6 mL) was added and the mixture 
irradiated with microwaves (300W, 110 
o
C) for 15 minutes. The crude mixture was 
then filtered through celite, which was washed with dichloromethane and the filtrate 
concentrated in vacuo. Purification by flash chromatography (40% dichloromethane 
in petrol) followed by trituration in diethyl ether yielded 70 as a light yellow powder 
(105 mg, 48%). m.p. 236 – 239 oC (powder, Et2O); Rf 0.26 (40% dichloromethane in 
petrol); IR (thin film) 1595, 1494, 1444, 1323, 1257, 1150, 1089, 731 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 3.89 (3H, s, CH3), 6.24 (2H, s, CH2), 6.88 – 6.99 (6H, m, ArH), 
7.13 – 7.19 (4H, m, ArH), 7.53 (2H, d, J = 8.9, ArH), 7.65 (4H, m, ArH), 7.81 (2H, 
d, J = 8.8, ArH), 7.92 (2H, d, J = 9.0, ArH), 8.03 (1H, s, ArH), 8.08 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 46.3 (CH2), 55.8 (CH3), 114.2 (CH), 123.8 (CH), 
124.1 (CH), 124.4 (CH), 124.7 (CH), 125.4 (CH), 125.6 (CH), 126.0 (C), 128.1 
(CH), 128.4 (CH), 128.5 (CH), 129.7 (C), 130.3 (CH), 130.7 (C), 131.4 (C), 131.5 
(C), 131.9 (C) 132.4 (C) 1 x (CH, Ar), 1x (C, Ar) not observed; MS (ES
+
) m/z 576 
[M+Na]
+
; HRMS (ES
+
) calcd. For C36H27NNaO3S = 576.1604 [M+Na]
+
, found 
576.1608. 
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3a,8[1',2']:9,13b[1'',2'']-Dibenzeno-1H-dibenzo[3,4:7,8]cycloocta[1,2]azetidine 
(N-4-methyl-benzenesulfonamide), 2,3,8,9-tetrahydro- (9CI) (71) 
 
A novel compound synthesised using standard photochemical 
conditions. 68 (20 mg, 0.037 mmol) was placed in a schlenk tube 
and made up with anhydrous dichloromethane (50 mL). It was 
then subjected to at least three cycles of freeze, pump (~ 1 mB) 
thaw and bubbling through argon. The schlenk was then placed 
under an argon atmosphere and irradiated with a 125 W medium pressure Hg lamp 
through a window of multi coated glass filter (Edmund Optics 365 nm band pass ± 
10 nm, P/N NT65-191) for 2 h then concentrated in vacuo. Purification by column 
chromatography (50% dichloromethane in petrol) yielded 71 as a colourless solid 
(8.7 mg, 44%). m.p. 200 
o
C (dec.); Rf = 0.33 (50% dichloromethane in petrol); 
1
H 
NMR (600 MHz, CD2Cl2) δ 2.56 (3H, s, CH3), 4.53 (1H, d, J = 11.6, CH), 4.61 (1H, 
d, J = 11.6, CH), 4.91 (2H, s, CH2), 6.84 – 6.97 (10H, m, ArH), 7.00 – 7.04 (4H, m, 
ArH), 7.37 – 7.41 (2H, m, ArH), 7.54 (2H, d, J = 8.0, ArH), 8.00 (2H, d, J = 8.2, 
ArH); 
13
C NMR (100 MHz, CDCl3) δ 21.6 (CH3), 46.8 (CH2), 52.5, (CH) 53.9 (CH) 
123.3 (CH), 124.7 (CH), 125.7 (CH), 125.8 (CH), 126.3 (CH), 126.6 (CH), 126.9 
(CH), 128.1 (CH), 130.0 (CH), quaternary carbons not observed; MS (ES
+
) m/z 
538.1 [M+H]
+
, 560 [M+Na]
+
; HRMS (ES
+
) Calc. For C36H28NO2S = 538.1835 
[M+H]
+
, found = 538.1839. 
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 (2S*,3R*)-2-Hydroxy-3-[(pyridin-2-ylmethyl)-amino]-succinic acid diethyl ester 
(74) 
 
A known compound synthesised following a reported procedure.
47
 
(2S*, 3S*)-oxirane-2,3- dicarboxylic acid diethyl ester (3.00 g, 16.0 
mmol, 1.0 eq) and 2-picolylamine (2.10 g, 19.2 mmol, 1.2 eq) were 
dissolved in ethanol (25 mL). The solution was heated to reflux for 
12 h. The reaction was allowed to cool to room temperature and solvent removed in 
vacuo. Purification by column chromatography (3% methanol in dichloromethane) 
yielded 74 as a yellow oil (4.67 g, 99%). Rf = 0.19 (3% methanol in 
dichloromethane); 
1
H NMR (400 MHz, CDCl3) δ 1.23 (6H, t, J = 7.2, CH3), 3.74 
(1H, d, J = 3.3, CH), 3.88 (1H, d, J = 14.9, CHH), 4.10 – 4.21 (5H, m, CH2, CHH), 
4.55 (1H, d, J = 3.3, CH), 7.14 (1H, dd, J = 7.5, 5.0, ArH), 7.28 (1H, d, J = 7.7, 
ArH), 7.62 (1H, td, J = 7.7, 1.8, ArH), 8.51 (1H, d, J = 5.0, ArH); 
13
C NMR (100 
MHz, CDCl3) δ 14.0 (CH3), 14.1 (CH3), 52.0 (CH2), 61.4 (CH2), 61.6 (CH2), 64.2 
(CH), 72.2 (CH), 122.0 (CH), 122.4 (CH), 136.7 (CH), 149.0 (CH), 159.2 (C), 171.0 
(C=O), 172.0 (C=O); MS (ES
+
) m/z 319 [M+Na
+
]. 
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(2R*,3R*)-1-Pyridin-2-ylmethyl-aziridine-2,3-dicarboxylic acid bismethylamide 
(75) 
 
A known compound synthesised using a reported procedure.
47
 To a 
stirred solution of amino alcohol 74 (1.38 g, 4.66 mmol, 1.0 eq) and 
PPh3 (1.59 g, 6.06 mmol, 1.3 eq) in THF (13 mL) at 0 °C, was slowly 
added diethyl azodicarboxylate (1.06 g, 6.06 mmol, 1.3 eq). The 
reaction was allowed to warm to room temperature and stirred for a further 12 h, 
then concentrated in vacuo. The solid/oil was first triturated with diethyl ether and 
the excess phosphine and phosphine oxide removed by filtration though celite. The 
filtrate was concentrated in vacuo. Purification by column chromatography (40 – 
50% EtOAc in petrol) gave 75 as a yellow oil (251 mg, 19%). Rf = 0.31 (50% 
EtOAc in petrol); 
1
H NMR (400 MHz, CDCl3) δ 1.15 – 1.29 (6H, m, CH3), 3.03 (1H, 
br s, NCH), 3.16 (1H, br s, NCH), 4.10 – 4.32 (6H, m, CH2CH3, NCH2), 7.15 (1H, t, 
J = 6.0, ArH), 7.44 (1H, d, J = 7.8, ArH), 7.65 (1H, td, J = 7.8, 1.8, ArH), 8.49 – 
8.54 (1H, m, ArH); 
13
C NMR (100 MHz, CDCl3) δ 14.1 (CH3), 14.4 (CH3), 41.1 
(CH), 43.9 (CH), 56.2 (CH2), 61.7 (CH2), 62.2 (CH2), 121.9 (CH), 122.1 (CH), 136.6 
(CH), 149.2 (CH), 158.0 (C), 166.5(C=O), 170.7 (C=O); MS (ES
+
) m/z 271 
[M+Na]
+
. 
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9-Anthryacetonitrile (77) 
 
A known compound synthesised following a reported procedure.
83
 A 
solution of 9-(chloromethyl)anthracene (3.00 g, 13.2 mmol, 1.0 eq) 
in DMF (43 mL) was added dropwise to a solution of sodium 
cyanide (1.29 g, 26.4 mmol, 2.0 eq) in DMF (58 mL) at 140 
o
C. The mixture was 
stirred for 4 h then allowed to cool to room temperature. Ice/water (100 mL) was 
then added and the yellow precipitate collected by filtration. The solid was 
recrystallised in multiple batches from hot ethanol yielding 77 as bright yellow 
needles (2.03 g, 71%). 
1
H NMR (400 MHz, CDCl3) δ 4.55 (2H, s, CH2), 7.52 (2H, 
ddd, J = 8.5, 6.5, 0.8, ArH), 7.62 (2H, ddd, J = 8.9, 6.5, 1.3, ArH), 8.04 (2H, d, J = 
8.5, ArH), 8.14 (2H, d, J = 8.9, ArH), 8.44 (1H, s, ArH); 
13
C NMR (100 MHz, 
CDCl3) δ 16.3 (CH2), 117.8 (C), 120.9 (C), 123.0 (CH), 125.4 (CH), 127.3 (CH), 
128.9 (CH), 129.5 (CH), 129.9 (C), 131.5 (C); MS (ES
+
) m/z 240 [M+Na]
+
;  
 
2-Anthracen-9-yl-ethylamine (78) 
 
A known compound prepared initially by reported procedure 
Method A
83
 and later using novel synthesis Method B. 
Method A: A solution of 9-anthrylacetonitrile 77 (2.42 g, 11.1 
mmol, 1.0 eq) in THF (40 mL) was added dropwise via cannula to a suspension of 
lithium aluminium hydride (1.14 g, 30.1 mmol, 2.7 eq) in THF (79 mL). The mixture 
was then heated to reflux for 4 h. After cooling to room temperature a 50:50 mixture 
of methanol and water (10 mL) was added dropwise. The resulting aluminium solid 
was removed by filtration and the filtrate concentrated in vacuo. The solid was 
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purified by column chromatography (5% sat. NH4OH(aq) in methanol), to give 78 as a 
yellow solid (660 mg, 27%). 
Method B: 10% Palladium on carbon (2 mg) was added to a solution of azide 83 
(1.10 g, 4.45 mmol, 1.0 eq in THF (31 mL). The flask was vacuum filled with 
hydrogen, and stirred overnight under a slight positive pressure of hydrogen. The 
resulting mixture was filtered through celite and the plug washed with 
dichloromethane. The filtrate was then concentrated in vacuo to give 78 as a yellow 
solid used without further purification (976 mg, quant.). Rf = 0.43 (5% sat. 
NH4OH(aq) in methanol); IR (thin film) 3379, 2919, 1668, 1599, 1317, 1035, 932, 
700 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.20 (2H, t, J = 7.3, CH2), 3.80 (2H, t, J =  
7.3, CH2), 7.43 – 7.55 (4H, m, ArH), 8.01 (2H, d, J = 8.4, ArH), 8.32 (2H, d, J = 8.8, 
ArH), 8.36 (1H, s, ArH); 
13
C NMR (75 MHz, CDCl3) δ 32.0 (CH2), 42.5 (CH2), 
124.4 (CH), 124.9 (CH), 125.7 (CH), 126.1 (CH), 129.3 (CH), 130.1 (C), 131.6 (C), 
132.0 (C); MS (ES
+
) m/z 222 [M+H]
+
, 443 [2M+H]
+
. 
 
Oxirane (80) 
 
A known compound synthesised using a reported procedure.
84
 2-chloro ethanol 
(4 g, 40 mmol) was dissolved in water (60 mL). The solution was then frozen using 
liquid nitrogen. Potassium hydroxide pellets (56 g, 1 mol) were added and the 
mixture slowly allowed to thaw. The gas which evolved vigorously was directed 
through a column of CaCl2 then condensed on a cold finger and collected in a flask 
cooled in an acetone / dry ice bath. 
1
H NMR (400 MHz, CDCl3) δ 2.49 (4H, s, CH2). 
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2-Anthracen-9-yl-ethanol (81) 
 
A known compound synthesised using a modified procedure.
84
 9-
bromoanthracene (4.10 g, 16.0 mmol, 1.0 eq) was dissolved in 
anhydrous diethyl ether (100 mL) and cooled to -78 
o
C. n-Butyl 
lithium 1.6 M in hexanes (12.0 mL, 19.2 mmol, 1.2 eq) was added dropwise via 
syringe. The green solution was allowed to warm to 0 
o
C, then connected directly to 
a chilled sealed flask containing excess freshly prepared oxirane. The oxirane flask 
was allowed to warm slowly so that oxirane was slowly bubbled through the solution 
of lithiated 9-bromoanthracene. Once the supply of oxirane was exhausted the 
solution was stirred for a further 1 h. Methanol (5 mL) was added dropwise and the 
solution allowed to warm to room temperature. Saturated ammonium chloride 
solution (25 mL) was added and the organics separated. The aqueous was extracted 
with dichloromethane (3 x 15 mL). The combined organics were washed with water 
(40 mL), brine (40 mL) then dried (MgSO4) and concentrated in vacuo. Two 
recrystallisations from toluene yielded 81 as long yellow/green crystals (1.74 g, 
50%). Rf = 0.46 (30% EtOAc in petrol); 
1
H NMR (400 MHz, CDCl3) δ 1.44 (1H, t, J 
= 5.8, OH), 3.95 (2H, t, J = 7.3, CH2), 4.10 (2H, m, CH2), 7.50 (4H, m, ArH), 8.02 
(2H, d, J = 8.3, ArH), 8.33 (2H, d, J = 8.7, ArH), 8.39 (1H, s, ArH); 
13
C NMR (100 
MHz, CDCl3) δ 31.2 (CH2), 43.5 (CH2) 63.6 (CH2), 124.4 (CH), 125.1 (CH), 126.0 
(CH), 126.6 (CH), 129.4 (CH), 130.3 (C), 130.5 (C), 131.7 (C); MS (ES
+
) m/z 223 
[M+H]
+
, 245 [M+Na]
+
. 
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Methanesulfonic acid 2-anthracen-9-yl-ethyl ester (82) 
 
A novel compound synthesised using standard mesylation 
conditions. 9-Anthryl ethanol (1.70 g, 7.65 mmol, 1.0 eq) was 
dissolved in dichloromethane (111 mL) and triethylamine (1.54 g, 
15.3 mmol, 2.0 eq) was added. The solution was cooled to 0 
o
C and 
mesyl chloride (1.75 g, 13.3 mmol, 2.0 eq) added dropwise by syringe. The solution 
was stirred for 2 h then quenched with water (50 mL) and the organics separated. 
The aqueous layer was extracted with dichloromethane (3 x 20 mL) and the 
combined organics washed with water (20 mL), brine (20 mL) and dried (MgSO4) 
then concentrated in vacuo. Purification by recrystallisation (hot ethanol) yielded 82 
as yellow crystals (1.97 g, 86%) which was used immediately following purification. 
Rf = 0.23 (30% dichloromethane in petrol); 
1
H NMR (400 MHz, CDCl3) δ 2.80 (3H, 
s, CH3), 4.13 (2H, t, J = 8.1, CH2), 4.58 (2H, t, J = 8.1, CH2), 7.49 (2H, m, ArH), 
7.58 (2H, ddd, J = 9.0, 6.7, 1.3, ArH), 8.03 (2H, d, J = 8.5, ArH), 8.27 (2H, d, J = 
9.0, ArH), 8.42 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 28.0 (CH2), 37.5 
(CH3), 69.1 (CH2), 123.7 (CH), 125.1 (CH), 126.5 (CH), 127.2 (C), 127.4 (CH), 
129.4 (CH), 130.3 (C), 131.5 (C); MS (ES
+
) m/z 323 [M+Na]
+
; HRMS (ES
+
) Calc. 
For C17H16NNaO3S = 323.0712 [M+Na]
+
, Found = 323.0712. 
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9-(2-Azido-ethyl)-anthracene (83) 
 
A novel compound synthesised using standard substitution 
conditions. Mesylate 82 (1.46 g, 4.86 mmol, 1.0 eq) was dissolved in 
DMF (7.3 mL) and sodium azide (474 mg, 7.29 mmol, 1.5 eq) 
added. The mixture was heated to 85 
o
C and stirred overnight. The solution was 
cooled to room temperature, then diluted with water (20 mL) and extracted with 
EtOAc (4 x 15 mL). The combined organics were washed with water (6 x 15 mL), 
brine (15 mL) then dried (MgSO4) and concentrated in vacuo. Purification by 
column chromatography (10% dichloromethane in petrol) yielded 83 as a yellow 
solid (1.11 g, 93%) which was used immediately following purification. Rf = 0.29 
(10% dichloromethane in petrol); IR (thin film) 2976, 2077, 1623, 1425, 1232, 878, 
839, 731 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.68 (2H, t, J = 7.6, CH2), 3.95 (2H, t, 
J = 7.6, CH2), 7.49 (2H, m, ArH), 7.56 (2H, m, ArH), 8.03 (2H, d, J = 8.4, ArH), 
8.25 (2H, d, J = 8.9, ArH), 8.41 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 34.8 
(CH2), 52.2 (CH2), 124.7 (CH), 124.9 (CH), 125.8 (CH), 126.8 (CH), 129.4 (CH), 
130.0 (C), 130.4 (C), 132.1 (C); MS (ES
+
) m/z 248 [M+H]
+
, 270 [M+Na]
+
; HRMS 
(ES
+
) Calc. For C16H13N3Na = 270.1109 [M+Na]
+
, Found = 270.1112. 
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(2S, 3S)-1-Benzyl-aziridine-2,3-dicarboxylic acid bis-propylamide (85) 
 
A novel compound synthesised using a modified procedure.
47
 
(2S, 3S)-1-Benzyl-aziridine-2,3-dicarboxylic acid diethyl 
ester 42 (50 mg, 0.18 mmol, 1.0 eq) was dissolved in 
chloroform (1 mL) and n-propylamine (426 mg, 7.20 mmol, 
40 eq) added and the solution stirred at room temperature for 4 days. The solution 
was concentrated in vacuo then purified by column chromatography (40 – 50% 
EtOAc in petrol), yielding 85 as a white solid (38 mg, 70%). m.p. 96 - 98 
o
C 
(powder, EtOAc / petrol); Rf = 0.19 (50% EtOAc in petrol); 
1
H NMR (400 MHz, 
CDCl3) δ 0.75 (3H, t, J = 7.3, CH3), 0.81 (3H, t, J = 7.3, CH3), 1.25 – 1.44 (4H, m, 
CH2), 2.48 (1H, d, J = 2.4, NCH), 2.91 (1H, d, J = 2.4, NCH), 2.92 – 3.22 (4H, m, 
CH2), 3.93 (1H, d, J = 13.3, NCHH), 3.97 (1H, d, J = 13.3, NCHH), 6.51 – 6.60 (1H, 
m, NH), 6.85 – 6.94 (1H, m, NH), 7.21 (5H, m, ArH); 13C NMR (100 MHz, CDCl3) 
δ 11.2 (CH3), 11.4 (CH3), 22.6 (CH2), 22.7 (CH2), 40.6 (CH2), 41.8 (CH2), 43.4 
(CH), 43.8 (CH), 53.5 (CH2), 127.3 (CH), 128.40 (CH), 128.43 (CH), 138.8 (C), 
165.2 (C=O), 169.3 (C=O); MS (ES
+
) m/z 326 [M+Na]
+
; HRMS (ES
+
) Calc. For 
C17H25N3NaO2 = 326.1839 [M+Na]
+
, Found = 326.1841. 
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(2R*,3R*)-1-Pyridin-2-ylmethyl-aziridine-2,3-dicarboxylic acid bis-hex-5-
enylamide (183) 
 
A novel compound synthesised using a modified 
procedure.
47
 42 (50 mg, 0.18 mmol, 1.0 eq) was 
dissolved in chloroform (1 mL) and Hex-5-
enylamine (356 mg, 3.60 mmol, 20 eq) was added 
via syringe. The solution was warmed to 50 
o
C and 
stirred for 5 days. After cooling to room temperature the solution was concentrated 
in vacuo. Purification by column chromatography (50 – 80% EtOAc in petrol) 
yielded 182 as a waxy white solid (52 mg, 76%). m.p 56-58 
o
C (powder, EtoAc / 
petrol); Rf = 0.34 (80% EtOAc in petrol); IR (thin film) 3279, 2926, 2857, 1638, 
1553, 1434, 1251, 908, 692 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.32 – 1.41 (4H, m, 
CH2), 1.41 – 1.53 (4H, m, CH2), 2.03 (4H, m, CH2), 2.71 (1H, br s, NCH), 2.98 (1H, 
br s, NCH), 3.01 – 3.27 (4H, m, CH2), 4.14 (1H, d, J = 14.6, NCHH), 4.24 (1H, d, J 
= 14.6, NCHH), 4.94 (2H, dm, J = 10.2, CHH), 4.98 (2H, ddt, J = 17.1, 3.5, 1.7, 
CHH), 5.75 (2H, ddt, J = 17.1,10.2, 6.7, =CH), 6.73 (1H, br s, NH), 7.05 – 7.25 (3H, 
m, ArH, NH), 7.63 (1H, td, J = 7.7, 1.9, ArH), 8.58 (1H, d, J = 4.8, ArH); 
13
C NMR 
(100 MHz, CDCl3) δ 26.1 (CH2), 28.9 (CH2), 30.5 (CH2), 33.3 (CH2), 77.3 (CH), 
114.9 (CH2), 122.3 (CH), 122.8 (CH), 136.6 (CH), 138.3 (CH), 149.3 (CH), 158.4 
(C); MS (ES
+
) m/z 385 [M+H]
+
, 407 [M+Na]
+
, 791 [2M+Na]
+
; HRMS (ES
+
) Calc. 
For C22H33N4NaO2 = 385.2598 [M+H]
+
, Found = 385.2599. 
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9,10-Ethanoanthracene-11,11-dicarboxylic acid, 9,10-dihydro-, 11,11-diethyl 
ester (97) 
 
A known compound synthesised using a reported procedure.
102
 A 
round bottom flask was charged with diethyl malonate (5.00 g, 
31.2 mmol, 1.0 eq), paraformaldehyde (1.90 g, 62.4 mmol, 2.0 eq), 
anthracene (5.56, 31.2 mmol, 1.0 eq), copper (II) acetate (1.13 g, 6.2 mmol, 0.2 eq), 
acetic acid (6.75 mL), and xylene (6.75 mL). The reaction mixture was heated to 100 
o
C for 2 h. The temperature was then raised to remove the majority of the acetic acid 
by distillation. Once most of the acetic acid had been removed, the copper catalyst 
precipitated. On cooling to room temperature, the precipitated catalyst and unreacted 
anthracene was removed by filtration, and the filtrate was concentrated in vacuo. The 
resulting oil crystallised on standing overnight and was then recrystallised (ethanol), 
yielding 97 as colourless crystals containing a minor impurity (7%) of anthracene 
(5.59 g, 51%). 
1
H NMR (400 MHz, CDCl3) δ 1.09 (6H, t, J = 7.1, CH3), 2.41 (2H, d, 
J = 2.7, CH3), 3.88 – 4.02 (4H, m, CH2CH3), 4.26 (1H, t, J = 2.7, CH), 4.90 (1H, s, 
CH), 6.97 – 7.05 (4H, m, ArH), 7.16 – 7.23 (2H, m, ArH), 7.22 – 7.29 (2H, m, ArH); 
13
C NMR (100 MHz, CDCl3) δ 14.1 (CH3), 36.5 (CH2), 44.0 (CH), 49.7 (CH), 59.8 
(C), 61.7 (CH2), 123.3 (CH), 125.7 (CH), 125.8 (CH), 128.5 (CH), 139.9 (C), 144.1 
(C), 170.3 (C=O); MS (ES
+
) m/z 351 [M+H]
+
. 
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Methylidenemalonic acid diethylester (98) 
 
A known compound synthesised using a reported procedure.
102
 An 
aliquot of paraffin oil for oil baths (Fisher Scientific) was distilled 
under nitrogen up to 250 
o
C. After cooling this high boiling point oil was used as the 
reaction solvent. Anthracene adduct 97 (5.50 g, 15.7 mmol, 1.0 eq) and powdered 
maleic anhydride were placed in a round bottom flask which had been previously 
washed with concentrated HCl then oven dried. The high boiling oil (25 mL) was 
added and the mixture stirred and heated to 225 
o
C using an aluminium heating 
block for 45 minutes. On cooling the maleic anhydride anthracene adduct 
precipitated and was removed by filtration. The remaining oil was distilled under 
reduced pressure (72 
o
C, 1 mbar) to yield the methylidenemalonic acid diethylester 
98 as a colourless oil (1.88 g, 70%). 
1
H NMR (400 MHz, CDCl3) δ 1.30 (6H, t, J = 
7.1, CH3), 4.26 (4H, q, J = 7.1, CH2), 6.48 (2H, s, =CH2); 
13
C NMR (100 MHz, 
CDCl3) δ 14.1 (CH3), 61.5 (CH2), 135.1 (C), 136.5 (CH2), 164.1 (C=O); MS (ES
+
) 
m/z 195 [M+Na]
+
. 
 
  
Experimental  Alexander J Hough 
 
- 170 - 
 
2-Bromo-2-bromomethyl-malonic acid diethyl ester (100) 
 
A known compound synthesised using a modified procedure.
103
 
Carbon tetrachloride was dried over 4 Å molecular sieves overnight. 
Methylidenemalonic acid diethylester 99 (100 mg, 0.58 mmol, 1.0 eq) was dissolved 
in the dried carbon tetrachloride (3 mL), and a separate solution of bromine (418 mg, 
2.60 mmol, 4.5 eq) in carbon tetrachloride (1 mL) was prepared then added 
dropwise. The solution was stirred for 2 days at room temperature then concentrated 
in vacuo. Purification by column chromatography (2 - 5% EtOAc in petrol) yielded 
100 as a light brown solid (108 mg, 56%). Rf = 0.24 (5% EtOAc in petrol); 
1
H NMR 
(400 MHz, CDCl3) δ 1.31 (6H, t, J = 7.1, CH3), 4.05 (2H, s, CH2Br), 4.32 (4H, q, J = 
7.1, CH2CH3); 
13
C NMR (100 MHz, CDCl3) δ 13.9 (CH3), 35.8 (CH2), 60.6 (C), 63.7 
(CH2), 64.9 (C=O); MS (ES
+
) m/z 353 [2
79
BrM+Na]
+
, 354 [
79
Br
81
BrM+Na]
+
, 355 
[2
81
BrM+Na]
+
. 
 
2-[4-(4-Nitro-phenylazo)-phenylamino]-ethanol (103) 
 
A previously reported compound synthesised using 
a modified procedure.
96
 4-Nitroaniline (4.40 g, 31.9 
mmol, 1.0 eq) was finely ground and dissolved in 
concentrated hydrochloric acid (32 mL) and water (240 mL) by vigorous stirring at 
room temperature for 3 h. The solution was then cooled to 0 
o
C and NaNO2 (2.32 g, 
33.6 mmol, 1.1 eq) added portion wise. The mixture was stirred at 0 
o
C for 1 h then 
used immediately in the azo coupling reaction. β-hydroxyethyl aniline (5.00 g, 28.8 
mmol, 0.9 eq) was dissolved in acetone (320 mL) and cooled to 0 
o
C. To this was 
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added the diazo solution slowly over 20 minutes via dropping funnel kept below 10 
o
C with ice. After addition, the red suspension was stirred for a further 1 h before 
acetic acid (1 mL) was added. 10% sodium hydroxide was added dropwise until the 
pH reached 3 - 4. The solid red precipitate was filtered and washed with warm and 
cold water, then dried in a desccicator. To give 103 as a dark orange solid which was 
used without further purification (7.97 g, 87%). 
1
H NMR (400 MHz, CDCl3) δ 3.44 
(2H, q, J = 4.9, CH2), 3.93 (2H, q, J = 4.9, CH2), 4.73 (1H, s, NH), 6.72 (2H, d, J = 
9.0, ArH), 7.89 (2H, d, J = 9.0, ArH), 7.93 (2H, d, J = 9.0, ArH), 8.33 (2H, d, J = 
9.0, ArH); 
13
C NMR (100 MHz, CDCl3) δ 45.4 (CH2), 61.1 (CH2), 112.5 (CH), 
122.7 (CH), 124.7 (CH), 126.3 (CH), 145.0 (C), 147.6 (C), 152.1 (C), 156.6 (C); MS 
(ES
+
) m/z 287 [M+H]
+
. 
 
[4-(4-Nitro-phenylazo)-phenyl]-[2-(toluene-4-sulfonyloxy)-ethyl]-ammonium 
chloride (107) 
 
A novel compound synthesised using a heavily 
modified procedure.
104
 103 (2.50 g, 9.20 mmol, 1.0 
eq), purified tosyl chloride (27.8 g, 92.0 mmol, 10 
eq) and DMAP (1.12 g, 9.20 mmol, 1.0 eq) were placed in a round bottom flask. 
Pyridine (150 mL) cooled to -20 
o
C was added via cannula. The mixture was stirred 
at -20 
o
C (ethylene glycol / EtOH / CO2 (s)) for 6 h, then quenched with MeOH (100 
mL) and the solvent removed by distillation. The solid was purified by column 
chromatography (10% acetone in petrol). To give a solid contaminated with 
ditosylate. The solid was dissolved in a minimum volume of anhydrous benzene and 
hydrogen chloride in diethyl ether was added dropwise until a red solid precipitated. 
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The solid was isolated by filtration and found to contain 17% of the HCl salt of 103 
(331 mg, 8%). m.p. 110 
o
C (dec.); Rf = 0.25; IR (thin film) 2813, 1614, 1557, 1508, 
1392, 1336, 1259, 1167, 1142, 1101, 1010, 812, 661 cm
-1
; 
1
H NMR (400 MHz, 
DMSO-d6) δ 2.22 (3H, s, ArCH3), 3.38 (2H, t, J = 5.3, CH2), 4.03 (2H, t, J = 5.3, 
CH2), 6.57 (2H, d, J = 9.0, ArH), 7.27 (2H, d, J = 8.1, ArH), 7.57 – 7.68 (4H, m, 
ArH), 7.82 (2H, d, J = 9.0, ArH), 8.26 (2H, d, J = 9.1, ArH); 
13
C NMR (100 MHz, 
DMSO-d6) δ 21.0 (CH3), 41.0 (CH2), 68.5 (CH2), 122.8 (CH), 125.0 (CH), 125.5 
(CH), 127.6 (CH), 128.3 (CH), 130.1 (CH), 131.8 (C), 143.2 (C), 144.7 (C), 146.8 
(C), 153.0 (C), 156.0 (C); MS (ES
+
) m/z 441 [M+H]
+
; HRMS (ES
+
) calcd. For 
C21H20N4O5SNa =  463.1047 [M+Na]
+
, found 463.1052. 
 
trans-(4-Aziridin-1-yl-phenyl)-(4-nitro-phenyl)-diazene (trans-90) 
 
A previously reported compound
94
 with limited data 
synthesised using a novel method. 60% NaH in mineral 
oil (42 mg, 1.1 mmol, 5.0 eq) was placed under nitrogen, 
washed with dry petrol (3 x 1 mL) and dried in vacuo. 107 (100 mg, 0.21 mmol, 1.0 
eq) was dissolved in DMF (10 mL), cooled to 0 
o
C, then transferred via cannula to 
the washed NaH and stirred at 0 
o
C for 3 h. The mixture was quenched with NH4Cl 
(10 mL) and extracted with EtOAc (3 x 10 mL). The combined organics were 
washed with water (6 x 15 mL), dried (MgSO4) and concentrated in vacuo. 
Purification by column chromatography (10% EtOAc / pet ether + 1% triethylamine) 
yielded 90 as a shiny orange solid (56 mg, 28%). Rf = 0.25 (10% EtOAc in 
petroleum ether + 1% triethylamine); IR (thin film) 2994, 1598, 1514, 1344, 1141, 
1105, 851 cm
-1
; UV λmax: 262, 381, 391 nm; 
1
H NMR (500 MHz, Toluene-d8) δ 1.66 
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(4H, s, NCH2), 6.78 (2H, d, J = 8.7, ArH), 7.59 (2H, d, J = 9.0, ArH), 7.85 (2H, d, J 
= 9.0, ArH), 7.88 (2H, d, J = 8.7, ArH); 
13
C NMR (125 MHz, Toluene-d8) δ 27.0 
(CH2), 121.1 (CH), 122.7 (CH), 124.2 (CH), 124.8 (CH), 148.1 (C), 148.3 (C), 155.6 
(C), 159.6 (C); MS (ES
+
) m/z 291 [M+Na]
+
; HRMS (ES
+
) calc. for C14H12N4NaO2 = 
291.0852, found 291.0857.  
 
cis-(4-Aziridin-1-yl-phenyl)-(4-nitro-phenyl)-diazene (cis-90) 
 
A novel compound synthesised using standard photochemical 
isomerisation techniques. trans-90 (6 mg, 0.012 mmol ) was 
dissolved in toluene-d8 (0.6 mL) then filtered into an NMR tube. 
The tube was suspended at the front of a 2 L beaker containing ice / water. The tube 
was irradiated with a 125 W medium pressure mercury lamp through a window of 
glass bandpass filter focused around 390 nm (Schott FSQ-UG1 UV bandpass filter). 
After being irradiated for 3 h the sample was removed and stored in ice until 
immediate NMR experiments could be performed. 
1
H NMR (400 MHz, Toluene-d8) 
δ 1.56 (4H, s, NCH2), 6.32 (2H, d, J = 8.8, ArH), 6.47 (2H, d, J = 8.8, ArH), 6.64 
(2H, d, J = 8.8, ArH), 7.59 (2H, d, J = 8.8, ArH). 
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trans-(4-Aziridin-1-yl-phenyl)-(4-nitro-phenyl)-diazene (trans-90) 
 
An NMR tube containing cis-90 (6 mg, 0.012 mmol) in 
toluene-d8 (0.6 mL) was immersed in an oil bath at 60 
o
C 
for 10 minutes resulting in complete regeneration of 
trans-90. The process of photochemical conversion and thermal reconversion was 
repeated three times in succession with no losses in conversion or degradation of the 
compounds. In fact over a period of weeks and many switching cycles very little 
degradation was observed. 
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3.3 Photoactivated Biologically Relevant β-lactams Experimental 
3.3.1 Biological Testing Procedures 
The agar plates were prepared using the following method. A 1% agar solution was 
warmed and 10 mL poured into each petri dish under a filtered atmosphere, and 
allowed to set overnight. The following day, two tubes (5 mL) of top agar (0.5%) 
were melted in a water bath, allowed to reach body temperature and inoculated with 
either B.Subtilis or E.Coli. Before the agar set it was poured evenly over the set agar 
plate to form one continuous thin layer. 
 
The compounds to be tested were dissolved in DMSO (20 μL) at various loadings up 
to 500 μg. The 20 µL aliquots were then placed on filter paper disks using an 
Eppendorf micropipette. The disks containing the test compounds, DMSO (20 µL) 
and ampicillin (20 µg) in water (20 μL) were placed on top of the set top agar in a 
predetermined pattern. The plates were then incubated overnight at 37 
o
C and the 
bacterial lawn growth observed. 
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9-Anthroyl chloride (142) 
 
A known compound synthesised using a published procedure.
183
 
Anthracene-9-carboxylic acid 141 (2.00 g, 9.00 mmol, 1.0 eq) was 
suspended in thionyl chloride (9.80 g, 83.0 mmol, 9.2 eq). The mixture was heated to 
reflux overnight then cooled to room temperature and concentrated in vacuo. The 
solid was washed twice with diethyl ether (2 mL then 12 mL) then the organics 
concentrated in vacuo yielding 142 as a yellow solid (1.68 g, 78%) This solid was 
very unstable and was therefore used immediately. IR (thin film) 3053, 1777, 1041, 
864, 782, 719 cm
-1
. 
 
Anthracene-9-carboxylic acid anthracen-9-ylamide (136) 
 
A reported compound but with limited data, synthesised using the 
documented procedure.
162
 To 9-aminoanthracene 59 (1.36 g, 7.00 
mmol, 1.0 eq) and 9-anthroyl chloride (1.70 g, 7.00 mmol, 1.0 eq) 
was added toluene (76 mL) and pyridine (2.5 mL) and the 
resulting mixture was heated to reflux overnight. The reaction mixture was cooled 
and the precipitate filtered off. The remaining solid was washed well with 5% HCl 
then dried (MgSO4) and concentrated in vacuo. The crude solids were combined and 
recrystallised from benzene to yield 136 as a light yellow powder (876 mg, 32%). 
m.p. 285 – 287 oC (Benzene) (Lit. 302 – 304 oC); IR (thin film) 3261, 3044, 1649, 
1480, 1214, 879, 726 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.53 – 7.70 (8H, m, ArH), 
8.07 – 8.16 (5H, m, NH, ArH), 8.42 (2H, d, J = 8.8, ArH), 8.55 (1H, s, ArH), 8.60 
(2H, d, J = 8.8, ArH), 8.63 (1H, s, ArH); 
13
C NMR (100 MHz, CDCl3) δ 123.3 (CH), 
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125.3 (CH), 125.5 (CH), 125.8 (CH), 126.8 (CH), 127.2 (CH), 127. 4 (C), 127.7 
(CH), 128.4 (C), 128.6 (C), 128.9 (CH), 129.0 (CH), 131.9 (C), 148.3 (CH), 148.6 
(C), 169.2 (C=O); MS (ES
+
) m/z 398 [M+H]
+
, 420 [M+Na]
+
; HRMS (ES
+
) calcd. 
For C29H19NNaO = 420.1359 [M+Na]
+
, found 420.1363. 
 
4-Methoxybenzyl bromide (184) 
 
A compound synthesised using a reported procedure.
184
 To a solution of 4-
methoxybenzyl alcohol (7.10 g, 52.0 mmol, 3.0 eq) in dichloromethane (75 
mL) at 0 
o
C was slowly added phosphorus tribromide (4.42 g, 16.5 mmol, 
1.0 eq) and the mixture stirred for 12 h. The mixture was poured into saturated 
sodium bicarbonate (150 mL) and extracted with dichloromethane (3 x 50 mL), dried 
(MgSO4) then concentrated in vacuo. The resulting yellow oil 183 was used without 
further purification (10.4 g, 99%). 
1
H NMR (400 MHz, CDCl3) δ 3.84 (3H, s, CH3), 
4.54 (2H, s, CH2), 6.91 (2H, d, J = 8.6, ArH), 7.37 (2H, d, J = 8.6, ArH); 
13
C NMR 
(100 MHz, CDCl3) δ 34.5 (CH2), 55.4 (CH3), 114.6 (CH), 129.8 (C), 130.2 (CH), 
159.7 (C); MS (ES
+
) m/z 201 [
79
BrM+H]
+
, 203 [
81
BrM+H]. 
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Anthracene-9-carboxylic acid anthracen-9-yl-methyl-amide (143) 
 
A novel compound prepared using standard alkylation procedures. 
Sodium hydride 60% in mineral oil (57 mg, 1.41 mmol, 2.0 eq) 
was washed with dry pentane (2 x 1 mL) and dried in vacuo. It 
was then suspended in THF (12.8 mL) and cooled to 0 
o
C. A 
solution of 136 (280 mg, 0.71 mmol, 1.0 eq) in THF (11.2 mL) was also cooled to 0 
o
C then added dropwise. After stirring for 30 minutes at 0 
o
C methyl iodide (120 mg, 
53 μl, 0.85 mmol, 1.2 eq) was added dropwise. The mixture was allowed to warm 
and stirred overnight. The reaction mixture was quenched with water (100 mL) and 
extracted with dichloromethane (3 x 60 mL). The combined organics were washed 
with water (60 mL), dried (MgSO4) and concentrated in vacuo. Purification was 
attempted by flash chromatography (10% EtOAc in petrol) however, spontaneous 
isomerisation in ambient light led to poor poor mass recovery. Rf = 0.44 (20% 
EtOAc in petrol); IR (thin film) 3044, 2360, 1750, 1453, 1379, 1291, 1015, 788, 722, 
719 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.18 (3H, s, CH3), 7.57 – 7.64 (4H, m, 
ArH), 7.69 – 7.78 (4H, m, ArH), 8.15 (2H, d, J = 8.4, ArH), 8.16 (2H, d, J = 8.4, 
ArH), 8.47 (2H, d, J = 8.9, ArH), 8.56 – 8.64 (4H, m, ArH); MS (ES+) m/z 412 
[M+H]
+
. 
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N-(Anthracene-9-carbonyl)-N-anthracen-9-yl-methanesulfonamide (144) 
 
A novel compound prepared using standard alkylation procedures. 
Sodium hydride 60% in mineral oil (10 mg, 0.25 mmol, 2.0 eq) 
was washed with dry pentane (2 x 1 mL) and dried in vacuo. It 
was then suspended in THF (2.3 mL) and cooled to 0 
o
C. A 
solution of 136 (50 mg, 0.13 mmol, 1.0 eq) in THF (2.5 mL) was also cooled to 0 
o
C 
then added dropwise. After stirring for 30 minutes at 0 
o
C, mesyl chloride (22 mg, 
0.19 mmol, 1.2 eq) was added. The mixture was allowed to warm and stirred 
overnight. The reaction mixture was quenched with water (25 mL) and extracted 
with dichloromethane (3 x 15 mL). The combined organics were washed with water 
(15 mL), dried (MgSO4) and concentrated in vacuo. The product was purified by 
column chromatography through silica gel (39% dichloromethane, 1% acetone in 
petrol) then triturated in diethyl ether. The product was found to isomerise in 
ambient light during purification resulting in poor mass recovery (20 mg, 32%). Rf = 
0.24 (39% dichloromethane, 1% acetone in petrol); MS (ES
+
) m/z 498 [M+H
+
] 
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N-(Anthracene-9-carbonyl)-N-anthracen-9-yl-4-methyl-benzenesulfonamide 
(145) 
 
A novel compound prepared using standard alkylation 
procedures. Sodium hydride 60% in mineral oil (10 mg, 0.25 
mmol, 2.0 eq) was washed with dry pentane (2 x 1 mL) and 
dried in vacuo. It was then suspended in THF (2.3 mL) and 
cooled to 0 
o
C. A solution of 136 (50 mg, 0.13 mmol, 1.0 eq) in THF (2.5 mL) was 
also cooled to 0 
o
C then added dropwise. After stirring for 15 minutes at 0 
o
C, tosyl 
chloride (30 mg, 0.15 mmol, 1.2 eq) was added. The mixture was allowed to warm 
to rt and stirred overnight. The reaction mixture was quenched with water (15 mL) 
and extracted with dichloromethane (3 x 5 mL). The combined organics were 
washed with water (5 mL), dried (MgSO4) and concentrated in vacuo. Purification 
was attempted by flash chromatography (10% EtOAc in petrol) however, 
spontaneous isomerisation in ambient light led to poor poor mass recovery. Rf = 0.31 
(10% EtOAc in petrol); 
1
H NMR (400 MHz, CDCl3) δ 2.58 (3H, s, CH3), 7.15 – 7.22 
(2H, m, ArH), 7.53 – 7.69 (8H, m, ArH), 8.04 – 8.15 (4H, m, ArH), 8.32 – 8.45 (4H, 
m, ArH), 8.51 – 8.64 (4H, m, ArH); MS (ES+) m/z 574 [M+Na+]. 
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Anthracene-9-carboxylic acid anthracen-9-yl-(4-methoxy-benzyl)-amide (146) 
 
A novel compound prepared using standard alkylation 
procedures. Sodium hydride 60% in mineral oil (33 mg, 
0.76 mmol, 2.0 eq) was washed with dry pentane (2 x 1 mL) 
and dried in vacuo. It was then suspended in THF (7 mL) 
and cooled to 0 
o
C. A solution of 136 (150 mg, 0.38 mmol, 1.0 eq) in THF (7.5 mL) 
was also cooled to 0 
o
C then added dropwise. After stirring for 30 minutes at 0 
o
C, 4-
methoxybenzyl bromide (115 mg, 0.57 mmol, 1.2 eq) was added dropwise. The 
mixture was allowed to warm to rt and stirred for 3 days. The reaction mixture was 
quenched with water (25 mL) and extracted with dichloromethane (3 x 15 mL). The 
combined organics were washed with water (15 mL), dried (MgSO4) and 
concentrated in vacuo. The product was used without further purification due to 
spontaneous isomerisation in ambient light. Rf = 0.32 (39% dichloromethane, 1% 
acetone in petrol); MS (ES
+
) m/z 518 [M+H
+
]. 
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 [(Anthracene-9-carbonyl)-anthracen-9-yl-amino]-acetic acid ethyl ester (147) 
 
A novel compound prepared using standard alkylation 
procedures. The entire preparation and purification of this 
compound was carried out in a dark room using only red light. 
Sodium hydride 60% in mineral oil (39 mg, 0.95 mmol, 2.0 eq) 
was washed with dry pentane (2 x 3 mL) and dried in vacuo. It was then suspended 
in THF (8.4 mL) and cooled to 0 
o
C. A solution of 136 (188 mg, 0.47 mmol, 1.0 eq) 
in THF (9 mL) was also cooled to 0 
o
C then added dropwise. After stirring for 30 
minutes at 0 
o
C, ethyl bromoacetate (119 mg, 0.71 mmol, 1.2 eq) was added 
dropwise. The mixture was allowed to warm and stirred overnight in the dark. 
Methanol (0.2 mL) was added and the mixture concentrated in vacuo. The resulting 
solid was dissolved in dichloromethane (20 mL) and washed with water (3 x 7 mL), 
dried (MgSO4) and concentrated in vacuo. The solid was purified by column 
chromatography (39.5% dichloromethane, 0.5% acetone in petrol) then (0.1% 
methanol in dichloromethane) yielding a yellow / green solid (46 mg, 20%) limited 
data was obtained due to instability in ambient light. Rf = 0.34 (39% 
dichloromethane, 1% acetone in petrol); 
1
H NMR (400 MHz, CDCl3) δ 0.70 (1.77H, 
t, J = 7.2, CH3, minor), 1.38 (3H, t, J = 7.1, CH3, major), 3.46 (1.1H, q, J = 7.2, 
CH2CH3, minor), 4.22 (1.1H, s, CH2), 4.38 (2H, q, J = 7.1, CH2CH3, major), 4.99 
(2H, s, CH2, major), 7.02 – 7.18 (8H, m, ArH), 7.33 – 7.45 (4H, m, ArH), 7.51 – 
7.59 (2.31H, m, ArH), 7.62 – 7.73, (4.28H, m, ArH), 8.04 – 8.12 (2.26H, m, ArH), 
8.29 (2H, d, J = 8.8, ArH), 8.42 (1.1H, d, J = 8.7, ArH), 8.46 (2H, d, J = 8.8, ArH), 
8.53 – 8.60 (2.11H, m, ArH); MS (ES+) m/z 484 [M+H]+.  
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2a,7:8,12b-Di-o-benzenodibenzo[3,4:7,8]cycloocta[1,2-b]azet-2(1H)-one,7,8-
dihydro-1-methyl-(8CI) (148) 
 
A novel compound prepared using standard photochemical 
isomerisation conditions. 143 (25 mg, 0.061 mmol) was 
transferred to a Shlenk tube using a small quantity of 
dichloromethane (5 mL) then dried in vacuo. Benzene (50 mL) was added and the 
solution degassed by freeze pump thaw cycles under argon. Sonication was applied 
during thawing and argon bubbled through for 10 minutes after thawing. This 
process was repeated 5 times. The solution was then irradiated with a 125 W 
medium pressure Hg lamp for 1 h. The paler solution was then concentrated in 
vacuo. Purification by flash chromatography (6:4:0.1 
petrol:dichloromethane:acetone) and trituration with diethyl ether yielded 148 as a 
white solid (14 mg, 56%). m.p. 280 
o
C (dec); Rf 0.26 (6:4:0.1 
petrol:dichloromethane:acetone); IR (thin film) 2364, 1751, 1453, 1378, 1292, 1016, 
789, 722, 701 cm
-1
: 
1
H NMR (400 MHz, CDCl3) δ 3.50 (3H, s, CH3), 4.56 (1H, d, J 
= 11.0, Ar2CH), 4.65 (1H, d, J = 11.0, Ar2CH), 6.85 – 6.97 (12H, m, ArH), 6.99 – 
7.12 (2H, m, ArH), 7.18 – 7.26 (2H, m, ArH); 13C NMR (100 MHz, DMSO-d6) δ 
28.2 (CH3), 51.1 (CH), 51.8 (CH), 122.4 (CH), 123.6 (CH), 125.6 (CH), 125.8 (CH), 
126.4 (CH), 126.5 (CH), 127.4 (CH), 127.8 (CH), 138.8 (C), 140.0 (C), 141.6 (C), 
142.1 (C) 2 x (C), 1 x (C=O) not observed; MS (ES
+
) m/z 434 [M+Na]
+
; HRMS 
(ES
+
) calcd. For C30H21NNaO = 434.1515 [M+Na]
+
, found 434.1510.  
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2a,7:8,12b-Di-o-benzenodibenzo[3,4:7,8]cycloocta[1,2-b]azet-2(1H)-one,7,8-
dihydro-1-(methanesulfonamide)-(8CI) (149) 
 
A novel compound prepared using standard photochemical 
isomerisation conditions. 144 (19.7 mg, 0.041 mmol) was 
transferred to a Shlenk tube using dichloromethane (5 mL) then 
dried in vacuo. Benzene (50 mL) was then added and the solution degassed by freeze 
pump thaw under argon. Sonication was applied during thawing and argon bubbled 
through for 10 minutes after thawing. This process was repeated 5 times. The 
solution was then irradiated by a 125 W medium pressure Hg lamp for 1 h. The paler 
solution was then concentrated in vacuo. Purification by flash chromatography 
(6:4:0.05 petrol:dichloromethane:acetone) and trituration with diethyl ether yielded 
149 as a white solid (13 mg, 65%). m.p. 200 
o
C (dec.); Rf = 0.28 (6:4:0.05 
petrol:dichloromethane:acetone); IR (thin film) 3036, 2927, 1746, 1454, 1349, 1165, 
724 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.86 (3H, s, CH3), 4.61 (1H, d, J = 11.1, 
CH), 4.68 (1H, d, J = 11.1, CH), 6.85 – 7.05 (12H, m, ArH), 7.07 – 7.14 (2H, m, 
ArH), 7.26 – 7.32 (2H, m, ArH); 13C NMR (175 MHz, CDCl3) δ 43.4 (CH3), 52.4 
(CH), 52.9 (CH), 78.4 (C), 84.4 (C), 123.5 (CH), 124.2 (CH), 126.27 (CH), 126.31 
(CH), 127.3 (CH), 127.4 (CH), 127.5 (CH), 128.0 (CH), 136.8 (C), 138.1 (C), 140.6 
(C), 141.6 (C), 165.5 (C=O); MS (ES
+
) m/z 498 [M+Na]
+
; HRMS (ES
+
) Calc. For 
C30H21NNaO3S =498.1134 [M+Na]
+
, Found = 498.1133. 
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2a,7:8,12b-Di-o-benzenodibenzo[3,4:7,8]cycloocta[1,2-b]azet-2(1H)-one,7,8-
dihydro-1-(4-methoxy-benzyl)-(8CI) (151) 
 
A novel compound prepared using unusual photochemical 
isomerisation conditions. 146 (19.7 mg, 0.041 mmol) was 
dissolved in laboratory grade chloroform (200 mL) and stirred in 
a direct sunlight for 4 h. The paler solution was then concentrated 
in vacuo. Purification by flash chromatography (6:4:0.05 
petrol:dichloromethane:acetone) and trituration with diethyl ether yielded 151 as a 
white solid (70 mg, 36% over 2 steps). m.p. 200 
o
C (dec.); Rf = 0.34 (6:4:0.1 
petrol:dichloromethane:acetone); IR (thin film) 1744, 1510, 1454, 1248, 1028, 791, 
722 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.89 (3H, s, OCH3), 4.56 (1H, d, J = 10.9, 
CH), 4.65 (1H, d, J = 10.9, CH), 4.93 (2H, s, CH2) 6.75 – 6.95 (12H, m, ArH), 7.00 
(4H, d, J = 8.5, ArH), 7.21 – 7.27 (2H, m, ArH), 7.63 (2H, d, J = 8.5, ArH); 13C 
NMR (175 MHz, CDCl3) δ 46.9 (CH2), 52.6 (CH), 53.2 (CH3), 55.3 (CH), 77.5 (C), 
79.0 (C), 114.3 (CH), 123.4 (CH), 124.6 (CH), 125.9 (CH), 126.0 (CH), 126.5 (CH), 
126.6 (CH), 127.4 (CH), 127.6 (CH), 129.8 (C), 130.2 (CH), 138.9 (C), 140.0 (C), 
141.5 (C), 141.7 (C), 159.2 (C), 167.7 (C=O); MS (ES
+
) m/z 518 [M+H]
+
, 540 
[M+Na]
+
; HRMS (ES
+
) Calc. For C37H27NNaO2 = 540.1934[M+Na]
+
, Found = 
540.1946. 
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2a,7:8,12b-Di-o-benzenodibenzo[3,4:7,8]cycloocta[1,2-b]azet-2(1H)-one,7,8-
dihydro-1-(acetic acid ethyl ester)-(8CI) (152) 
 
A novel compound prepared using standard photochemical 
isomerisation conditions. Crude 147 (69 mg, 0.14 mmol) was 
dissolved in dichloromethane (10 mL) and 5 mL added to two 
schlenk tubes (100 mL) then dried in vacuo. Benzene (50 mL) 
was added to each and the solution degassed by freeze pump thaw under argon. 
Sonication was applied during thawing and argon bubbled through for 10 minutes 
after thawing. This process was repeated 5 times. The solution was then irradiated by 
a 125 W medium pressure Hg lamp for 1 h. The paler solution was then concentrated 
in vacuo. Purification by flash chromatography (6:4:0.05 
petrol:dichloromethane:acetone) and trituration with diethyl ether yielded 152 as a 
white solid (60 mg, 33% over 2 steps). m.p. 200 
o
C (dec.); Rf = 0.22 (6:4:0.05 
petrol:dichloromethane:acetone); IR (thin film) 3038, 1746, 1470, 1383, 1202, 790, 
724 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 1.43 (3H, t, J = 7.1, CH2CH3), 4.46 (2H, q, 
J = 7.1, CH2CH3), 4.49 (2H, s, NCH2CO), 4.58 (1H, d, J = 11.1, CH), 4.66 (1H, d, J 
= 11.1, CH), 6.85 – 6.98 (10H, m, ArH), 7.00 – 7.06 (2H, m, ArH), 7.08 – 7.14 (2H, 
m, ArH), 7.25 – 7.32 (2H, m, ArH); 13C NMR (175 MHz, CDCl3) δ 14.2 (CH3), 44.5 
(CH2), 52.6 (CH), 53.1 (CH), 62.1 (CH2), 77.9 (C), 78.0 (C), 122.6 (CH), 124.7 
(CH), 126.0 (CH), 126.1 (CH), 126.2 (CH), 126.6 (CH), 126.8 (CH), 127.5 (CH), 
127.6 (CH), 138.5 (C), 140.1 (C), 141.6 (C), 166.9 (C=O), 167.6 (C=O); MS (ES
+
) 
m/z 484 [M+H]
+
, 506 [M+Na]
+
; HRMS (ES
+
) Calc. For C33H25NNaO3 = 506.1727 
[M+Na]
+
, Found = 506.1734. 
 
Experimental  Alexander J Hough 
 
- 187 - 
 
2a,7:8,12b-Di-o-benzenodibenzo[3,4:7,8]cycloocta[1,2-b]azet-2(1H)-one,7,8-
dihydro-1-(acetic acid)-(8CI) (154) 
 
A novel compound prepared using standard hydrolysis conditions. 
152 (90 mg, 0.19 mmol) was dissolved in a 50:50 mixture of THF 
and water (4 mL), powdered NaOH (15 mg, 0.38 mmol, 2.0 eq) 
was added, and the mixture stirred for 2.5 h. The solution was 
diluted with water (10 mL) and acidified with 1M HCl until pH = 1 (litmus). This 
was then extracted with dichloromethane (3 x 15 mL), the combined organics were 
washed with water (10 mL), dried (MgSO4) and concentrated in vacuo yielding 154 
as a white solid which did not require further purification (72 mg, 83%). m.p. 200 
o
C 
(dcc.); IR (thin film) 3042, 2360, 1764, 1715, 1453, 1193, 788, 725, 702 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 4.57 (2H, s, CH2), 4.66 (1H, d, J = 11.1, CH), 4.73 (1H, 
d, J = 11.1, CH), 6.85 (4H, m, ArH), 6.89 (4H, m, ArH), 7.01 (2H, m, ArH), 7.05 
(2H, m, ArH), 7.15 (2H, m, ArH), 7.18 (2H, m, ArH); 
13
C NMR (100 MHz, DMSO-
d6) δ 44.1 (CH2), 51.3 (CH), 51.7 (CH), 76.6 (C), 77.0 (C), 122.8 (CH), 123.8 (CH), 
125.56 (CH), 125.64 (CH), 126.4 (CH), 127.2 (CH), 127.7 (CH), 138.7 (C), 140.1 
(C), 141.5 (C), 142.1 (C), 165.7 (C=O), 169.3 (C=O); MS (ES
+
) m/z 478 [M+Na]
+
; 
HRMS (ES
+
) Calc. For C31H21NNaO3 = 4748.141 [M+Na]
+
, Found = 478.1419 . 
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[(Anthracene-9-carbonyl)-anthracen-9-yl-amino]-acetic acid (155) 
 
A novel compound synthesised using standard hydrolysis 
conditions. In a dark room, 147 (46 mg, 0.095 mmol, 1.0 eq) 
was dissolved in a 1:1 mixture of THF:water (2 mL). Sodium 
hydroxide (8 mg, 0.19 mmol, 2.0 eq) was added and the mixture 
stirred at room temperature overnight. No reaction was observed by TLC so the 
mixture was heated to reflux for 6 h then allowed to cool to room temperature. The 
solution was diluted with water (10 mL) and acidified with 1M HCl until pH = 1 
(litmus). This was then extracted with dichloromethane (3 x 15 mL), the combined 
organics were washed with water (10 mL), dried (MgSO4) and concentrated in vacuo 
yielding 154 as a yellow solid which did not require further purification (19 mg, 
44%). Limited data was obtained due to poor stability. 
1
H NMR (300 MHz, Acetone 
d6) δ 5.13 (2H, s, CH2), 7.17 – 7.37 (8H, m, ArH), 7.51 – 7.71 (4H, m, ArH), 8.01 
(1H, s, ArH), 8.07 (1H, s, ArH), 8.49 – 8.57 (2H, m, ArH), 8.83 (2H, d, J = 8.8, 
ArH); MS (ES
+
) m/z 456 [M+H]
+
. 
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4-Methoxypyridine N-oxide (165) 
 
A known compound synthesised using a published procedure.
185
 Sodium 
(1.50 g, 65.2 mmol, 2.0 eq) was dissolved in MeOH (100 mL) at 0 
o
C. When 
hydrogen evolution had stopped 4-nitropyridine N-oxide (5.01 g, 35.8 mmol, 
1.0 eq) was added and the mixture heated to reflux overnight. The reaction mixture 
was cooled to room temperature and quenched carefully with saturated ammonium 
chloride solution (30 mL) then extracted with CHCl3 (4 x 100 mL). The combined 
organics were washed with water (50 mL), brine (50 mL) then dried (MgSO4) and 
concentrated in vacuo yielding 165 a white solid which was used without further 
purification, (3.95 g, 90%). 
1
H NMR (300 MHz, CDCl3) δ 3.85 (3H, s, CH3), 6.79 
(2H, d, J = 7.7, ArH), 8.11 (2H, d, J = 7.7, ArH); 
13
C NMR (75 MHz, CDCl3) δ 56.2 
(CH3), 111.9 (CH), 140.2 (CH), 158.0 (C); MS (ES
+
) m/z 126 [M+H]
+
, 148 
[M+Na]
+
. 
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4-Methoxy-2-pyridone (167) 
 
A known compound synthesised using a known procedure.
186
 4-
methoxypyridine N-oxide (2.48 g, 19.8 mmol) was dissolved in acetic 
anhydride (80 mL) and heated to reflux for 6 h. The solvent was removed 
in vacuo and the intermediate purified by kugelrohr distillation (90 
o
C, 2 mbar). The 
product was dissolved in methanol (10 mL) and water (10 mL) and stirred at room 
temperature for 1 h. The solvent was removed in vacuo and the resulting solid 
recrystallised from acetonitrile producing 167 as colourless flakes (960 mg, 39%). IR 
(thin film) 3078, 2943, 2834, 2361, 2341, 1648, 1576, 1483, 1427, 1341, 1209, 1023, 
851, 777 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.77 (3H, s, CH3), 5.87 (1H, d, J = 2.5, 
ArH), 5.96 (1H, dd, J = 7.3, 2.5, ArH), 7.20 (1H, d, J = 7.3, ArH), 12.98 (1H, s, 
NH); 
13
C NMR (100 MHz, CDCl3) δ 55.5 (CH3), 97.2 (CH), 101.3 (CH), 134.7 
(CH), 167.5 (C), 169.9 (C); MS (ES
+
) m/z 126 [M+H]
+
, 148 [M+Na]
+
. 
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5-Methoxy-2-aza-bicyclo[2.2.0]hex-5-en-3-one (168) 
 
A known compound synthesised using a modified procedure.
186
 Anhydrous 
acetonitrile (500 mL) was degassed by freeze pump thaw then added via 
cannula to 4-methoxy-2-pyridine (150 mg, 1.20 mmol) in a large Schlenk 
tube. This solution was stirred and irradiated with a 125 W medium pressure Hg 
lamp through a < 355 nm cut off filter for 1 day. After irradiation the solution was 
concentrated in vacuo then purified by column chromatography (40 – 50% EtOAc in 
petrol) yielding 168 as a white solid (150 mg, quant.). Rf = 0.26 (50% EtOAc in 
petrol). IR (thin film) 1744, 1246,1056 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 3.70 
(3H, s, CH3), 4.16 – 4.21 (1H, m, CH), 4.23 (1H, d, J = 2.5, CH), 5.18 (1H, d, J = 
1.1, CH), 7.37 (1H, s, NH); 
13
C NMR (100 MHz, acetone-d6) δ 42.9 (CH), 57.1 
(CH3), 61.4 (CH), 103.3 (CH), 161.4 (C), 170.5 (C=O); MS (ES
+
) m/z 126 [M+H]
+
, 
148 [M+Na]
+
, 273 [2M+Na]
+
. 
 
  
Experimental  Alexander J Hough 
 
- 192 - 
 
4-Benzyloxypyridine N-oxide (169) 
 
A previously reported compound synthesised using a modified version 
of a reported procedure.
185
 Sodium (0.38 g, 16.3 mmol, 2.0 eq) was 
dissolved in benzyl alcohol (25 mL) at 0 
o
C. When hydrogen evolution 
had stopped, 4-nitropyridine N-oxide (1.14 g, 8.15 mmol, 1.0 eq) was added and the 
mixture heated to reflux overnight. The reaction mixture was cooled to room 
temperature and quenched carefully with saturated ammonium chloride solution (10 
mL) then extracted with CHCl3 (4 x 25 mL). The combined organics were washed 
with water (10 mL), brine (10 mL) then dried (MgSO4) and concentrated in vacuo 
yielding a yellowish solid which was purified by trituration with diethyl ether giving 
169 as a white powder (850 mg, 52%). 
1
H NMR (300 MHz, CDCl3) δ 5.10 (2H, s, 
CH2), 6.86 (2H, d, J = 7.7, ArH), 7.29 – 7.51 (5H, m, ArH), 8.11 (2H, d, J = 7.7, 
ArH); 
13
C NMR (100 MHz, CDCl3) δ 69.8 (CH2), 113.6 (CH), 129.2 (CH), 129.4 
(CH), 129.5 (CH), 136.7 (C), 140.4 (CH), 163.4 (C); MS (ES
+
) m/z 202 [M+H]
+
, 224 
[M+Na]
+
, 403 [2M+H]
+
, 425 [2M+Na]
+
. 
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4-Benzyloxy-2-pyridone (170) 
 
A known compound synthesised using a modified procedure.
186
 4-
benzyloxypyridine N-oxide (0.85 g, 4.1 mmol) was dissolved in 
acetic anhydride (28 mL) and heated to reflux for 6 h. The solvent 
was removed in vacuo and the intermediate purified by kugelrohr distillation 
(110 
o
C, 2 mbar). The product was dissolved in methanol (5 mL) and water (5 mL) 
and stirred at room temperature for 1 h. The solvent was removed in vacuo and the 
resulting solid recrystallised from acetonitrile producing 170 as colourless flakes 
(440 mg, 50%). IR (thin film) 2786, 2360, 1623, 1450, 1201, 996, 819, 776, 739, 
694 cm
-1
; 
1
H NMR (300 MHz, MeOD) δ 5.10 (2H, s, CH3), 5.99 (1H, d, J = 7.4, 
ArH), 6.17 (1H, dd, J = 7.4, 2.5, ArH), 7.27 – 7.47 (6H, m, ArH); 13C NMR (125 
MHz, Acetone-d6) δ 69.7 (CH2), 98.0 (CH), 99.6 (CH), 127.8 (CH), 128.1 (CH), 
128.5 (CH), 134.9 (CH), 136.3 (C), 164.4 (C), 168.1 (C); MS (ES
+
) m/z 224 
[M+Na]
+
, 425 [2M+Na]
+
; HRMS (ES
+
) Calc. For C12H12NO2 = 202.0863 [M+H]
+
, 
Found 202.0868; CHN Calc. For C12H11NO2 C, 71.63 H, 5.51 N, 6.96%, Found C, 
71.54 H, 5.50 N, 6.92%. 
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(4-Methoxy-2-oxo-2H-pyridin-1-yl) acetic acid ethyl ester (175) 
 
A novel compound synthesised using standard alkylation conditions. 4-
Methoxy-2-pyridone (200 mg, 1.60 mmol, 1.0 eq), ethyl bromoacetate 
(267 mg, 1.60 mmol, 1.0 eq) and potassium carbonate (2.00 g, 16.0 
mmol, 10 eq) were dissolved in DMF (4 mL) and stirred at room 
temperature overnight. The mixture was diluted with ammonium chloride (50 mL) 
and extracted with dichloromethane (3 x 25 mL). The combined organics were 
washed with water (6 x 20 mL), brine (20 mL), dried (MgSO4) and concentrated in 
vacuo. The resulting solid was then triturated with diethyl ether leaving 175 as a 
white powder (240 mg, 73%). m.p. 158 - 160 
o
C; IR (thin film) 2360, 1737, 1653, 
1592, 1197, 1018, 821, 795 cm
-1
; 
1
H NMR (300 MHz, MeOD) δ 1.27 (3H, t, J = 7.1, 
CH2CH3), 3.83 (3H, s, OCH3), 4.22 (2H, q, J = 7.1), 4.66 (2H, s, NCH2CO), 5.94 
(1H, d, J = 2.4, ArH), 6.12 (1H, dd, J = 7.6, 2.6, ArH), 7.47 (1H, d, J = 7.6, ArH); 
13
C NMR (75 MHz, MeOD) δ 14.4 (CH3), 51.1 (CH2), 56.4 (CH3), 62.7 (CH2), 97.2 
(CH), 102.8 (CH), 140.3 (CH), 165.1 (C), 170.0 (C=O), 170.3 (C=O); MS (ES
+
) m/z 
234 [M+Na]
+
; HRMS (ES
+
) Calc. For C10H13NNaO4 = 234.0737 [M+Na]
+
, Found 
234.0744; CHN Calc. For C10H13NO4 C, 56.86 H, 6.20 N, 6.63%, Found C, 56.83 H, 
6.18 N, 6.70%. 
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(4-Benzyloxy-2-oxo-2H-pyridin-1-yl) acetic acid ethyl ester (176) 
 
A novel compound synthesised using standard alkylation 
procedures. 4-benzyloxy-2-pyridone (150 mg, 0.75 mmol, 1.0 eq), 
ethyl bromoacetate (125 mg, 0.75 mmol, 1.0 eq) and potassium 
carbonate (956 mg, 7.50 mmol, 10 eq) were dissolved in DMF (3 
mL) and stirred at room temperature overnight. The mixture was diluted with 
ammonium chloride (30 mL) and extracted with dichloromethane (3 x 15 mL). The 
combined organics were washed with water (6 x 10 mL), brine (10 mL), dried 
(MgSO4) and concentrated in vacuo. The resulting solid was then triturated with 
diethyl ether leaving 176 as a white solid (120 mg, 55%). m.p. 171 - 173 
o
C; IR (thin 
film) 2361, 1732, 1662, 1603,1221, 1200, 1024, 728 cm
-1
; 
1
H NMR (300 MHz, 
MeOD) δ 1.27 (3H, t, J = 7.1, CH3), 4.21 (2H, q, J = 7.1, OCH2CH3), 4.66 (2H, s, 
CH2), 5.11 (2H, s, CH2), 6.03 (1H, d, J = 2.7, ArH), 6.18 (1H, dd, J = 7.6, 2.7, ArH), 
7.30 – 7.52 (6H, m, ArH); MS (ES+) m/z 288 [M+H]+, 310 [M+Na]+; HRMS (ES+) 
Calc. For C16H17NNaO4 = 310.1050 [M+Na]
+
, Found 310.1053; CHN Calc. For 
C16H17NO4 C, 66.71 H, 5.96 N, 4.88%, Found C, 66.27, H, 5.91 N, 4.88%.   
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(4-Benzyloxy-2-oxo-2H-pyridin-1-yl)-(4-methoxy-phenyl)-acetic acid ethyl ester 
(177) 
 
A novel compound synthesised using standard alkylation 
procedures. 4-benzyloxy-2-pyridone (150 mg, 0.75 mmol, 1.0 
eq), 174 (204 mg, 0.75 mmol, 1.0 eq) and potassium carbonate 
(956 mg, 7.50 mmol, 10 eq) were dissolved in DMF (3 mL) 
and stirred at room temperature overnight. The mixture was diluted with ammonium 
chloride (30 mL) and extracted with dichloromethane (3 x 15 mL). The combined 
organics were washed with water (6 x 10 mL), brine (10 mL), dried (MgSO4) and 
concentrated in vacuo. The resulting solid was then triturated with diethyl ether 
leaving 177 as a white solid (155 mg, 53%). m.p. 144 - 146 
o
C; IR (thin film) 2361, 
2343, 1750, 1653, 1198, 1176, 1028, 826, 742 cm
-1
; 
1
H NMR (300 MHz, MeOD) δ 
1.25 (3H, t, J = 7.1, CH2CH3), 3.83 (3H, s, OCH3), 4.26 (2H, q, J = 7.1, CH2CH3), 
5.10 (2H, s, CH2Ph), 6.01 – 6.11 (2H, m, ArH), 6.33 (1H, s, CH), 6.98 – 7.09 (3H, 
m, ArH), 7.25 – 7.45 (7H, m, ArH); MS (ES+) m/z 416 [N+Na]+; HRMS (ES+) Calc. 
For C22H23NNaO5 = 416.1468 [M+Na]
+
, Found 416.1480; CHN Calc. For 
C22H23NO5 C, 70.2 H, 5.89 N, 3.56%, Found C, 69.89 H, 5.90 N, 3.59%. 
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5-Benzyloxy-2-aza-bicyclo[2.2.0]hex-5-en-3-one (178) 
 
A known compound synthesised using a modified procedure.
186
 
Anhydrous acetonitrile (250 mL) was degassed by freeze pump thaw then 
added via cannula to 4-methoxy-2-pyridine (80 mg, 0.40 mmol) in a large 
Schlenk tube. This solution was stirred and irradiated with a 125 W medium pressure 
Hg lamp through a <355 nm cut off filter for 1 day. After irradiation the solution was 
concentrated in vacuo then purified by column chromatography (30 – 40% EtOAc in 
petrol) yielding 178 as a white solid (63 mg, 79%). Rf = 0.24 (40% EtOAc in petrol). 
1
H NMR (400 MHz, acetone-d6) δ 2.90 (1H, s, NH), 4.23 – 4.27 (2H, m, CH), 4.96 
(1H, d, J = 12.0, CHH), 4.99 (1H, d, J = 12.0, CHH), 5.25 (1H, d, J = 1.2, =CH), 
7.35 – 7.48 (5H, m, ArH); 13C NMR (100 MHz, acetone-d6) 43.2 (CH), 61.6 (CH), 
72.2 (CH2), 104.5 (CH), 128.7 (CH), 129.0 (CH), 129.3 (CH), 137.2 (C), 160.2 (C), 
170.5 (C=O); MS (ES
+
) m/z 202 [M+H]
+
. 
 
  
Experimental  Alexander J Hough 
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 (5-Benzyloxy-3-oxo-2-aza-bicyclo[2.2.0]hex-5-en-2-yl)-acetic acid ethyl ester 
(179) 
 
A novel compound synthesised using modified photochemical 
procedures.
186
 176 (60 mg, 0.21 mmol) was dissolved in dry 
acetonitrile (200 mL) in a large Schlenk tube and degassed by 
three freeze, pump, thaw cycles under argon. The solution 
was irradiated with a 125 W medium pressure Hg lamp through a <355 nm cut off 
filter for 2 days. The solution was then concentrated in vacuo and the solid purified 
by column chromatography (20 – 30% EtOAc in petrol) to yield 179 as a white solid 
(34 mg, 57%). m.p. 130 
o
C (dec.); Rf 0.68 (50% EtOAc in petrol); IR (thin film) 
3039, 1751, 1717, 1454, 1193, 789, 724, 702 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
1.28 (3H, t, J = 7.2, CH3), 3.60 (1H, d, J = 17.9, CHH), 4.12 – 4.26 (3H, m, 
CH2CH3, CHH), 4.33 (1H, m, CH), 4.41 (1H, d, J = 2.2, CH), 4.86 (1H, d, J = 11.9, 
CHH), 4.91 (1H, d, J = 11.9, CHH), 5.11 – 5.15 (1H, m, =CH), 7.26 – 7.43 (5H, m, 
ArH); 
13
C NMR (100 MHz, CDCl3) δ 14.2 (CH3), 44.7 (CH2), 47.6 (CH), 59.9 (C), 
60.0 (CH), 61.4 CH2), 71.77 (CH2), 101.1 (CH), 127.6 (CH), 128.4 (CH), 128.6 
(CH), 135.4 (C), 158.4 (C), 168.5 (C); MS (ES
+
) m/z 310 [M+Na]
+
, 597 [2M+Na]
+
; 
HRMS (ES
+
) Calc. For C16H17NNaO4 expect 310.1050, Found 310.1053 
  
Experimental  Alexander J Hough 
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(5-Methoxy-3-oxo-2-aza-bicyclo[2.2.0]hex-5-en-2-yl)-acetic acid ethyl ester (180) 
 
A novel compound synthesised using modified alkylation 
conditions.
186
 Lactam 167 (50 mg, 0.40 mmol, 1.0 eq), ethyl 
bromoacetate (67 mg, 0.40 mmol, 1.0 eq) and potassium carbonate 
(500 mg, 4.00 mmol, 10 eq) were dissolved in DMF (1.2 mL) and stirred at room 
temperature overnight. The mixture was diluted with ammonium chloride (15 mL) 
and extracted with dichloromethane (3 x 7.5 mL). The combined organics were 
washed with water (6 x 5 mL), brine (5 mL), dried (MgSO4) and concentrated in 
vacuo. Purification by column chromatography (20 - 30% EtOAc in petrol + 0.1% 
triethylamine) yielded 180 as a colourless oil (32 mg, 38%). Rf = 0.3 (30% EtOAc in 
petrol + 0.1% triethylamine); IR (thin film) 1741, 1612, 1454, 1029 cm
-1
; 
1
H NMR 
(400 MHz, acetone-d6) δ 1.30 (3H, t, J = 7.2, CH3), 3.71 (3H, s, CH3), 3.73 (1H, d, J 
= 17.6, CHH), 4.11 (1H, d, J = 17.6, CHH), 4.20 (2H, q, J = 7.2, CH2), 4.30 (1H, dd, 
J = 2.4, 1.1, CH), 4.38 (1H, d, J = 2.4, CH), 5.27 (1H, d, J = 1.1, =CH) ; 
13
C NMR 
(100 MHz, acetone-d6) δ 14.5 (CH3), 45.2 (CH2), 47.8 (CH), 57.2 (CH3), 59.6 (C), 
60.4 (CH), 61.6 (CH2), 101.3 (CH), 159.2 (C), 169.2 (C=O); MS (ES
+
) m/z 234 
[M+Na]
+
, 445 [2M+Na]
+
; HRMS (ES
+
) Calc. For C16H14NO4 = 212.0917 [M+H]
+
, 
Found 212.0919. 
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APPENDIX 1 – Calculation of Activation Parameters 
 
 
 
Tc Calculations Method 
 
∆G‡ at coalescence 
 
Where ∆G‡ is the Gibbs free energy of activation, R is the gas constant, Tc is the coalescence 
temperature in Kelvin and ∆v is the shift separation in Hz of the fully resolved exchanging signals. 
 
Where Tc = 188 K and ∆υ = 373.2 Hz at 178 K 
∆G‡ @ 188 K = 34.8 KJ mol-1 
 
Line Shape Fitting Method 
Insufficient NMR data obtainable in the slow regime to calculate position of υA and 
υB  
  
)]ln(23[‡


Tc
RTcG
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Tc Calculations Method 
 
∆G‡ at coalescence 
 
Where Tc = 207 K and ∆υ = 296.7 Hz at 183 K 
∆G‡ @ 207 K = 38.9 kJ mol-1 
Line Shape Fitting Method 
T 
(K) va obs vb obs va calc vb calc 
va-vb 
calc va-vb obs Rate K 1/T Ln K Ln (K/T) 
183 890.80 594.00 891.73 592.79 298.95 296.80 92.00 0.0055 4.5218 -0.6877 
188 894.00 600.00 893.24 601.19 292.05 294.00 165.00 0.0053 5.1059 -0.1305 
193 896.00 608.35 894.75 609.59 285.15 287.65 261.00 0.0052 5.5645 0.30183 
198 895.16 619.23 896.26 618.00 278.26 275.93 447.30 0.0051 6.1032 0.81496 
203     897.76 626.40 271.36   833.40 0.0049 6.7255 1.41231 
205     898.37 629.76 268.60   1069.50 0.0049 6.9749 1.65194 
207     898.97 633.13 265.85   1387.50 0.0048 7.2353 1.90254 
209     899.57 636.49 263.09   1674.30 0.0048 7.4232 2.08082 
211     900.18 639.85 260.33   1974.30 0.0047 7.588 2.23611 
213     900.78 643.21 257.57   2394.40 0.0047 7.7809 2.4196 
215     901.38 646.57 254.81   2811.50 0.0047 7.9415 2.57084 
217     901.99 649.93 252.05   3263.50 0.0046 8.0906 2.71066 
219     902.59 653.30 249.30   3921.60 0.0046 8.2743 2.88518 
221     903.19 656.66 246.54   4771.60 0.0045 8.4704 3.07227 
223     903.80 660.02 243.78   5641.70 0.0045 8.6379 3.23077 
228     905.30 668.42 236.88   9141.70 0.0044 9.1206 3.69126 
233     906.81 676.83 229.99   13761.60 0.0043 9.5296 4.0786 
243     909.83 693.63 216.19   31611.70 0.0041 10.361 4.86822 
 
)]ln(23[‡


Tc
RTcG
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y = 0.3016x + 836.54 
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∆H‡ can be calculated from the gradient and ∆S‡ from the intercept using the linear 
form of the Eyring equation.  
 
 
Where: k is the rate constant in s
-1
, T is the temperature in Kelvin, kB is the boltzman constant, h is 
planks constant, R is the gas constant, ∆G‡ is the Gibbs free energy of activation, ∆H
‡
 is the enthalpy 
energy of activation, ∆S‡ is the entropy of activation. 
 
∆G‡ can then be calculated at any temperature using the constant temperature Gibbs 
free energy relationship. 
 
 
H# (kJ/mol) 34.4 
S# (J/Kmol) -16.3 
G# (at 298) 39.2 
G# (at 207) 37.7 
G# (at 223) 38.0 
 
  
cmxy
R
S
h
k
TR
H
Tk B





‡‡
ln
1
)/ln(
‡‡‡ STHG 
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Tc Calculations Method 
 
∆G‡ at coalescence 
 
Where Tc = 223 K and ∆υ = 288.9 Hz at 183 K 
∆G‡ @ 223 K = 42.2 kJ mol-1 
Line Shape Fitting Method 
T 
(K) va obs vb obs va calc vb calc 
va-vb 
calc va-vb obs Rate K 1/T Ln K Ln (K/T) 
183 848.20 558.40 848.30 559.04 289.26 289.80 46.30 0.0055 3.8351 -1.374 
188 850.10 565.50 850.05 564.78 285.27 284.60 49.40 0.0053 3.9 -1.336 
193 852.00 571.00 851.80 570.52 281.28 281.00 82.50 0.0052 4.4128 -0.85 
198 853.40 575.70 853.55 576.26 277.29 277.70 134.60 0.0051 4.9023 -0.386 
203     855.30 582.00 273.30   266.70 0.0049 5.5861 0.2729 
205     856.00 584.30 271.70   323.80 0.0049 5.7801 0.4571 
229     864.40 611.85 252.55   3133.80 0.0044 8.05 2.6163 
231     865.10 614.15 250.95   3603.80 0.0043 8.1897 2.7473 
233     865.80 616.44 249.36   4493.80 0.0043 8.4105 2.9594 
238     867.55 622.18 245.37   7553.80 0.0042 8.9298 3.4575 
243     869.30 627.92 241.38   11583.80 0.0041 9.3574 3.8643 
253     872.80 639.40 233.40   23342.80 0.004 10.058 4.5247 
263     876.30 650.88 225.42   40502.80 0.0038 10.609 5.037 
273     879.80 662.36 217.44   61232.80 0.0037 11.022 5.413 
 
H# (kJ/mol) 35.3 
S# (J/Kmol) -21.4 
G# (at 298) 41.7 
G# (at 207) 39.7 
G# (at 223) 40.1 
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APPENDIX 2 – Photochemical Experimental Setups 
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Appendix 3 – Isomerisation Rate Data 
 
 
Regeneration of trans-90 measured by integration of the well separated aziridine 
1
H NMR signals at 
1.56 ppm in the cis isomer and 1.66 in the trans isomer. 
 
 
Determination of the rate constant. 
 
y = 56.055e-2E-04x 
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